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The majority of cell-to-cell communication relies on the stimulated release of 
neurotransmitter. Two forms of Ca2+-dependent stimulated release, synchronous and 
asynchronous, have been identified. Synchronous release is the initial release that occurs within 
milliseconds of stimulation. Critical for efficient synaptic communication, synchronous release is 
the dominant form of release at most synapses. Alternatively, asynchronous release occurs over 
longer time periods, with implications in synaptic plasticity and development. However, its 
mechanisms are poorly understood.  
Both synchronous and asynchronous release rely on Ca2+ sensors to confer their distinct 
characteristics. Synaptotagmin 1 is widely accepted as the Ca2+ sensor for fast, synchronous 
release, but its role in asynchronous release is unclear. Previous studies have led to the 
hypothesis that synaptotagmin 1, particularly Ca2+ binding by its C2A domain, is needed to 
inhibit aberrant asynchronous fusion events. However, recent studies have raised questions 
regarding the interpretation of the results that led to this conclusion.  
 In chapter 2, I have directly tested the effect of Ca2+ binding by synaptotagmin 1’s C2A 
domain on asynchronous release utilizing an alternant Ca2+-binding mutant. This novel mutation 
was designed to block Ca2+ binding without introducing the artifacts of the original Ca2+-binding 
mutation. By investigating asynchronous events in vivo at the Drosophila neuromuscular 
junction, I found no significant effect on asynchronous release when C2A Ca2+ binding was 
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blocked. Thus, I conclude that Ca2+ binding by synaptotagmin’s C2A domain is not needed for 
regulation of asynchronous release, in contrast to the previous study that inadvertently 
introduced an artifact described below.  
To prevent Ca2+ binding, the original aspartate to asparagine mutations (sytD-N) removed 
some of the negatively-charged residues that coordinate Ca2+. This simultaneously introduced 
aberrant fusion events, because it also interrupted the electrostatic repulsion between 
synaptotagmin’s negatively-charged C2A Ca2+-binding pocket and the negatively-charged 
presynaptic membrane which is required to clamp constitutive SNARE-mediated fusion. 
Previous Reist lab results demonstrate that the sytD-N mutations in the C2A domain are likely 
behaving as ostensibly constitutively bound Ca2+. Indeed, I report that the sytD-N mutation 
displays slower release kinetics. To directly test if this mutation is the cause of the increase in 
asynchronous events, I generated additional mutations that prevent interactions with the 
presynaptic membrane coupled to the originally published sytD-N mutations.  
In chapter 3 of this dissertation, I investigated these novel mutations at the Drosophila 
neuromuscular junction. I reported no increase in asynchronous release relative to control, 
providing evidence that the increased asynchronous events in sytD-N mutants are a result of the 
original mutation acting as an asynchronous sensor. Together, my results contradict the current 
hypothesis in the field and provide the likely mechanism for the increased asynchronous release 
observed in the original study.  
This dissertation also investigated the relatively new role for synaptotagmin mutations in 
the etiology of neuromuscular disease. With increased availability of high-throughput 
sequencing, over 20 candidate genes have been implicated in different forms of congential 
myasthenic syndromes. These inherited disorders are caused by mutations in genes needed for 
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effective neuromuscular signaling. Two families, presenting with similar myasthenic syndromes, 
carry point mutations in the C2B Ca2+ binding pocket of synaptotagmin, expressed as an 
autosomal dominant disorder. One of theses families contains a proline to leucine substitution 
(sytP-L) a residue that had not been previously investigated for synaptotagmin function.  
In chapter 4, I investigated the functional importance of this mutation and created a 
disease model for this familial condition by driving the expression of a homolous proline-leucine 
synaptotagmin substitution in the central nervous system of Drosophila. I demonstrated that the 
proline residue plays a functional role in efficient transmitter release by testing its function in an 
otherwise synaptotagmin null genetic background. Additionally, this mutation displayed 
characteristics similar to the human disorder when expressed in a heterozygous synaptotagmin 
background, similar to the familial expression. Namely, the sytP-L mutants exhibited a decreased 
release probability, which resulted in decreased evoked responses that facilitate upon high 
frequency stimulation, a rightward shift in Ca2+ sensitivity, and behavioral deficits, including 
decreased motor output and increased fatigability. Thus, these studies establish the causative 
nature of the sytP-L mutation in this rare form of congenital myasthenic syndrome and highlight 
the utility of the Drosophila system for disease modeling. 
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CHAPTER 1. OVERVIEW OF SYNAPTIC TRANSMISSION AND  
NEUROMUSCULAR DISEASE 
	  
1.1 Overview  
Nervous system function relies upon the transmission of signals between neurons. 
Neurons transmit information across long distances through action potentials, which generally do 
not propagate between spatially distinct cells. To cross the gap between nerve cells, the majority 
of cell-to-cell signaling relies on release of neurotransmitters. The majority of neurotransmitter 
release from active neurons occurs in a Ca2+ dependent manner at synapses.  
Within synapses, small, synaptic vesicles filled with a quantum of neurotransmitter fuse 
with the presynaptic membrane in a tightly regulated series of steps. There are two distinct forms 
of stimulated Ca2+-dependent fusion and subsequent neurotransmitter release, synchronous and 
asynchronous release. These release events are dependent on Ca2+ sensors. One essential protein, 
synaptotagmin 1, is widely accepted as the Ca2+ sensor for synchronous release. Previous studies 
implicate a regulatory role for synaptotagmin 1 in the other form of stimulated release, 
asynchronous release, but its precise mechanism is unclear. This dissertation investigates 
whether synaptotagmin 1 plays a regulatory role in the asynchronous form of Ca2+-dependent 
release. 
This dissertation also investigates the role of synaptotagmin in a newly characterized 
congenital myasthenic syndrome, a rare subset of neuromuscular disorders caused by genetically 
inherited synaptic protein mutations. As synaptic transmission is tightly regulated, dysfunction of 
any protein needed for release or response of neurotransmitter can result in human disease.  
Multiple diseases at the neuromuscular junction result from dysfunctional synaptic 
proteins. Clinicians diagnose neuromuscular disorders using nerve conduction studies, exercise 
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testing, and genetic sequencing. However, the need to uncover mechanisms mediating these 
disorders is currently unmet. Drosophila offer a quick, economical, and genetically flexible 
method for investigation of rare human diseases. By modeling this newly characterized 
synaptotagmin congenital myasthenic disease using Drosophila, I investigate a causative role in 
a synaptotagmin point mutation in the etiology of disease symptoms and uncover some of its 
mechanistic underpinnings. 
 
1.2 Neuronal structure 
Neuronal structure is highly variable, from long projection neurons in the motor system 
to small bipolar cells of the retina. However, the canonical structure consists of three major 
structures: dendrites, the cell body, and the axon. Dendrites typically project out from a cell body 
to neighboring cells and receive neurotransmitter signals from the presynaptic cell terminal. 
These dendrites respond with small depolarizations or hyperpolarizations that spread passively to 
the axon hillock. The neuronal cell body houses many components typically found in other cells, 
such as the nucleus, smooth and rough endoplasmic reticulum, mitochondria, and golgi 
apparatus. The axon contains the axon hillock, which integrates all depolarizing and 
hyperpolarizing signals received from the dendrites. If the incoming summative signal reaches 
the threshold potential, the cell will fire a self-propagating electrical signal, or action potential, 
down the neuron’s axon, stimulating neurotransmitter release at the axon terminal. This release 
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1.3 Cellular membranes 
The interior and exterior of a neuron is separated by a cellular membrane, which consists 
of a lipid bilayer with outer hydrophilic head groups and inner hydrophobic fatty acid tails. This 
lipid bilayer is impermeable to ions. It is responsible for maintaining ionic and electrical 
gradients between the cytosol and extracellular space. In this way, cellular membranes act as 
capacitors separating charge.  
Controlled ion movement across the membrane is important for electrical activity. Hence, 
the cellular membrane contains many proteins, which allow ions or other proteins access across 
the membrane. These gatekeepers can either be passive, or they can use energy to pump ions 
across the membrane, called active transport. Passive gatekeepers include ion channels, which 
are gated pores that have some selectivity to ions. Some channels allow specific ions to cross the 
membrane and others allow more general ion flux. They can be voltage-gated, which only allow 
ionic flow when the membrane potential is depolarized or hyperpolarized, while others require 
binding of a ligand before allowing ion passage. Channel properties allow the cell to regulate its 
ionic concentrations and thus its electrical signaling. Diseases may arise when these channels 
lose their ability to function correctly, discussed later in this dissertation.  
 
1.4 Action potentials 
An action potential propagates down the axon until it reaches the axon terminal. Here, the 
depolarization opens voltage-gated Ca2+ channels. The concentration of Ca2+ outside the cell is 
much greater than inside. Upon Ca2+ channel opening, Ca2+ enters the presynaptic terminal and 
results in the fusion of neurotransmitter-filled synaptic vesicles with the presynaptic terminal 
membrane. This results in the release of neurotransmitter into the synaptic cleft where it can then 
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generate signals in the next cell. Ca2+-dependent neurotransmitter release will be discussed in 
detail throughout this dissertation.  
 
1.5 Quantal release 
 Identification of individually fusing synaptic vesicles as the source of neurotransmitter 
release was groundbreaking in our understanding of synaptic transmission. Katz and colleagues 
proposed the quantal release hypothesis in the early 1950s [1-3]. Their studies at the frog 
neuromuscular junction identified spontaneous, small postsynaptic voltage changes that occurred 
in the absence of neural activity. These depolarizations resemble end plate potentials (EPPs) 
following an action potential, but on a smaller scale. These events are referred to as miniature 
end-plate potentials (mEPPs). The mEPPs appear to be random and between 0.3 and 0.5 mV. 
This suggests neurotransmitter is being released in discrete packets. Furthermore, they 
hypothesized that an action potential causes the synchronous release of a large number of these 
packets and generates a large EPP.  
The concept that synaptic transmission could be explained by the quantized release of 
neurotransmitter was proposed around the same time that small membranous vesicles within 
nerve terminals were first identified by electron microscopy [4, 5]. Together, these findings led 
to the vesicular hypothesis for neurotransmitter release, which states that each synaptic vesicle 
contains a similar amount of neurotransmitter (1 quantum), and that the transmitter release 
following an action potential results from a discrete number of vesicles fusing synchronously 
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1.6 Modulation of the chemical synapse 
 
The response of a given postsynaptic cell to the same level of activity in a presynaptic 
cell can vary depending on the efficacy of the synapse. Synaptic efficacy is based on many 
factors, including the quantal content (number of neurotransmitter-filled synaptic vesicles that 
fuse in response to a given stimulus) and the type and number of postsynaptic receptors. 
Importantly, these pre- and postsynaptic parameters can be regulated by activity patterns. The 
capacity to modulate synaptic efficacy is an important mechanism underlying learning and 
memory. These activity-dependent changes in synaptic strength are known as synaptic plasticity.  
Experimentally, synaptic plasticity is measured both pre- and postsynaptically. Synapses 
may have high or low quantal content (m) relative to other synapses. m depends on the number of 
vesicles available to fuse (n), and the release probability of each vesicle (p). The release 
probability is dependent on the magnitude and duration of Ca2+ influx, the speed of Ca2+ 
clearance, and the proximity of the Ca2+ sensor to the channel. Presynaptically, the amount of 
neurotransmitter released can be decreased or increased, leading to depressed or facilitated 
responses. Experiments in which two closely spaced stimuli are administered, or paired pulse 
experiments, are commonly used to monitor changes in release probabilities. When the ratio of 
the second response to the first response, or paired pulse ratio (PPR) decreases, it is indicative of 
increased release probability, and decreases are consistent with decreased release probability [6]. 
High quantal content synapses result in large responses in the postsynaptic cell upon single 
stimulations, barring any postsynaptic adaptations. Alternatively, low quantal content synapses 
have the opposite characteristics and result in smaller postsynaptic responses.  
Depression can be observed in high quantal content synapses during paired pulse 
experiments, in which two closely spaced stimuli are administered to a cell [7, 8]. At high 
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quantal content synapses, the first stimulation is sufficient to release a large fraction of the 
readily releasable vesicles. Accordingly, there are fewer vesicles available to fuse during the 
second stimulus, which results in a reduced postsynaptic response. Therefore, the first response 
is robust, while the second response is reduced. Another example of synaptic depression occurs 
during presynaptic high-frequency stimulus trains [9, 10]. Since exocytosis is more rapid than 
endocytosis, such stimulation depletes the readily releasable pool of synaptic vesicles, even at 
low quantal content synapses, and quantal content is decreased.  
Facilitation is an incremental increase in the postsynaptic response to a given presynaptic 
stimulation observed in paired pulse experiments at low quantal content synapses. Since the first 
stimulus at such a synapse results in the fusion of only a small fraction of the readily releasable 
pool, the number of vesicles available for fusion following the second impulse is not 
significantly reduced. If the delay between the two stimuli is within tens of milliseconds (ms), 
not all the Ca2+ that entered during the first pulse has been removed by the time of the second 
pulse. Therefore, the [Ca2+] experienced by the release machinery during the second pulse is 
higher and triggers a greater number of synaptic vesicles to fuse. If the delay between stimuli is 
long enough to allow the Ca2+ from the first pulse to be removed, the second response is not 
facilitated. This is known as the residual Ca2+ hypothesis [11-13], and this form of presynaptic 
facilitation is very short-lived. 
Postsynaptically, changes in synaptic activity can lead to changes in the morphological 
makeup of the postsynaptic membrane through insertion or removal of receptors. Any change in 
receptor density results in a change in response strength to a given signal. These changes are 
referred to as either long-term potentiation, which is characterized by a long-lasting facilitated 
response in the postsynaptic cell following a brief tetanic stimulation of a strong input or 
 
	   	   	  7	  
simultaneous stimulation of multiple weaker inputs, or long-term depression, which is a long-
lasting, activity-dependent depressed postsynaptic response induced by prolonged low-frequency 
stimulation [14].  
 
1.7 Active zones 
Functionally, the role of the active zone is to transduce an electrical nerve terminal 
depolarization into neurotransmitter release. Couteaux and Pecot-Dechavassinein coined the term 
“active zone” in 1970 when they noticed docked vesicles at the frog neuromuscular junction 
adjacent to electron dense material at the presynaptic membrane in electron micrographs [15]. 
Subsequent ultrastructure studies revealed similar morphologies across organisms. The structure 
of the active zone material (AZM) varies among different types of synapses, but must include the 
requisite protein machinery for vesicle docking, priming, and fusion. Fusion machinery, Ca2+ 
channels, and Ca2+ sensors are all found at active zones.  
 
Fusion machinery 
 The minimum machinery required to fuse a vesicle with its target membrane is the 
SNARE (SNAP [soluble NSF (n-ethlymaleimide-sensitive factor) attachment protein] receptor) 
fusion complex, which is comprised of a vesicle-associated SNARE protein (vSNARE) and 
target-membrane associated SNARE proteins (tSNAREs). At the synapse, the vSNARE is 
synaptobrevin-2, also known as vesicle-associated membrane protein 2 (VAMP2) and the 
tSNAREs are syntaxin-1 and synaptosomal-associated protein of 25 kDa (SNAP-25).  
 The discovery of SNAREs as the fusion machinery in the late 1980’s and early 1990’s 
have been pivotal in our understanding of neurotransmission. Rothman’s group originally 
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discovered the cytosolic proteins NSF [16] and SNAP [17] in the late 1980’s and suggested their 
importance for membrane fusion [18, 19]. They determined interactions between both NSF, 
SNAP, and an unknown integral membrane protein needed for their interaction [20]. 
Simultaneously, synaptic vesicle and target membrane proteins were being identified [21-25] and 
implicated in neurotransmission through the use of neurotoxins [26-30].  
Together, the seminal study using NSF and SNAP proteins to extract SNAP receptors, or 
SNAREs, from brain tissue was performed. Once purified, the proteins were identified as 
SNAP25, synaptobrevin, and syntaxin [31]. Furthermore, it was shown that without NSF and 
SNAP, the SNAREs form stable complexes [32] that bind much more efficiently if all three are 
present [33].  
Each SNARE protein contains at least one SNARE motif of ~65 residues with a 
propensity to form coiled coils [34]. Synaptotobrevin and syntaxin each contain one SNARE 
motif, and SNAP-25 contains two [35]. Prior to vesicle docking, syntaxin is found in a stable, 
closed conformation, with its SNARE motif bound to a three-helix-bundle regulatory domain, 
making it inaccessible for interactions with other SNARE proteins [36]. Syntaxin undergoes a 
conformational change, which allows its SNARE motif to interact with the SNARE motifs of 
synaptobrevin and SNAP-25. This creates a trans-SNARE complex associated with both the 
vesicular membrane and the presynaptic plasma membrane. The formation of multiple SNARE 
complexes [37] contributes to the energy required to drive fusion of the vesicle and target 
membranes [32, 38]. SNARE complexes mediate both constitutive and regulated vesicle fusion 
events throughout cells.  
The basic concept of the minimal machinery necessary to fuse a vesicular with its target 
membrane is as follows: SNARE proteins on both the vesicular and target membranes associate 
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to form a tight coiled-coil configuration. When maximally coiled, trans-SNARE complexes 
force the two membranes together, thereby destabilizing the membranes’ natural curvature. 
Together with additional proteins such as Ca2+ sensors, fusion of the two membranes occurs. 
Once fused, the vSNAREs and tSNAREs form a cis-SNARE complex, and the vesicular contents 
are released.  
 
Ca2+ channels and sensors  
The presence of voltage-gated Ca2+ channels at active zones is necessary to couple 
neuronal depolarization to vesicle fusion events. Not only do these channels need to be present at 
active zones, their precise localization within an active zone can have immense effects on the 
efficacy of synaptic transmission. Ca2+ channels are located within 50 nm from docked vesicles 
[39-41]. When the cell is depolarized, the Ca2+ channels briefly open, creating a nanodomain of 
particularly high [Ca2+] immediately adjacent to each channel. This [Ca2+] reaches hundreds of 
uM at the mouth of the channel [42] and drops off rapidly with distance [43-46].  
As the availability of Ca2+ is limited temporally and spatially, the closer the channel is 
located to a Ca2+ sensor, the greater the odds of saturating sensor binding and triggering vesicle 
fusion. Even a 5 nm change in the distance between the channel and the sensor has profound 
effects on vesicle release probability [47]. There are multiple Ca2+ sensors that transduce Ca2+ 
influx into neurotransmitter release, such as some synaptotagmins and double C2-containing 
protein (Doc2). These Ca2+ sensors exhibit varying Ca2+ affinities and release kinetics and result 
in differential forms of release, which is a major subject of this dissertation. In particular, I focus 
on synaptotagmin 1, a Ca2+-sensor postulated to perform distinct roles in multiple forms of Ca2+-
dependent release.  
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1.8 Synaptic vesicle cycle 
 Before transmitter release, synaptic vesicles must undergo a distinct, tightly regulated 
series of steps. First, the vesicles are loaded with neurotransmitter and are then transported to the 
active zone. Vesicles are docked to the presynaptic membrane at the active zone by way of 
specific molecular interactions, but only a subset of docked vesicles are fusion competent at any 
given time; namely, those that are maximally primed. In a resting terminal, individual maximally 
primed vesicles can spontaneously fuse with the presynaptic membrane, resulting in the release 
of a single quantum of neurotransmitter. In an activated neuron, the influx of Ca2+ through 
voltage-gated Ca2+ channels initiates a series of steps essential for the evoked release of 
neurotransmitter. Ca2+-sensing proteins activate the fusion machinery, which mediates the fusion 
of multiple maximally primed vesicles with the presynaptic membrane. These fusion events 
result in the release of neurotransmitter into the synaptic cleft. After neurotransmitter release, the 
fusion machinery is disassembled and recycled for subsequent use. Concurrently, the synaptic 
vesicle membrane and associated proteins are retrieved through endocytosis to form new 
synaptic vesicles. This series of distinct events is known as the synaptic vesicle cycle (Fig 1.1). 
This dissertation will focus on the priming and fusion steps.  
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Fig 1.1. Cartoon depiction of the synaptic vesicle cycle. Each tightly regulated step is 
represented with a letter, including vesicle loading with neurotransmitter (a), vesicle docking (b), 
variable vesicle priming (c), maximally-primed, docked vesicle (d), depolarization-triggered 
Ca2+ entry (e), vesicle fusion with presynaptic membrane (f), vesicle membrane collapse (g), 
endocytosis (h), and recycling endosome (i). 
 
 
1.9 Synaptic vesicle priming 
 After a vesicle is docked to the presynaptic membrane, additional interactions increase 
the probability of vesicle fusion. These interactions are termed “priming.” Munc13, an essential 
active zone protein, is thought to orchestrate the first step in fusion machinery assembly (note: 
Munc13 should not to be confused with the SM protein, Munc18). Munc13 binds to the closed 
conformation of syntaxin and facilitates the conformational change in syntaxin from its “closed” 
to its “open” state [36, 48]. Only then can syntaxin’s SNARE motif interact with the SNARE 
motifs of SNAP-25 and synaptobrevin to form the trans-SNARE complex.  
Recent work suggests that vesicle priming is in a state of dynamic equilibrium, such that 
only docked vesicles with the largest area of contact with the presynaptic membrane are 
maximally primed and ready to fuse upon Ca2+ influx [49]. One mechanism of accomplishing 
variable priming would be a balance between the repulsive forces of the vesicular and 
presynaptic membranes that result in SNARE complex uncoiling to favor minimal priming and 
SNARE complex coiling to favor maximal priming [49]. At any given moment, only a 
subpopulation of docked synaptic vesicles has a sufficient number of maximally coiled trans-
SNARE complexes to produce maximal SV-PM contact area (Fig 1.2). These synaptic vesicles 
constitute the maximally primed population that is most likely to fuse upon Ca2+ influx.  
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Fig 1.2. Variable priming of synaptic vesicles. Left, schematic depicting a docked, minimally 
primed vesicle at the presynaptic membrane, defined by the small area of contact between the 
vesicle and plasma membranes. Right, SNARE-coiling pulls the vesicle and presynaptic 
membranes together, increasing the area of contact, resulting in a maximally primed vesicle that 




1.10 Synaptic vesicle fusion 
 At the synapse, fusion events can occur in the absence of stimulation or can be evoked 
when the arrival of an action potential depolarizes the presynaptic terminal. Here, fusion is 
defined as any time a vesicle membrane combines with the presynaptic membrane, releasing its 
contents into the synaptic cleft. Evoked release results from depolarization-dependent Ca2+ 
influx that triggers the fusion of maximally primed vesicles with the presynaptic membrane. 
 
Miniature release 
Miniature release occurs when a single vesicle fuses with the presynaptic membrane in 
the absence of experimental stimulation. These events are thought to result from low probability 
conformational changes that complete coiling of the SNARE proteins. As these spontaneously 
fusing vesicles are in a maximally primed, fusion-competent state, less energy is required to 
overcome the fusion barrier.  
Discovered by Katz and colleagues and deemed “spontaneous miniature end plate 
potentials” at the neuromuscular junction [1, 2], these spontaneously occurring events are 
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observed both peripherally and centrally. Central synapses are innervated by many upstream 
signaling sources, so all stimulation-independent responses (spontaneous events) are difficult to 
differentiate from the events that result from one vesicle fusing with the presynaptic membrane 
(miniature events). To distinguish all spontaneous events from miniature events, researchers 
employ the use of tetrodotoxin, which blocks voltage-gated Na+ channels and prevents 
propagation of upstream action potentials. In this way, only miniature events are recorded.  
At the neuromuscular junction, the innervating nerve is isolated and severed to prevent 
upstream spontaneous signals. Therefore, all recorded events in the absence of stimulation are 
considered miniature events. To support this, the effect of tetrodotoxin to distinguish 
spontaneous events and miniature events at the neuromuscular junction in both invertebrate and 
mammalian systems has been investigated. At these synapses, all recorded spontaneous release is 
largely analogous to miniature events [50, 51]. As the remainder of this dissertation focuses on 
events at the neuromuscular junction, spontaneous release and miniature release will be used 
interchangeably. 
 
Synchronous fusion events 
 Fast, synchronous release of neurotransmitter is the multiquantal stimulated release that 
occurs within ms of depolarization. Synchronous fusion events are Ca2+ dependent, relying on 
the large Ca2+ influx of open Ca2+ channels at active zones. This release is dominant in the 
majority of synapses, and is the canonical release type typically described in textbooks. It is the 
dominant form of release at Drosophila neuromuscular junctions, but becomes less apparent in 
certain synaptic mutants. Synaptotagmins 1 and 2 are Ca2+ sensors responsible for synchronous 
fusion events.  
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Asynchronous fusion events  
 Asynchronous release is another form of Ca2+-dependent release that continues for 100’s 
of ms up to a second following stimulation. While most synapses exhibit little to no asynchronos 
release following a single action potential, it	  is	  still	  observed	  in	  many	  synapse	  types	  [52-­‐61]	  and	  
has	  implications	  in	  synaptic	  plasticity	  [62-­‐65]	  and	  development	  [66,	  67].	  In some specialized 
synapses, such as specific interneurons of the hippocampus and brainstem, asynchronous release 
is predominant [59-61]. Interestingly, asynchronous release is commonly triggered by a single 
action potential at synapses in synaptotagmin 1/2 knockouts, when fast, synchronous release is 
nearly abolished [68]. The total amount of neurotransmitter released remains similar between 
wild type and synaptotagmin knockout neurons, although the method of release has shifted from 
predominantly synchronous to predominantly asynchronous [69, 70]. Asynchronous 
neurotransmitter release is observed in many neuronal types under particular circumstances, such 
as during and following extended high frequency activity. More research is needed for a full 
understanding of this release mechanism.  
 
1.11 Ca2+ sensors for synchronous and asynchronous release 
 Synchronous and asynchronous release phases require Ca2+ sensors with distinct 
characteristics. Synchronous release requires a Ca2+ sensor with fast Ca2+-binding kinetics to 
trigger the fusion of multiple quanta within a few ms, thus nearly simultaneously. The tradeoff 
for these fast binding kinetics is a lower affinity for Ca2+, so more Ca2+ is needed to saturate the 
Ca2+ sensors. Therefore, this Ca2+ sensor only triggers vesicle fusion when [Ca2+] is high. 
Alternatively, asynchronous Ca2+ sensors must exhibit high affinities for Ca2+ with slower Ca2+ 
interaction kinetics, triggering fusion events over a long period of time when [Ca2+] is decreased. 
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The Ca2+ sensors for fast, synchronous release are synaptotagmins 1 and 2. They are both 
located on synaptic vesicles and play functionally homologous roles in different parts of the 
nervous system. In mammals, synaptotagmin 1 is expressed predominantly in the cerebral 
hemispheres, while synaptotagmin 2 is expressed predominantly in the brainstem and spinal cord 
[71, 72]. Drosophila do not have a synaptotagmin 2 gene and synaptotagmin 1 (Dsyt1) is 
responsible for triggering fast, synchronous neurotransmitter release throughout the nervous 
system.  
Synaptotagmins 1 and 2 are low-affinity Ca2+ sensors and only bind Ca2+ when 
intracellular [Ca2+] is very high, as found in Ca2+ nanodomains. Without Ca2+, synaptotagmin 
interacts with SNARE proteins. In the Ca2+-bound state, synaptotagmin interacts with both 
SNARE proteins [73-78] and negatively charged phospholipid membranes in vitro [79-81]. Upon 
Ca2+ binding in vivo, synaptotagmins 1 and 2 trigger the fast, synchronous phase of 
neurotransmitter release [82]. These precise mechanisms are covered in more detail later in this 
chapter.  
 The identity of the Ca2+ sensor for asynchronous release is still debated. Synaptotagmin 7 
and Doc2 are currently the mammalian candidates for the Ca2+ sensor for triggering 
asynchronous neurotransmitter release. They are both enriched at synapses and exhibit high Ca2+ 
affinity and slow Ca2+ interaction kinetics [83-85]. The absence of either Doc2 or synaptotagmin 
7 attenuates asynchronous release in synaptotagmin 1 knockout models, where asynchronous 
release is usually elevated [83, 84].  
Even in the presence of synaptotagmin 1, synaptotagmin 7 knockouts attenuate 
asynchronous release under prolonged stimulation [84], although synaptotagmin 7 null mice are 
viable and fertile [86]. Recently, investigators report synaptotagmin 7’s role as a regulator of 
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asynchronous release at granule cell synapses, also [87]. However, the effect of Doc2 mutants is 
controversial [88, 89]. Doc2 knockout models are not yet available, but rabphilin, a Doc2-like 
protein that contains an additional N-terminal zinc finger domain, knockout mice display no 
obvious phenotype [90]. Additionally, some studies did not observe decreased asynchronous 
release upon Doc2 knockdown, although differences in experimental procedures can complicate 
results [88, 89]. 
 The invertebrate candidate for asynchronous release is unknown. There is very little 
research on the identity of the invertebrate asynchronous sensor. Homologues of mammalian 
candidates Doc2 and synaptotagmin 7 are intuitive candidates. However, Doc2 is not present in 
invertebrate systems, and synaptotagmin 7, although present in Drosophila, displays expression 
patterns not consistent with a role as the Ca2+ sensor needed at active zones for asynchronous 
release. In third instar Drosophila larvae, synaptotagmin 7 is relegated to neuronal cell bodies in 
the central nervous system, and not detectable at the neuromuscular junction [91]. In double 
knockdowns of synaptotagmin 4 and 7, asynchronous release remains intact, eliminating it as the 
asynchronous sensor [92]. In C. elegans, synaptotagmin 7, together with synaptotagmin 4, is 
implicated in somatodendritic dopamine release, but not vesicle release at synaptic terminals 
[93]. Within the last year, a C. elegans neuronal Ca2+-sensing protein (NCS-2) has been 
implicated in asynchronous cholinergic release [94]. However, its Drosophila homologue 
frequenin, a high-affinity Ca2+ sensor present throughout the nervous system, has not been 
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1.12 Synaptotagmin 1 in synchronous release  
Synaptotagmin 1’s role in synchronous release is well elucidated. Originally discovered 
and called p65 [95], Sudhof’s group suggested it plays a role in membrane interactions during 
exocytosis by calling attention to p65’s cytosolic domain that appeared homologous to the C2A 
domain of protein kinase C and could interact with membranes [96]. A year later, they showed 
that p65 (now deemed synaptotagmin) is highly conserved across species, including Drosophila 
[97]. Much like the studies used to isolate the SNARE proteins, they utilized neurotoxins. Using 
the spider venom alpha-latrotoxin, which increases neurotransmitter release, Petrenko et al 
showed the toxin receptor binds specifically to synaptotagmin, suggesting its role in 
neurotransmitter release [98]. Synaptotagmin’s C2 domains bind Ca2+ at physiological levels in a 
complex that contained negatively charged membranes, providing evidence that synaptotagmin 
is a Ca2+ sensor associated with release [99]. Importantly, synaptotagmin was directly linked to 
stimulating fast, synchronous release in 1994, when hippocampal cultures from synaptotagmin 1 
null mice display abolished synchronous release, but asynchronous and spontaneous release 
persisted [100]. 
Synaptotagmin 1 acts as a synchronous Ca2+ sensor in stimulated release. It binds Ca2+ 
by its two C2 domains, C2A and C2B. These Ca2+ binding domains are lined with highly 
conserved negatively charged aspartate residues, resulting in a net negative charge before Ca2+ is 
bound. Ca2+ binding neutralizes the negative charge of the Ca2+ binding pockets and results in a 
net positive charge. This electrostatic change enhances interactions with the negatively charged 
presynaptic membrane and potentially with trans-SNARE complexes [73, 79, 101, 102]. Thus, 
Ca2+ binding allows synaptotagmin 1 to act as an “electrostatic switch” [103-106] from repulsion 
at rest to attraction upon Ca2+ influx.  
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Switching from electrostatic repulsion to electrostatic attraction permits hydrophobic 
residues in synaptotagmin 1’s C2 domains to escape the aqueous cytosol by penetrating into the 
hydrophobic core of the presynaptic membrane [101, 107]. One of these hydrophobic membrane-
penetrating residues in C2A has been studied in vivo and results in a 50% knockdown of function 
when this phenylalanine (F) is mutated to a glutamate (E, P[sytF-E]) [108]. Moreover, when the 
hydrophobic residue found in C2B is mutated to a glutamate, the result is embryonic lethality. 
Therefore, the membrane interactions via these hydrophobic residues are critical for efficient 
synchronous fusion [108]. The insertion of these hydrophobic residues is thought to enhance 
fusion by two mechanisms. First, the inserted side chains occupy space, which induces positive 
curvature in the presynaptic membrane, bringing it closer to the curvature needed for fusion. 
Second, the insertion destabilizes the presynaptic membrane, again favoring fusion [81]. 
Therefore, synaptotagmin 1 can be thought of as providing the final push, much like popping a 
tightly inflated balloon, to trigger fusion.  
 
1.13 Synaptotagmin 1 in asynchronous release 
The role of synaptotagmin 1 in asynchronous release remains unclear. It was originally 
postulated that the Ca2+ binding C2A domain of synaptotagmin 1 was actively regulating, or 
inhibiting, asynchronous release. This hypothesis is based on experimental results from two 
synaptotagmin mutants. Initially, studies reported increased asynchronous release in 
synaptotagmin 1 knockouts [82, 109-112]. Additionally, another study investigated the role of 
the C2A domain in both synchronous and asynchronous release [113]. In this study, Ca2+ binding 
in synaptotagmin’s C2A domain was blocked by mutating two negatively charged aspartates (D) 
found in the C2A Ca2+-binding pocket to neutral asparagines (N), here after called the P[sytD-N] 
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mutation. This mutation effectively prevents Ca2+ binding by altering the charge profile of the 
binding pocket. This P[sytD-N] mutant study reports no decrease in evoked release and an 
increase in asynchronous release. This study and the synaptotagmin 1 knockout studies that 
report increased asynchronous release led to the hypothesis that Ca2+ binding in synaptotagmin 
1’s C2A domain is not necessary for fast, synchronous release, but is necessary to regulate, or 
inhibit, the asynchronous release sensor. I will call this hypothesis the inhibition hypothesis. 
 Subsequently, Striegel et al [106] determined Ca2+ binding by synaptotagmin 1’s C2A 
domain is needed for efficient synchronous release, contrary to the results in the P[sytD-N] study. 
Striegel generated an alternative C2A Ca2+-binding mutation in which an essential aspartate (D) 
was mutated to a negatively charged glutamate (E), here after called the P[sytD-E] mutant. This 
mutant maintains the negative charge of the pocket while structural inhibiting C2A Ca2+ binding 
[106] and exhibits a significant ~80% decrease in synchronous release.  
A major function of synaptotagmin is to act as an electrostatic switch, which alters 
interactions with SNARE complexes and triggers an interaction with presynaptic membranes. 
The P[sytD-N] mutation effectively trips this electrostatic switch by neutralizing the Ca2+ binding 
pocket [106]. In this light, it is not surprising that in the presence of a wild type C2B domain, the 
P[sytD-N] mutant exhibits no impact on synchronous release since it is mimicking Ca2+ binding 
[106]. Additionally, the P[sytD-N] mutant responds more robustly at lower [Ca2+] for both 
synchronous and asynchronous release [113], indicating an increased affinity for Ca2+.  
 Since the P[sytD-N] mutation mimics Ca2+ binding for synchronous release, its reported 
effect on asynchronous release also comes into question. An increase in Ca2+ affinity and 
mimicking bound Ca2+ may result in increased asynchronous release by triggering release events 
at lower [Ca2+]. These aberrant asynchronous events would be an artifact of the P[sytD-N] 
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mutation, and not the actual role of C2A in regulating asynchronous release. This sheds doubt 
onto the importance of synaptotagmin C2A Ca2+ binding in the regulation of asynchronous 
release.  
 Increases in asynchronous events seen in the P[sytD-N] mutant may be a result of the 
P[sytD-N] mutation mimicking the asynchronous sensor itself. Asynchronous Ca2+ sensors 
exhibit slower binding and unbinding kinetics for Ca2+, permitting release on a longer timescale 
[53]. The P[sytD-N] mutants exhibit release events over longer time scales [113]. Asynchronous 
sensors exhibit higher affinities for Ca2+, which would allow the asynchronous sensor to bind 
Ca2+ at lower [Ca2+]. Indeed, the P[sytD-N] mutation exhibits increased affinity for Ca2+ [113]. 
In contrast, P[sytD-E] mutants exhibit decreased Ca2+ affinity [106], again providing evidence 
that P[sytD-N] mutant may be mimicking an asynchronous sensor.  
 
1.14	  Clarification	  of	  synaptotagmin’s	  role	  in	  asynchronous	  release	  
In chapter 2 of this dissertation, I directly test the role of Ca2+ binding in C2A in 
asynchronous release in vivo by utilizing the P[sytD-E] mutation, which prevents C2A Ca2+ 
binding while maintaining C2A’s inherently negative charge. If C2A Ca2+ binding is clamping 
the asynchronous Ca2+ sensor, an increase similar to that seen in the P[sytD-N] mutant should 
occur in the P[sytD-E] mutant. Such a result would corroborate the current hypothesis in the 
field. If, however, Ca2+ binding in C2A is not needed to regulate asynchronous events, the 
P[sytD-E] mutation will exhibit no increase in asynchronous events. I compare asynchronous 
release events in both the C2A P[sytD-N] and P[sytD-E] transgenic mutants to a transgenic 
control in a synaptotagmin null background of Drosophila. 
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   In chapter 3, I test the possibility that the P[sytD-N] mutant is mimicking the 
asynchronous Ca2+ sensor in vivo by generating Drosophila mutants that contain the original 
P[sytD-N] mutation with additional mutations of the hydrophobic residues to prevent interactions 
with the presynaptic membrane. I generate a P[sytD-N] mutation coupled to a previously studied 
P[sytF-E] mutation (P[sytD-N,F-E]). I also generated the P[sytD-N,F-E] mutation with an 
additional hydrophobic mutation, methionine (M) 222, to a glutamate (E), hereafter called 
P[sytM-E,D-N,F-E]. If the P[sytD-N] mutation is simply mimicking the high-affinity asynchronous 
sensor, then preventing the downstream membrane interactions needed for triggering fusion 
events should prevent any aberrant increase in asynchronous release caused by P[sytD-N]’s 
neutralization of the pocket. Conversely, if the synaptotagmin P[sytD-N] mutation is not 
mimicking an asynchronous sensor, but is regulating the asynchronous sensor, consistent with 
the inhibition hypothesis, the increase in asynchronous release seen in the P[sytD-N] mutation 
should remain.  
From these studies, I conclude that C2A Ca2+ binding is not needed to regulate 
asynchronous release. The P[sytD-E] mutation does not exhibit increased asynchronous events. 
Moreover, I report no changes to asynchronous release in either the P[sytD-N,F-E] or P[sytM-E,D-
N,F-E] mutations, supporting the conclusion that the P[sytD-N] mutant is mimicking an 
asynchronous sensor. These results contradict the inhibition hypothesis. Instead, together these 
results support an alternative hypothesis, the competition hypothesis, which suggests that 
synaptotagmin blocks access to SNARE interactions with the asynchronous sensor. The previous 
synaptotagmin knockout studies also support this hypothesis, as synapses without synaptotagmin 
1 would provide more space for asynchronous sensor release interactions.  
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1.15 Neuromuscular disorders 
 Many tightly regulated mechanisms are needed to result in efficient release of 
neurotransmitter and subsequent responses in the postsynaptic cell. When proteins needed for 
these processes are dysfunctional, synaptic disease may arise. For this dissertation, I will focus 
primarily on disorders associated with proteins found at the neuromuscular junction. These 
disorders can be categorized by location of the affected structures, be it presynaptic, synaptic 
cleft, or postsynaptic. Conditions such as myasthenia gravis affect synaptic proteins in the 
postsynaptic muscle cell, while neuromyotonia and Lambert-Eaton myasthenic syndrome affect 
proteins in the presynaptic neuron. They can also be categorized by origin of dysfunction, such 
as an immune disorder or a congenital disorder. Myasthenia gravis and Lambert-Eaton 
myasthenic syndrome are both autoimmune disorders, while congenital myasthenic syndromes 
are associated with rare familial mutations and can exhibit their own distinct symptoms. 
Neuromuscular diseases in human patients can be diagnosed using a combination of nerve 
conduction studies, exercise testing, immunological tests, and genetic sequencing.  
 
Nerve conduction studies 
Nerve conduction studies (NCS) are performed on patients with clinical presentations 
that are consistent with neuromuscular disorder. These tests help delineate neuromuscular 
junction diseases from one another. Clinicians perform NCS by placing surface electrodes over a 
muscle and the nerve that innervates it. The clinician will stimulate the nerve and progressively 
increase the stimulus intensity until the muscle response does not increase. This is the 
supramaximal stimulation used. Once the largest response of the muscle fiber is recorded, one 
can conclude that all motor nerve fibers are recruited, and therefore all the innervated muscle 
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fibers within the muscle are responding. This muscle response is called the compound muscle 
action potential (CMAP) [114].  
 CMAP amplitude is dependent on two major factors: 1.) the number of innervated muscle 
fibers available to respond to a given stimulus and 2.) amount of neurotransmission at the 
neuromuscular junction. The CMAP can detect a gross loss of motor unit innervation to the 
muscle, indicative of a progressive neurogenic disorder. If this is the case, the CMAP amplitude 
will be decreased. During the early phases of these disorders, however, the CMAP may appear 
normal due to compensatory reinnervation. As one motor unit becomes deinnervated, other 
motor axons send compensatory motor terminal branches to the muscle. If the new motor 
branches can maintain a similar innervation level to the rate of deinnervation, there may be no 
detection of deinnervation. 
 The second factor that affects CMAP amplitude is the efficacy of neurotransmission at 
the neuromuscular junction. In this case, if there is a normal amount of innervated muscle fibers, 
but signal transmission from the pre- to postsynaptic cell is hindered, the result is a decreased 
CMAP amplitude. Unlike progressively deinnervating diseases, the deficits in neuronal 
transmission can be modulated and recorded through repetitive nerve stimulation tests. These 
tests are similar to single evoked CMAPs during baseline nerve conduction studies, but 
stimulations at varying frequencies are administered. These tests can help to localize the deficit. 
Facilitated amplitudes in response to high frequency stimuli (30 – 50 Hz) indicate a presynaptic 
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Lambert-Eaton myasthenic syndrome 
Lambert-Eaton Myasthenic Syndrome (LEMS) is an autoimmune disease in which 
patients experience muscle weakness due to a decrease in Ca2+-triggered neurotransmitter 
release at the neuromuscular junction [115]. This is the second most common neuromuscular 
disease, but is still 20 times less prevalent than the other immune-mediated neuromuscular 
junction disease, myasthenia gravis. As an immune-mediated disorder, IgG antibodies attack the 
presynaptic voltage-gated Ca2+ channels needed for efficient neurotransmission in most patients 
[116].  
Patients experience the most muscle weakness after periods of rest. Strength improves 
with brief exercise, but does not sustain long periods of activity. Like myasthenia gravis, this 
disorder is also often co-morbid with cancer. Sixty percent of patients with LEMS experience 
small cell carcinoma [117]. LEMS usually affects patients over 40 years old.  
 Nerve conduction studies of LEMS patients result in decreased CMAP amplitudes. 
Repetitive nerve stimulation (RNS) tests exhibit depression at low frequencies (2-3 Hz) and 
facilitation at high frequencies (30-50 Hz). A classic hallmark of LEMS is a facilitated CMAP 
amplitude response after 10 seconds of voluntary muscle contraction [118]. Interestingly, 
approximately 20% of LEMS patients express antibodies against the intravesicular domain of 
synaptotagmin, the only portion of the protein exposed to antibodies in the synaptic cleft upon 
vesicle fusion [119]. This is the first indication that synaptotagmin could be a candidate for 





	   	   	  25	  
Congenital myasthenic syndromes 
 Congenital myasthenic syndromes (CMS) are genetically linked defects in one or 
multiple proteins found at the neuromuscular junction, including presynaptic, cleft, and 
postsynaptic proteins [118]. As of 2018, over 20 CMS genes were identified [120]. Some of the 
affected proteins and their importance have been discussed in this dissertation, including SNAP-
25, acetylcholine receptors, postsynaptic Na+ channels, and cleft enzymes that breakdown 
acetylcholine (acetylcholinesterase). Importantly for this dissertation, synaptotagmin 2, the fast, 
synchronous Ca2+ sensor at mammalian neuromuscular junctions, has also been implicated in 
CMS etiology [121, 122]. With the wide variety of proteins, nerve conduction tests, and clinical 
presentations, clinicians can point to candidate genes. Once candidate genes are identified, 
genetic testing aides in diagnosis and treatment plans. In patients, however, there is no way to 
definitively link a mutation to observed symptoms, necessitating the use of model systems to 
positively identify disease-causing mutations. 
 
1.16 High throughput sequencing 
The decreasing cost and increasing availability of DNA sequencing has led to an 
increased incidence of genomic sequencing during patient diagnoses. This ever-increasing 
process will undoubtedly lead to the discovery of additional synaptic mutations and associated 
genetic disorders. The need for a relatively quick and cost effective method to begin elucidating 
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1.17 Synaptotagmin-related disorders  
It is only recently that mutations in the syt1 and syt2 genes have been directly implicated 
in human disease [121-123]. A patient with a de novo mutation in the human syt1 gene presented 
with an early onset dyskinesia, severe motor delay, and profound cognitive deficits attributed to a 
single amino acid substitution in the C2B Ca2+-binding pocket: an isoleucine to threonine (I-T) 
substitution [123]. This hydrophobic isoleucine residue had been shown previously to mediate 
Ca2+-dependent membrane penetration by synaptotagmin [79, 81, 124, 125]: an effector 
interaction critical for coupling Ca2+ influx with neurotransmitter release from neurons [83, 108]. 
Since this syt mutation results in the most severe deficits in an animal system [108] and is 
located in the syt1 gene, which is preferentially expressed in the cerebral hemispheres [71, 72], 
this patient experienced extreme cognitive deficits and the most severe motor deficits observed 
in a synaptotagmin disease to date [123]. 
Two additional mutations in the human syt2 gene were implicated in the etiology of 
congenital myasthenic syndrome patients shortly after: a proline to leucine (sytP-L) mutation and 
an adjacent aspartate to alanine (sytD-A) mutation. Both of these highly conserved residues are 
located in synaptotagmin’s C2B Ca2+-binding pocket [96, 126, 127]. The sytP-L mutation had 
never been studied. However, previous studies have demonstrated that the C2B domain Ca2+-
binding aspartate (D) residues are essential for synaptotagmin function [82, 121, 125, 128], at 
times resulting in lethality in animal models [82, 121]. For the sytD-A familial mutation, 
expression of the mutant syt from a transgene in syt Drosophila heterozygotes resulted in 
lethality in 4 of 6 independent transgenic lines and a dramatic decrease in evoked response in the 
remaining two lines [121]. It is noteworthy, then, that deficits in the affected human family are 
comparatively mild [121, 122].  
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The proline residue affected by the second family is located directly adjacent to one of 
these previously studied aspartates residues. We speculate that this proline residue may provide 
conformational rigidity important for stabilizing the C2B Ca2+-binding pocket. By mutating the 
proline to a leucine, the rigid R group found in the proline residue would be lost, potentially 
affecting the precise conformation of the pocket and impacting the ability of the adjacent 
aspartate to bind Ca2+. Such a mechanism could result in a decreased, albeit not demolished, 
ability of the C2B domain to bind Ca2+ [82, 108, 113, 121-123]. A decreased ability of 
synaptotagmin to bind Ca2+ would hinder the efficacy of neurotransmission, and potentially to 
myasthenic disease symptoms. This mutation could be causing the symptoms seen in the affected 
family, but the correlations between those with the disorder and the mutation provide no direct 
evidence that the proline mutation leads to disease symptoms.  
 
1.18 Drosophila as a model system 
 One approach to directly assess the responsibility of the proline-leucine mutation in this 
congenital myasthenia is to leverage the power of Drosophila genetics. Rare disorders such as 
this synaptotagmin-implicated myasthenia are often underfunded and overlooked, as the need for 
medical research of these diseases does not affect the masses and receive little attention. 
However, the advances in human genetic sequencing are uncovering more of these rare genetic 
disorders. Drosophila are an ideal organism to investigate these mechanisms. Drosophila are 
economical, rapidly regenerate, and possess a genetic toolbox that allows us to drive the 
mutation of interest in subsets of cells. By creating a homologous mutation in Drosophila syt1, 
emergence of disease symptoms would create a direct link between the proline-leucine mutation 
and this congenital myasthenia. Electrophysiological tests where an intracellular electrode is 
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inserted directly into the fly body wall muscle fiber and its innervating nerve is stimulated can 
uncover mechanisms of disease etiology. The amplitude of the response can be measured much 
like a CMAP. Unlike a CMAP, the Drosophila tests examine a single muscle fiber, so deficits in 
the number of innervating nerve cells onto the muscle are not distinguished. This allows a direct 
investigation of synaptic transmission deficiency. If similar symptoms are detected, researchers 
can examine the mechanisms mediating this disorder more completely, as there would be a 
disease model readily available and a causal link between the mutation and disease symptoms.  
 
1.19 Investigation of a synaptotagmin disorder  
 In chapter 4 of this dissertation I directly test the importance of the previously 
uninvestigated proline residue in vivo by creating a homologous mutation in Drosophila. Our in 
silico modeling predicts a conformational change in the C2B Ca2+-binding pocket, potentially 
affecting synaptotagmin’s efficiency. I report homologous symptoms between the Drosophila 
mutation and human disorder, including: 1) decreased neurotransmission, 2) facilitated 
neurotransmission in response to high frequency stimulation, and 3) muscle fatigability. This 
study also provides mechanistic insight into this disease, as the mutation exhibits results 
consistent with decreased release probability and decreased Ca2+ affinity. Therefore, results 
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CHAPTER 2: CLARIFICATION OF CA2+ BINDING IN SYNAPTOTAGMIN 1’S C2A 
DOMAIN IN ASYNCHRONOUS NEUROTRANSMITTER RELEASE1 
 
2.1 Summary 
Following nerve stimulation, there are two distinct phases of Ca2+-dependent 
neurotransmitter release: a fast, synchronous release phase, and a prolonged, asynchronous 
release phase. Each of these phases is tightly regulated and mediated by distinct mechanisms. 
Synaptotagmin 1 is the major Ca2+ sensor that triggers fast, synchronous neurotransmitter release 
upon Ca2+ binding by its C2A and C2B domains. It has also been implicated in the regulation of 
asynchronous neurotransmitter release. As blocking Ca2+ binding by the C2A domain of 
synaptotagmin 1 results in a dramatic increase in asynchronous release, C2A Ca2+ binding is 
postulated to directly inhibit asynchronous release. However, the mutation used to block Ca2+ 
binding in the previous experiments had the unintended side effect of mimicking Ca2+ binding, 
raising the possibility that the increase in asynchronous release was an artifact of ostensibly 
constitutive Ca2+ binding. To test whether Ca2+ binding by C2A is required for the direct 
regulation of asynchronous release, we utilize an alternate C2A mutation that we designed to 
block Ca2+ binding without mimicking it. Analysis of both the original mutation and our 
alternate mutation at the Drosophila neuromuscular junction shows opposite effects on: 
spontanteous release frequency, synchronous release kinetics, and asynchronous release events. 
Importantly, we found that asynchronous release is not increased in our novel mutant. Thus, our 
work provides new mechanistic insight into synaptotagmin 1 function during Ca2+-evoked 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Authors: Mallory Shields, Matthew Bowers, McKenzie Fulcer, Lara Perinet, Marissa Metz, 
Noreen Reist 
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synaptic transmission and demonstrates that Ca2+ binding by the C2A domain of synaptotagmin 
1 does not actively inhibit asynchronous neurotransmitter release in vivo.  
 
2.2 Introduction 
Following nerve stimulation, there are two phases of Ca2+-dependent neurotransmitter 
release. Fast, synchronous release is the large burst of neurotransmitter release that occurs within 
milliseconds (ms) of the arrival of the action potential. At most healthy synapses, the majority of 
release occurs during the synchronous phase [1]. Synaptotagmin 1, which contains two Ca2+-
binding C2 domains, C2A and C2B [2], is essential for coupling Ca2+ binding to efficient, 
synchronous release [3-6]. 
Asynchronous release can last from 10’s of ms to 10’s of seconds (s) [7], and has	  been	  
functionally	  implicated	  in	  synaptic	  plasticity	  [8-­‐11]	  and	  development	  [12,	  13]. While most 
synapses exhibit little to no asynchronous release, it	  is	  observed	  in	  many	  synapse	  types	  [7].	  In 
some specialized synapses, such as specific hippocampal and brainstem interneurons, 
asynchronous release is predominant [14-16].  
 In addition to being the Ca2+ sensor for fast, synchronous release, synaptotagmin 1 is 
proposed to directly regulate asynchronous release. Increases in asynchronous release are 
reported in synaptotagmin 1 null mutants [17, 18] and in a synaptotagmin 1 point mutant in 
which Ca2+ binding by the C2A domain is blocked [19]. Importantly, synchronous release 
remains intact in this C2A point mutant. Thus, the authors conclude that Ca2+ binding in C2A is 
not needed for efficient synchronous release, but does play a role in preventing asynchronous 
neurotransmission [19]. Together, these studies result in the inhibition hypothesis: that Ca2+ 
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binding by the C2A domain of synaptotagmin is directly inhibiting asynchronous 
neurotransmitter release.  
 More recently, our group demonstrated that Ca2+ binding by the C2A domain is required 
for efficient synchronous release [4], contrary to previous studies [20-22]. The original point 
mutations used to block Ca2+ binding by C2A removed negative charge from the Ca2+ binding 
pocket; key, negatively-charged aspartate residues (D) essential for coordinating Ca2+ were 
replaced with neutral asparagines (N), sytD-N. Since synaptotagmin 1 functions as an 
electrostatic switch [23, 24], removing negative charge may mimic Ca2+ binding and permit 
downstream effector interactions [20].  
To directly test this hypothesis, we generated a novel Ca2+-binding mutation where an 
essential C2A aspartate was mutated to a negatively-charged glutamate (E) [4]. The sytD-E 
mutation maintains the negative charge of the pocket but prevents Ca2+ binding by steric 
hindrance resulting in an ~80% decrease in synchronous neurotransmitter release. This finding 
demonstrated that an intact C2B Ca2+-binding domain is sufficient to trigger the electrostatic 
switch in the absence of C2A Ca2+ binding only if the C2A Ca2+-binding pocket was neutralized. 
Thus, the failure of sytD-N mutations to impair synchronous release is an artifact of removing the 
electrostatic repulsion of the presynaptic membrane.  
The current interpretation, that a sytD-N mutation fails to inhibit asynchronous release 
because it cannot bind Ca2+, may be subject to the same artifact. By comparing a sytD-N mutation 
with the sytD-E mutation in Drosophila, we test whether Ca2+ binding by the C2A domain of 
synaptotagmin 1 is required to regulate asynchronous release events. If C2A Ca2+ binding clamps 
asynchronous release, the increased asynchronous release seen in the sytD-N mutation should also 
occur in the sytD-E mutation. However, if increased asynchronous release is an artifact of 
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ostensibly constitutive Ca2+ binding in sytD-N, then the sytD-E mutation should not result in 
increased asynchronous release. We now show the sytD-E mutation had no impact on 
asynchronous release, demonstrating that C2A Ca2+ binding does not regulate asynchronous 
neurotransmitter release.  
 
2.3 Results  
Synaptotagmin mutations 
 To test the function of Ca2+ binding by the C2A domain of synaptotagmin during vesicle 
fusion events, we completed a direct comparison of two disparate mutations that both block Ca2+ 
binding (Fig 2.1). Mutating the third and fourth of the Ca2+-binding Ds to Ns (sytD-N, Fig 2.1B) 
blocks Ca2+ binding and Ca2+-dependent C2A interactions by removing some of the negative 
charges required to coordinate Ca2+. Mutating the second D to an E (sytD-E, Fig 2.1C) in C2A 
blocks Ca2+ binding by steric hindrance while maintaining the negative charge of the pocket. In 
all experiments, synaptotagmin 1 was expressed as a transgene (P[syt]) in the absence of native 
synaptotagmin 1. 
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Fig 2.1. C2A domain of wild type and mutant synaptotagmin and their interactions with the 
negatively-charged presynaptic membrane. A) Cartoon depicting the C2A Ca2+-binding pocket 
of wild type synaptotagmin (sytWT) repeling the negatively-charged presynaptic membrane prior 
to Ca2+ entry due to 5 negatively-charged aspartate residues (magenta, left) and penetrating the 
presynaptic membrane via hydrophobic residues (grey) once Ca2+ binding results in a net 
positive charge that attracts the membrane (right). B) The sytD-N mutation in C2A blocks Ca2+ 
binding by partially neutralizing the pocket when two aspartate residues are replaced with neutral 
asparagines (green). C) The sytD-E mutation in C2A blocks Ca2+ binding by steric hinderance 
when one aspartate residue deep in the Ca2+-binding pocket is replaced with a larger, negatively-
charged glutamate residue (magenta, larger).  
 
 
Transgenic synaptotagmin expression and targeting 
To compare levels of protein expression between P[sytWT], P[sytD-N], and P[sytD-E], 
western analysis was performed on the central nervous system (CNS) of individual third instar 
larvae. There were no significant differences in expression of the synaptotagmin transgenes. 
Mean normalized expression ± standard error of the mean (SEM) in P[sytD-N] was 104.6 ± 8.4% 
of control (Fig 2.2A, p = 0.70, student t-test). Mean expression in P[sytD-E] was 112.6 ± 10.4% 
of control (Fig 2.2B, p = 0.29, student t-test). To assess protein targeting, third instar larval body 
 
	   	   	  41	  
wall preparations were labeled with an anti-synaptotagmin antibody, which was visualized with a 
fluorescent secondary antibody by confocal microscopy. All transgenic synaptotagmin labeling 
is appropriately localized to the neuromuscular junction (Fig 2.2C).  
 
Fig 2.2. Transgenic synaptotagmin expression levels and localization. (A,B) Above, 
Representative western blots showing expression levels of synaptotagmin and the actin loading 
control. (A) Below, P[sytWT] (black) and P[sytD-N] (green) exhibit similar levels of 
synaptotagmin expression. (B) Below, P[sytWT] and P[sytD-E] (magenta) exhibit similar levels 
of synaptotagmin expression. All measurements were normalized to actin levels. Error bars 
depict SEM, and n’s within bars represent number of CNS samples tested. (C) Anti-
synaptotagmin labeling of third instar body wall musculature demonstrated that transgenic 
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synaptotagmin is highly concentrated at the neuromuscular junction in all genotypes. Scale bars 
= 20 µm. 
 
 
Opposite effects of Ca2+-binding mutants on synchronous release amplitude 
Both the P[sytD-N] and P[sytD-E] mutations block Ca2+ binding by the C2A domain [4, 
19]. We determined the amplitude of excitatory junction potential (EJP) responses in third instars 
under our recording conditions (Fig 2.3) to ensure that our two electrode voltage clamp (TEVC) 
recordings attained a ≥ 90% clamp of this response. As previously reported by voltage clamp in 
embryonic preparations [19], the P[sytD-N] mutation supports efficient synchronous 
neurotransmitter release at the neuromuscular junction in third instar larvae. However, the 
P[sytD-E] mutation does not [4]. ANOVA analysis showed a significant difference between the 
three genotypes (p < 0.0001). There was no significant difference between the mean EJP 
amplitude in P[sytWT] larvae (30.85 ± 1.69 mV, mean ± SEM) and P[sytD-N] (Fig 2.3B, 30.88 ± 
1.05 mV, p = 0.99, Dunnett’s correction). The mean EJP amplitude in P[sytD-E] larvae was 
significantly reduced (Fig 2.3B, 7.15 ± 1.01 mV, p < 0.0001, Dunnett’s correction). Thus, as 
seen previously [4], the P[sytD-E] mutation resulted in ~80% decrease in neurotransmitter 
release. These results demonstrate Ca2+ binding by the C2A domain is critical for efficient 
synchronous neurotransmitter release.  
The discrepancy in the effects of these two distinct C2A Ca2+-binding mutations during 
synchronous neurotransmitter release could be explained by the charge differences within the 
Ca2+-binding pocket. The P[sytD-N] mutation in C2A may permit downstream effector 
interactions initiated by Ca2+ binding to the C2B domain, since synaptotagmin acts as an 
electrostatic switch [4, 18, 23, 25] and this mutation decreases resting repulsion between 
synaptotagmin and the presynaptic membrane. In contrast, the P[sytD-E] mutation in C2A 
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maintains the pocket’s negative charge and does not allow these interactions despite Ca2+ 
binding by C2B [4]. This discrepancy during synchronous release highlights the need to re-
examine the putative regulatory role of Ca2+ binding by C2A in asynchronous release.  
  
Fig 2.3. Differential effects of C2A Ca2+ binding mutants on amplitude of synchronous release. 
(A) Representative EJP traces of P[sytWT] (black), P[sytD-N] (green), and P[sytD-E] (magenta). 
Scale bars = 5 mV, 0.1 s. (B) Mean EJP amplitude in P[sytWT] and P[sytD-N] was similar, but 
was significantly decreased in P[sytD-E] (*p < 0.0001). Error bars depict SEM, and n’s within 




Opposite effects of Ca2+-binding mutants on spontaneous release  
The decrease in evoked response P[sytD-E] could have been a result of decreased quantal 
size. We compared mean mEJP amplitudes and found no significant differences in any genotype 
(Fig 2.4B, p = 0.19, Kruskal-Wallis Test).). Mean mEJP amplitude ± SEM in P[sytWT] was 0.93 
± 0.05 mV, in P[sytD-N] was 0.97 ± 0.03 mV, and in P[sytD-E] was 1.02 ± 0.05 mV. Thus, the 
decrease in synchronous evoked release in the P[sytD-E] mutants was not due to a change in 
quantal size.  
Synaptotagmin regulates the rate of spontaneous vesicle fusion events. In synaptotagmin 
null mutants, the frequency of miniature EJPs (mEJPs) is significantly increased [6, 26-29]. 
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Thus, synaptotagmin acts as a clamp to prevent these spontaneous fusion events. P[sytD-N] 
mutants also exhibited an increased rate of spontaneous fusion events at Drosophila embryonic 
neuromuscular junctions [19]. We verified this effect at third instar neuromuscular junctions and 
found statistically significant differences in mEJP frequency among genotypes (Fig 2.4C, p = 
0.02, ANOVA). The mEJP frequency in P[sytD-N] mutants was 4.49 ± 0.39 Hz (mean ± SEM) 
which was significantly increased compared to P[sytWT] at 2.81 ± 0.43 Hz (p = 0.01, Dunnett’s 
correction). In contrast, mEJP frequency in P[sytD-E] was 3.28 ± 0.43 Hz, similar to control (p = 
0.66, Dunnett’s correction). Thus, the negative charge of the Ca2+-binding pocket is the key 
characteristic required to clamp spontaneous fusion events. The differential effect of these 
mutations on both spontaneous and synchronous events supports synaptotagmin’s role as an 
electrostatic switch, where electrostatic repulsion between its C2 domains and the presynaptic 
membrane is required to prevent vesicle fusion. 
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Fig 2.4. The negative charge of the C2A Ca2+-binding pocket is required to clamp spontaneous 
vesicle fusion events. (A) Representative mEJP traces from P[sytWT] (black,) P[sytD-N] (green), 
and P[sytD-E] (magenta) showing 3 consecutive seconds of spontaneous mEJPs. Scale bars = 1 
mV, 0.2 s. (B) Mean mEJP amplitude was similar among genotypes. (C) Mean mEJP frequency 
was increased in P[sytD-N] but unchanged in P[sytD-E] relative to P[sytWT] (*p = 0.01). All error 
bars depict SEM, and n’s within bars represent number of muscle fibers tested.  
 
 
Readily releasable pool size was unaltered 
A decrease in the readily releasable pool of synaptic vesicles could explain the decreased 
neurotransmitter release seen in the P[sytD-E] mutants. Hypertonic solutions stimulate a Ca2+-
independent form of release, which has been used to estimate the readily releasable pool of 
synaptic vesicles [30-32]. To estimate the size of this pool in our lines, we puff applied a 0.3 M 
sucrose solution to the neuromuscular junction. Sucrose application triggered an increase in the 
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frequency of fusion events in all genotypes (Fig 2.5A,B). To account for the increase in 
spontaneous mEJP frequency in P[sytD-N] mutants (Fig 2.4C), event frequencies were 
normalized to the mean mEJP frequency before sucrose application (Fig 2.5C). In all genotypes, 
sucrose application increased the frequency of fusion events (mean fold increase ± SEM between 
0-40 s after sucrose application onset for P[sytWT] = 2.55 ± 0.14, for P[sytD-N] = 2.55 ± 0.08, 
and for P[sytD-E] = 2.91 ± 0.13). Both P[sytD-N] and P[sytD-E] mutants displayed similar 
increases in neurotransmitter release events relative to control during the sucrose response (Fig 
2.5C, p = 0.08, Kruskal-Wallis test, p = 0.99 comparing P[sytWT] to P[sytD-N] and p = 0.13 
comparing P[sytWT] to P[sytD-E], Dunn’s correction). Therefore, the decrease in synchronous 
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Fig 2.5. The readily releasable pool remains unchanged. (A) Representative traces of event 
frequency both before and during sucrose-stimulated neurotransmitter release. Scale bars = 2 
mV, 0.5 s. (B) Event frequencies over time in response to a 5 s application of a hypertonic 
sucrose solution. n = 11 fibers for each genotype. (C) Event frequencies over time normalized to 
the basal mEJP frequency prior to sucrose application. No statistically significant changes were 
found relative to control during the sucrose response. The black bar above the traces in B,C 
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Opposite effects of Ca2+-binding mutants on release probability 
 Another potential explanation for the decrease in synchronous neurotransmitter release in 
the P[sytD-E] mutants is that this mutation caused a decrease in presynaptic release probability. 
Since an increase in the paired pulse ratio is correlated to a decrease in release probability [33] 
we compared paired pulse ratios in each genotype. When muscle fibers were stimulated with two 
pulses at an interpulse interval of 20 ms, statistically significant differences in paired pulse ratios 
were seen (Fig 2.6, p < 0.0001, ANOVA). While the paired pulse ratio in P[sytD-N] (1.09 ± 0.01, 
mean ± SEM) was nearly identical to P[sytWT] (1.09 ± 0.02, p = 0.99, Dunnett’s correction), the 
paired pulse ratio in P[sytD-E] (1.51 ± 0.05, mean ± SEM) was significantly larger (p = 0.0001, 
Dunnett’s correction). The increase in paired pulse ratio indicates that the sytD-E mutation caused 
a decrease in release probability.  
 
Fig 2.6. Release probability was decreased in P[sytD-E] mutants. (A) Representative paired pulse 
traces with a 20 ms interpulse interval from P[sytWT] (black), P[sytD-N] (green), and P[sytD-E] 
(magenta). Scale bars = 5 mV, 0.1 s. (B) There was a significant difference in paired pulse ratios 
among genotypes with a significantly increased paired pulse ratio in P[sytD-E] compared to 
control (*p < 0.0001). There was no change in paired pulse ratios between control and P[sytD-N] 
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Ca2+-binding mutants display prolonged synchronous release time course 
Although the amplitude of synchronous release was unimpaired in the P[sytD-N] mutants, 
we noticed that the kinetics of the synchronous release phase appeared to be slowed. The decay 
time constant (τ) is a characteristic that provides insight into release kinetics, and is defined as 
the time it takes for the response to reach 1-1/e, which is ~ 63.2% of the final value. More 
simply, it is a measure of how long it takes a trace to recover from peak response to 36.8% of 
baseline value. We assessed decay time constants using two-electrode voltage clamp analysis, as 
it provided the adequate temporal resolution that current clamp recordings did not.  
There were differences in decay constants (Fig 2.7 left, p < 0.0001, ANOVA). The 
P[sytD-N] mutation exhibited a significantly longer decay constant than control (Fig 2.7B left, 
mean τ ± SEM of P[sytWT] = 5.01 ± 0.05 ms, and P[sytD-N] = 5.87 ± 0.11 ms, p < 0.0001, 
Tukey’s multiple comparisons test). The P[sytD-E] mutation also exhibited a significantly longer 
decay time constant than control (Fig 2.7B, P[sytD-E] mean τ ± SEM = 5.56 ± 0.11 ms, p < 
0.0001, Tukey’s multiple comparisons test). Interestingly, differences were also observed 
between C2A Ca2+-binding mutants (p = 0.04, Tukey’s multiple comparisons test).  
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Fig 2.7. Synchronous release kinetics were altered in C2A Ca2+ binding mutants. (A) 
Representative traces of P[sytWT] (black), P[sytD-N] (green), and P[sytD-E] (magenta). Scale 
bars = 25% of total response, 5 ms. (B). Both the P[sytD-N] and P[sytD-E] mutants exhibited 
longer decay time constants compared to P[sytWT] (**p < 0.0001). The P[sytD-N] and P[sytD-E] 
mutants also exhibited different decay time constants from one another (*p = 0.04). Error bars 
are SEM, and n’s within bars represent number of fibers tested. 
 
 
Opposite effects of Ca2+-binding mutants on asynchronous release 
We counted release events that occurred from 280 ms before stimulation through 580 ms 
after stimulation. Latency histograms of the number of events/stimulus before and after 
stimulation are shown in Fig 2.8. Control larvae and P[sytD-E] mutants both showed a trend 
toward an increase in release events during the 20-300 ms time window compared to the 
frequency of 280 ms pre-stimulation events (125% increase for control and 111% increase for 
P[sytD-E]), but these increases were not statistically significant (Fig 2.8D, prestimulation event 
frequency for P[sytWT] ± SEM = 3.15 ± 0.36 Hz and during the asynchronous release period was 
3.95 ± 0.38 Hz, p = 0.09, paired t-test. Prestimulation event frequency for P[sytD-E] was 4.31 ± 
0.57 Hz and during asynchronous release was 4.40 ±0.51 Hz, p = 0.52, paired t-test). The P[sytD-
N] mutants showed a robust and significant increase in asynchronous release of 167% (Fig 2.8D, 
prestimulation event frequency was 5.06 ± 0.60 Hz and during asynchronous release was 8.45 ± 
0.83 Hz , p = 0.001, paired t-test). Release event frequency returned to basal levels 
approximately 300 ms after the stimulus, as event frequency was not elevated in any genotype 
from 300 - 580 ms after stimulation compared to prestimulation values (Fig 2.8E, mean event 
frequencies from 300 – 580 ms after stimulation ± SEM for P[sytWT], P[sytD-N], and P[sytD-E] 
were 2.44 ± 0.44 Hz, 3.87 ± 0.54 Hz, and 3.19 ± 0.42 Hz, respectively, where p = 0.1, 0.13, and 
0.26, respectively, paired t-tests. This is consistent with the timeline of asynchronous release at 
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Drosophila neuromuscular junctions in synaptotagmin null mutants, where asynchronous release 
is prevalent [18, 19].  
To quantify Ca2+-stimulated, asynchronous release across genotypes while controlling for 
the variable rate of spontaneous release among genotypes, the mean number of stimulus-
independent mEJP events that occured during the 280 ms prior to stimulation was subtracted 
from the mean number of stimulus-dependent asynchronous events that occurred during the 280 
ms after the synchronous response. In this way, we could assess stimulation-dependent 
asynchronous release by comparing event differences among genotypes. Directly comparing 
asynchronous release between genotypes revealed significant differences (Fig 2.8F, p = 0.03, 
Kruskal-Wallis test). Consistent with previous reports [19], the P[sytD-N] mutants exhibited an 
increase in the number of asynchronous release events (0.95 ± 0.27 events) compared to control 
(Fig 2.8F, 0.21 ± 0.13 events, p = 0.04, Dunn’s correction). Importantly, the P[sytD-E] mutant 
exhibited no increase in asynchronous release events (Fig 2.8F, 0.12 ± 0.19 events, p > 0.99, 
Dunn’s correction) compared to control. Thus, blocking Ca2+ binding by the C2A domain of 
synaptotagmin had no impact on asynchronous release provided that the electrostatic repulsion of 
the presynaptic membrane was maintained.  
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Fig 2.8. Asynchronous release was increased in P[sytD-N] mutants but not P[sytD-E] mutants. 
(A-C) Left, Representative traces from P[sytWT] (black), P[sytD-N] (green), and P[sytD-E] 
(magenta) showing 280 ms before and 300 ms after stimulation (large dotted arrow). Release 
events before and after the burst of synchronous release are indicated (small arrows). Scale bars 
= 1 nA, 0.1 s. Right, histograms plotting the mean number of events/stimulus for all genotypes 
spanning the period of 280 ms before to 580 ms after single stimulations. Data were collected 
into 10 ms bins and are presented as the number of events/stimulus. A synchronous event 
occurred within the 0-20 ms bins following every stimulus. (D) Mean frequencies for each 
genotype 280 ms before stimulation and during the asynchronous time period (20-300 ms post-
stimulus) were compared within genotypes. No significant increase in stimulation-dependent 
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asynchronous release was determined for control (or P[sytD-E] larvae. P[sytD-N] larvae exhibited 
a robust asynchronous release response (*p = 0.001). (E) Mean frequencies for each genotype 
280 ms before stimulation and 300 – 580 ms post-stimulus were compared within genotypes. No 
significant increases in stimulation-dependent asynchronous release were determined. (F) Mean 
event differences between stimulation-dependent asynchronous release events and stimulation-
independent spontaneous release reveal increased asynchronous release relative to control in 
P[sytD-N] mutants (*p = 0.04), while P[sytD-E] mutants displayed no increase in asynchronous 





We investigated the role of Ca2+ binding by the C2A domain of synaptotagmin 1 during 
neurotransmitter release by comparing two distinct C2A Ca2+-binding mutations. The P[sytD-N] 
mutant, which blocks Ca2+ binding by removing negative charge from the pocket, displayed: no 
deficits in the amplitude of synchronous release (Fig 2.3) or the pool of readily releasable 
vesicles (Fig 2.5), an increase in spontaneous release frequency (Fig 2.4), and an increase in 
asynchronous release events compared to control (Fig 2.8). These findings are consistent with 
previous reports [19-22]. The paired pulse ratio was similar to control (Fig 2.6), indicating no 
impact on release probability. However, the slowed kinetics of synchronous release (Fig 2.7) 
demonstrates that the rate of synchronous vesicle fusion events is impaired.  
The P[sytD-E] mutants, which block Ca2+ binding while maintaining the pocket’s 
negative charge, exhibited: dramatic reduction in the amplitude of synchronous release (Fig 2.3) 
and no change in spontaneous release frequency (Fig 2.4), as seen previously [4]. In addition, 
there was no change in the readily releasable pool (Fig 2.5) or in the number of asynchronous 
release events (Fig 2.8). There was a decrease in release probability (Fig 2.6), and in the kinetics 
of synchronous release (Fig 2.7).  
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Why might these two C2A mutations that block Ca2+ binding have opposite effects on the 
amplitude of synchronous release, release probability, spontaneous release frequency, and 
asynchronous release? The most likely explanation springs from synaptotagmin’s mechanism of 
action: serving as an electrostatic switch to trigger vesicle fusion events. Once Ca2+ binds to C2A 
and C2B, synaptotagmin’s electrostatic repulsion of the negatively-charged presynaptic 
membrane (Fig 1A, left) switches to electrostatic attraction [4, 23-25]. This attraction allows 
hydrophobic residues at the tips of the C2 domains to penetrate into the hydrophobic core of the 
presynaptic membrane (e.g., Fig 1A right, grey residues) [34, 35], favoring fusion.  
For synchronous neurotransmitter release, the sytD-N mutation, by virtue of decreasing 
the electrostatic repulsion of the presynaptic membrane (Fig 1B), may participate in these 
downstream effector interactions. Thus, it would support the same level of synchronous release 
(Fig 3). As there is an intact C2B domain, the net effect of the sytD-N mutation is to mimic C2A 
Ca2+ binding required for synchronous neurotransmitter release. The finding that the kinetics of 
synchronous release were slowed in the P[sytD-N] mutant suggests that this ostensibly 
constitutive Ca2+ binding may slow synaptotagmin’s association with/disassociation from the 
membrane. The sytD-E mutation is expected to have the opposite impact in terms of electrostatic 
switch function. Since electrostatic repulsion remains intact (Fig 2.1C), the sytD-E mutation 
cannot participate in downstream membrane interactions [4]. Therefore, the release probability is 
significantly reduced (Fig 2.6) and fewer vesicles are triggered to fuse, resulting in decreased 
synchronous response amplitude (Fig 2.3) [4].  
For spontaneous release, the sytD-N and sytD-E mutations are also expected to display 
opposite effects. At rest, SNARE proteins mediate constituitive vesicle-target membrane fusion 
reactions throughout cells [36]. At the synapse, synaptotagmin is required to prevent aberrent 
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spontaneous fusion events [6, 26-28] The electrostatic repulsion between the C2 domains of 
synaptotagmin and the presynaptic membrane are thought to mediate this inhibitory role. Thus, it 
is not surprising that the sytD-N mutation, which decreases this electrostatic repulsion resulted in 
increased spontaneous fusion events, while the sytD-E mutation that maintains the electrostatic 
repulsion did not (Fig 2.4) [4, 19]. 
The differential effect on asynchronous release in the Ca2+ binding mutants is consistent 
with synaptotagmin’s role as an electrostatic switch. In the sytD-N mutation, the constitutive 
removal of electrostatic repulsion by C2A likely mimics bound Ca2+, thereby allowing this 
mutation to trigger fusion events for a longer period of time, much like an asynchronous sensor. 
Our alternant sytD-E mutation did not exhibit increased asynchronous release, directly 
contradicting the current hypothesis that states C2A Ca2+ binding inhibits asynchronous release.  
This inhibition hypothesis spawned from two major findings: 1.) that synaptotagmin 1 
null mutants showed increased asynchronous release, indicating that synaptotagmin 1 functions 
to suppress this form of release [17, 18], and 2.) increased asynchronous release in the sytD-N 
mutation that blocked Ca2+ binding by C2A domains, in either synaptotagmin 1 [19] or Doc2 
[37]. 
Our comparison of the sytD-N to sytD-E mutations refutes the inhibition hypothesis. 
Therefore, another mechanism must result in the changes in asynchronous release seen in 
synaptotagmin null mutants and C2A domain mutations. One simple explanation may be a spatial 
competition for regulation of SNARE-mediated fusion between synaptotagmin and an 
asynchronous Ca2+ sensor. This competition hypothesis can account for the rates of 
asynchronous release in synaptotagmin null mutants, as well as various previous manipulations 
of synaptotagmin 1 at the synapse.  
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In null mutants, the situation is simple. When synaptotagmin 1 is no longer present at the 
synapse, the asynchronous sensor has unimpeded access to SNARE complexes to trigger 
asynchronous release in the absence of synchronous release. Explaining the results reported in 
the C2A sytD-N mutation is more complicated. With an intact C2B domain, the sytD-N mutation 
can function reasonably well during synchronous release and appears to mimic an asynchronous 
sensor during asynchronous release. Indeed, the sytD-N mutation triggered more robust release at 
lower [Ca2+] than control both in vitro [20] and in vivo [19], consistent with an increased Ca2+ 
affinity and is characteristic of an asynchronous sensor.  
The precise subcellular location of the sensor is likely a critical factor for distinct modes 
of neurotransmitter release [38], further supporting the spatial competition hypothesis. Even a 5 
nm difference in distance between the sensor and the Ca2+ channel can profoundly affect fusion 
probability [39]. The current candidates for the mammalian asynchronous sensor are Doc2, a 
cytosolic protein [40, 41], and synaptotagmin 7, a presynaptic membrane protein [42]. 
Interestingly, when synaptotagmin 1 was expressed either cytosolically or tethered to the 
presynaptic membrane, abolished synchronous release and increased asynchronous release were 
reported [38]. This would be expected if only an asynchronous sensor were present, and provides 
evidence that competition for optimal space may determine which mode of release is employed. 
 
2.5 Conclusion 
 Here we show a shift in the current hypothesis regarding the role of syt 1’s Ca2+-binding 
role in synchronous, spontaneous, and asynchronous release. Using two distinct C2A Ca2+-
binding mutations, we report opposing effects on synchronous, spontaneous, and asynchronous 
neurotransmitter release. Using the sytD-N Ca2+-binding mutation, which inadvertently mimics 
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Ca2+ binding, we observed robust yet kinetically slower synchronous release, increased 
spontaneous release, and increased asynchronous release, all of which are consistent with this 
mutation partially flipping the electrostatic switch as a mutational artifact. However, the alternant 
P[sytD-E] mutation that maintains electrostatic repulsion between the C2A binding pocket and 
presynaptic membrane displayed opposing results in synchronous, spontaneous, and 
asynchronous release relative to sytD-N. These results indicate that, in contrast to the current 
inhibition hypothesis in the field, the role of synaptotagmin’s C2A domain does not regulate 
asynchronous release. Instead, we introduce the spatial competition hypothesis, which resolves 
the seemingly dischordant results of the differing C2A Ca2+ binding mutations. 
 
2.6 Materials and methods 
Drosophila strains  
The aspartate to asparagine line used was sytD282,284N [generously provided by Motojiro 
Yoshihara, University of Massachusetts Medical School, Worcester, MA, [19]]. The aspartate to 
glutamate line used was sytD229E [4]. GeneWiz (South Plainfield, New Jersey) synthesized 
cDNA of the Drosophila wild type syt1 gene flanked by 5’ EcoRI and 3’ BglII restriction sites. 
We included some 5’ and 3’ untranslated sequence [43] to match the mutant syt transgenes as 
closely as possible. This wild type transgene was placed under the control of the UAS promoter 
by directional subcloning of the synthesized cDNA into the pUAST-attB vector using the EcoRI 
and BglII restriction sites. The transgene was inserted in the attP2 landing site on the third 
chromosome in Drosophila using the PhiC31 targeted insertion system [44] by Genetivision 
(Houston, TX). The UAS/Gal4 system was used to drive neuronal expression of our syt 1 
transgenes [45, 46]. To assess the functional significance of the mutations, all transgenes were 
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expressed in the absence of endogenous synaptotagmin by crossing them into the sytnull mutant 
background, sytAD4 [47]. The genotypes of experimental larvae were the following: yw; 
sytnullelavGal4/sytnull; P[UASsytWT]/+ line 1 (transgenic control, referred to as P[sytWT]), yw; 
sytnullelavGal4/sytnull; P[UASsytD282,284N]/+ (referred to as P[sytD-N]), and yw; 
sytnullelavGal4/sytnull; P[UASsytD229E]/+ (referred to as P[sytD-E]). As no gender selection was 
employed, experimental larvae included both males and females.  
 
Immunoblotting  
The level of synaptotagmin expression was determined by western blot analysis using 
actin levels as a loading control. Third instar larval central nervous systems (CNSs) were 
dissected in HL3.1 saline [70 mM NaCl, 5 mM KCl, 4 mM MgCl2, 10 mM NaHCO3, 5 mM 
Trehalose, 115 mM sucrose, 5 mM HEPES, pH 7.2 [48]]. Individual CNSs were sonified for 5 
pulses using a Branson Sonifier 450 (VWR Scientific, Winchester, PA) in Laemmli buffer (Bio-
Rad, Hercules, CA) containing 5% β-mercaptoethanol. Each sample was electrophoresed, 
transferred to Immobilon membranes (Millipore, Bedford, MA), and washed in blocking solution 
as previously described [49]. Membranes were probed with a 1:2500 dilution of anti-syt 
antibody, Dsyt-CL1 [3] and 1:10,000 dilution of anti-actin antibody, MAB 1501 (Millipore 
Bioscience Research Reagents, Billerica, MA), overnight at 4°C. An Epichemi3 Darkroom and 
Labworks Imaging Software (UVP BioImaging, Upland, CA) were used to visualize the protein 
bands. Quantification: for each blot, synaptotagmin/actin ratios were calculated and normalized 
to the mean synaptotagmin/actin ratio of the control lanes to permit comparison of 
synaptotagmin signals between blots. Outliers in actin levels were excluded from analysis. 
Statistical significance was determined using one-way ANOVA.  
 
	   	   	  59	  
Immunolabeling  
To visualize transgenic synaptotagmin at the neuromuscular junction, third instar larvae 
were dissected in Ca2+-free HL3.1 saline and fixed in phosphate-buffered saline (PBS, 137 mM 
NaCl, 1.5 mM KH2PO4, 2.7 mM KCl, 8.1 mM Na2HPO4) containing 4% formaldehyde for 1 
hour. Samples were probed overnight in a 1:400 dilution of Dsyt-CL1 in dilution media [PBS 
with 0.1% Triton, 1% bovine serum albumin (Millipore-Sigma, Burlington, MA), and 1% 
normal goat serum (Fitzgerald Industries International, Acton, MA)]. Samples were washed in 
PBS with 0.1% Triton for 1-3 hours, incubated in dilution media containing a 1:400 dilution of 
Alexa Fluor 488 goat anti-rabbit antibody (Invitrogen, Carlsbad, CA) for 1 hour at room 
temperature, washed in PBS with 0.1% Triton for one hour, and mounted on microscope slides in 
Citifluor (Ted Pella, Redding, CA). Images of neuromuscular junctions of abdominal muscles 
6/7 in segments 3 and 4 were acquired using a Zeiss 880 light scanning microscope, a 40X 
objective, and Zeiss Zen 2.1 acquisition software, version 11,0,3,190. 
 
Electrophysiological experiments and analyses 
All electrophysiological events were collected with an Axoclamp 2B amplifier 
(Molecular Devices, Sunnyvale, CA), a Powerlab 4/35 A/D converter (ADInstuments, Sydney, 
Australia), and LabChart software (ADInstruments, Sydney, Australia). All statistical analyses 
were performed using Prism 7 software. 10-20 MΩ intracellular electrodes were pulled using a 
Sutter model P-97 (Novato, CA) and filled with 3 parts 2 M K3C6H5O7 to 1 part 3 M KCl. Third 
instar larvae were dissected in Ca2+-free HL3.1 saline to expose the body wall musculature and 
the CNS was removed. Recordings were made from muscle 6 of abdominal segments 3 and 4. 
Fibers were held at -55 mV by applying no more than 1 nA of current.  
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Single evoked excitatory junction potentials (EJPs) were evoked at 0.04 Hz using a 
stimulating electrode filled with bath solution. Events were evoked in HL3.1 saline containing 
1.0 mM Ca2+. The averages of 10 EJPs collected were calculated for each fiber. Statistical 
significance was determined using a one-way ANOVA with Dunnett’s correction. 
Miniature excitatory junction potentials (mEJPs) were acquired for 3 minutes in HL3.1 
saline. Events were identified manually after recordings had been randomized and blinded to the 
researcher for analysis. Mean mEJP amplitudes were determined from 50 consecutive 
events/fiber, beginning after two minutes of recording, from each recording to eliminate bias. 
Statistical significance was determined using the Kruskal-Wallis test. To determine mEJP 
frequency, all spontaneous events between the 2nd and 3rd minute of recording from each fiber 
were counted. Statistical significance for mEJP frequency was determined using a one-way 
ANOVA with Dunnett’s correction.  
For paired pulse analysis, stimulations were applied using a 0.02 s interpulse interval. 
Paired pulse ratios were determined by dividing the EJP amplitude of the second stimulation by 
the amplitude of the first stimulation. Mean paired pulse ratios were compared between 
genotypes using a one-way ANOVA with Dunnett’s correction. 
For hypertonic solution stimulations, a puff application of modified HL3.1 saline 
containing 0.3 M sucrose was administered to the junctional region of muscles 6/7 in abdominal 
segments 3 and 4 of third instars using a PicoSpritzer III (Parker Hannifan, Pine Brook, NJ). The 
puff application was administered for 5 s at ~ 5 pounds per square inch. Recordings were 
acquired in a bath solution of Ca2+-free HL3.1 saline. All recordings were randomized and 
blinded to the researcher for analysis. Frequency of mEJP events were counted manually and 
parsed into 1 s bins for 70 s, including 10 s prior to sucrose application to determine a baseline 
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mEJP frequency. To determine each genotype’s response to the hypertonic solution, the average 
mEJP frequency during the 40 s following the initiation of the sucrose application was 
calculated. Statistical significance was determined using a one-way ANOVA with Dunnett’s 
correction to compare mutant genotypes to control.  
To quantify asynchronous events, synaptic currents were recorded using two-electrode 
voltage clamp as described [50]. A second intracellular electrode of 10-15 MΩ resistance was 
pulled. Following insertion of both intracellular electrodes, recordings with muscle input 
resistances < 5 MΩ were excluded. Fibers were voltage clamped at -55 mV using no more than 1 
nA of current. Traces were acquired in HL3.1 saline containing 1.0 mM Ca2+ and fibers were 
stimulated at 0.2 Hz for 5 stimulations. To measure decay time constants, the mean time to decay 
63.2% from the peak EJC response was calculated. ANOVA analysis was performed to 
determine overall significance, with Tukey’s correction to compare all genotypes. Latency 
analysis of asynchronous release was accomplished by manually binning all miniature EJCs 
(mEJCs) into 10 ms bins, and graphing the number of events/stimulation in each bin. The 
difference in mEJC events during the 280 ms before vs. the 20-300 ms after stimulation was 
calculated (# events after stimulation - # events prior to stimulation) and averaged per genotype. 
The 20 ms immediately following stimulation was excluded, as synchronous responses occurred 
during this time period. Statistical significance between genotypes was determined using a 
Kruskal-Wallis test with Dunn’s correction. 
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CHAPTER 3: HYDROPHOBIC RESIDUES IN SYNAPTOTAGMIN 1’S C2A DOMAIN 




Synaptotagmin 1 is the proposed Ca2+ sensor for fast, synchronous neurotransmitter 
release, but its role in asynchronous neurotransmitter release remains unclear. Until recently, the 
Ca2+-binding C2A domain of synaptotagmin was thought to regulate an asynchronous release 
sensor. However, a previously published point mutation that led to this hypothesis invited 
additional asynchronous release events as an artifact of the mutation. Recent studies report that 
Ca2+ binding in the C2A domain of synaptotagmin in asynchronous release regulation is not 
needed. Instead, mutational artifacts from the original mutation may function as an asynchronous 
sensor. We investigated the side effects of the original mutation in vivo by introducing additional 
mutations that prevented C2A interactions with the presynaptic membrane. These mutations 
prevented aberrant asynchronous events. We conclude that the original Ca2+ binding mutation is 
mimicking an asynchronous Ca2+ sensor, which supports the hypothesis that synaptotagmin’s 
C2A domain is not actively regulating an asynchronous sensor. 
 
3.2 Introduction 
Stimulation-dependent neurotransmitter (NT) release is divided into two temporally 
distinct phases. The first is a fast, synchronous neurotransmitter release that occurs within 
milliseconds (ms) of the stimulus. Synchronous release is dominant in the majority of synapses, 
and is the canonical release type typically described in textbooks. The second is a slower, more 
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prolonged asynchronous phase of release. While most synapses exhibit little to no asynchronous 
release following a single action potential, it	  is	  still	  observed	  in	  many	  synapse	  types	  [1-­‐10]	  and	  
has	  implications	  in	  synaptic	  plasticity	  [11-­‐14]	  and	  development	  [15,	  16].	  In some specialized 
synapses, such as specific interneurons of the hippocampus and brainstem, asynchronous release 
is predominant [8-10]. Both phases require Ca2+ sensors with different requisite characteristics.  
 It has long been established that synaptotagmin 1 is a Ca2+ sensor for fast, synchronous 
NT release. Synaptotagmin 1 is a low affinity Ca2+ sensor and exhibits fast binding and 
unbinding kinetics for Ca2+. Therefore, upon a large influx of Ca2+, synaptotagmin 1 can fully 
bind and unbind Ca2+ quickly and trigger fast, synchronous neurotransmitter release within ms. 
Synaptotagmin 1 senses Ca2+ via its two Ca2+-binding C2 domains, C2A and C2B. These 
Ca2+-binding domains contain 5 highly conserved negatively charged aspartate residues, 
resulting in a resting net negative charge of the binding pocket. Upon high [Ca2+] entry into the 
cell, each C2 domain binds Ca2+. Ca2+ binding results in a net positive charge of the Ca2+-
binding pockets, which enhances interactions with the negatively charged presynaptic membrane 
and potentially trans-SNARE complexes [17-20]. Thus, Ca2+ binding allows synaptotagmin 1 to 
act as an “electrostatic switch” [21-24].  
Switching from electrostatic repulsion to electrostatic attraction also permits two 
hydrophobic residues in each of synaptotagmin 1’s C2 domains to escape the hydrophilic cytosol 
by penetrating into the hydrophobic core of the presynaptic membrane and encouraging fusion 
[18, 25] (Fig 3.1). When one of these hydrophobic residues was mutated in synaptotagmin’s C2B 
domain, the result was embryonic lethal, reporting the most severe synaptotagmin phenotype in 
vivo to date [26]. Additionally, when the homologous hydrophobic residue in C2A is mutated, a 
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50% knockdown of function was observed [26]. Therefore, hydrophobic residues found in 
synaptotagmin’s C2 domains are critical for efficient synchronous neurotransmission. 
 
Fig 3.1. Synaptotagmin’s C2A Ca2+ binding and membrane penetrating pocket. Left, cartoon of 
synaptotagmin’s C2A domain, with 5 negatively charged essential aspartate residues (red) that 
repel the presynaptic membrane at rest and bind Ca2+ (orange) upon Ca2+ entry into the cell. 
Right, once bound, the pocket is neutralized, flipping the electrostatic switch to allow 
hydrophobic resides (yellow) to insert into the presynaptic membrane, favoring fusion.  
 
 Alternatively, asynchronous NT release requires a high affinity Ca2+ sensor with 
accompanying slower Ca2+ binding and unbinding kinetics. This allows fusion events to occur 
when [Ca2+] is lower and lasts for 100’s of ms. Synaptotagmin 1’s role in asynchronous release 
remains elusive, because previous studies report contradictory results. It was originally 
postulated that the Ca2+ binding C2A domain of synaptotagmin 1 was actively regulating 
asynchronous release. This hypothesis is referred to as the inhibition hypothesis. Initial studies 
resulted in increased asynchronous release in synaptotagmin knockouts [27-30]. Another study 
investigated the role of the C2A domain in asynchronous release. In this study, Ca2+ binding by 
C2A domain was blocked by mutating two C2A negatively charged aspartates (D) to neutral 
asparagines (N), referred to as the P[sytD-N] mutation [30]. This mutation exhibited increased 
asynchronous release and led to the hypothesis that synaptotagmin 1’s C2A domain actively 
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More recent studies have uncovered inadvertent artifacts of the P[sytD-N] mutation ([24] 
and Shields, unpublished). These studies utilized an alternative C2A Ca2+ binding mutation that 
structurally blocked Ca2+ from binding C2A while maintaining C2A’s inherently negative charge. 
These studies demonstrated that the P[sytD-N] mutant mimicked Ca2+ binding by neutralizing the 
C2A pocket [24, 31] and allowed more interaction with both SNARE complexes and the 
presynaptic membrane (Fig 3.2 left panel). The alternative mutation did not exhibit an increase in 
asynchronous release, providing evidence that Ca2+ binding in the C2A domain is not necessary 
to regulate asynchronous NT release (Shields, unpublished). This is contradictory to the 
inhibition hypothesis.  
 
Fig 3.2. C2A Ca2+ binding mutants with and without additional mutations to prevent membrane 
insertion. Left, the P[sytD-N] mutation prevented Ca2+ binding by removing attractive negative 
charge to the C2A pocket by mutating two of five negatively charged aspartate resides (red) to 
neutral asparagines (green). This partially neutralized the C2A pocket, which allowed more 
presynaptic membrane interactions via two hydrophobic residues (yellow). Middle, the P[sytD-
N,F-E] mutation prevents additional membrane interactions by also mutating the hydrophobic 
phenylalanine residue (F) to a negatively charged glutamate (blue). Right, the P[sytM-E,D-N,F-E] 
mutation mutates both membrane-penetrating hydrophobic residues to negatively charged 
glutamates.  
 
 As the P[sytD-N] mutant acted as though Ca2+ was bound, which flipped the electrostatic 
switch, additional fusion events in response to Ca2+ influx over a longer time course could occur. 
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mutant, as previously reported [30, 31]. This mutation may not only have mimicked Ca2+ 
binding, it may also have mimicked an asynchronous Ca2+ sensor.  
 In this study we directly tested this possibility in vivo by generating Drosophila mutants 
that contained the original P[sytD-N] mutations with additional hydrophobic residue mutations 
that prevented interactions with the presynaptic membrane. We generated the P[sytD-N] mutation 
coupled to the previously studied hydrophobic mutation (P[sytD-N,F-E], Fig 3.2 middle panel). A 
second mutation with both hydrophobic C2A membrane penetrating residues mutated to 
glutamates coupled to the original P[sytD-N] mutation was also generated. This mutant is 
hereafter called P[sytM-E,D-N,F-E] (Fig 3.2 right panel). Together, these new mutations are 
referred to as the hydrophobic mutants.  
If the P[sytD-N] mutation was mimicking the high-affinity asynchronous sensor (e.g., 
triggering asynchronous release), then preventing membrane interactions needed for triggering 
fusion events would prevent any aberrant increase in asynchronous release. Conversely, if the 
synaptotagmin P[sytD-N] mutation was not acting as an asynchronous sensor, but was regulating 
the asynchronous sensor, consistent with the inhibition hypothesis, the increase in asynchronous 
release would remain. We found no changes to asynchronous release in either newly generated 
hydrophobic mutant, which supported the hypothesis that the original P[sytD-N] was mimicking 
an asynchronous sensor. Further, our results contradict the inhibition hypothesis and support an 
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3.3 Results  
Transgenic synaptotagmin exhibits appropriate expression 
 
We generated transgenic synaptotagmin (syt) transgenes and drove pan-neuronal 
expression of all syt transgenes in the sytnull background using the elavGal4 promoter. These 
genotypes are hereby referred to as P[sytWT] (transgenic control), P[sytD-N,F-E] (original Ca2+-
binding mutation with one additional hydrophobic mutation that prevented presynaptic 
membrane interactions), and P[sytM-E,D-N,F-E] (original Ca2+-binding mutation with both 
mutated hydrophobic residues). See methods for full genotypes. To verify comparable levels of 
protein expression between P[sytWT], P[sytD-N,F-E], and P[sytM-E,D-N,F-E], western analysis 
was performed on individual central nervous systems (CNSs) of third instar larvae. No 
significant changes in expression levels were determined for P[sytWT] (n = 21) and P[sytD-N,F-E] 
(n = 14) or P[sytWT] (n = 25) and P[sytM-E,D-N,F-E] (n = 19) (Fig 3.3A, P[sytD-N,F-E] was 126.3 
% ± 13.5 % of control, p = 0.11, student t-test, and Fig 3.3B, P[sytM-E,D-N,F-E] was 119.6 % ± 
9.9 % of control, p = 0.08, student t-test). Transgenic syt labeling at the neuromuscular junction 
in an otherwise sytnull background identified correct transgene localization (Fig 3.3C).  
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Fig 3.3. Transgenic synaptotagmin expression levels and localization. (A,B) Above. 
Representative blots showing synaptotagmin expression levels and actin loading control. (A) 
Below, western analysis exhibited similar synaptotagmin expression between P[sytWT] (black, n 
= 21) and P[sytD-N,F-E] (red, n = 14, p = 0.11, student t-test) (B) Below, western analysis 
quantification between P[sytWT] (black, n = 25 and P[sytM-E,D-N,F-E] (blue, n = 19, p = 0.08, 
student t-test) resulted in similar synaptotagmin expression levels. (C) Transgenic third instar 
larvae with antibodies against synaptotagmin localized at the neuromuscular junction. Scale bars 
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Spontaneous release frequency was increased in P[sytD-N,F-E] mutants 
 A known role of syt 1 is to clamp stimulation-independent fusion events, or spontaneous 
miniature excitatory junction potentials (mEJPs), at a relatively low frequency. However, the 
P[sytD-N] mutation mimicked Ca2+ binding and resulted in an increase in spontaneous events 
[24, 30, 31] (also Shields, unpublished). By preventing membrane interaction of synaptotagmin’s 
C2A domain, the P[sytD-N,F-E] and P[sytM-E,D-N,F-E] mutations may have clamped this mEJP 
frequency back to control frequency. Surprisingly, differences were determined between 
P[sytWT] (mean mEJP frequency ± SEM for P[sytWT]= 2.81 ± 0.43 Hz, n = 15) and P[sytD-N,F-
E] (Fig 3.4C, mean mEJP frequency ± SEM for P[sytD-N,F-E] = 5.09 ± 0.40 Hz, n = 12, p < 
0.0001, student t-test). However, there were no significant differences between P[sytWT] (mean 
mEJP frequency ± SEM for P[sytWT]= 2.72 ± 0.23 Hz, n = 9) and P[sytM-E,D-N,F-E] (Fig 3.4E, 
mean mEJP frequency ± SEM for P[sytM-E,D-N,F-E] = 3.26 ± 0.54 Hz, n = 10, p = 0.39, student 
t-test). Frequency was determined with manual counts of mEJP events for one consecutive 
minute during recordings. These results support the need for both hydrophobic residues to 
prevent the aberrant spontaneous release events introduced in the P[sytD-N] mutation.  
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Fig 3.4. Spontaneous release frequency was increased in P[sytD-N,F-E] mutants. (A) 
Representative mEJP traces of P[sytWT] (black) and P[sytD-N,F-E] (red). Scale bar represents 1 
mV, 0.2 s. (B) Representative mEJP traces of (black) and P[sytM-E,D-N,F-E] (blue). (C) Mean 
mEJP frequency was increased in P[sytD-N,F-E] (n = 12) relative to control (n = 15, p < 0.0001, 
student t-test) (D) Mean mEJP amplitude was unchanged between P[sytWT] (n = 9) and P[sytM-
E,D-N,F-E] (n = 10, p = 0.52, Mann-Whitney test). (E) Mean mEJP frequency was similar 
between P[sytWT] and P[sytM-E,D-N,F-E] (p = 0.39, student t-test). (F) Mean mEJP amplitude 
was unchanged between P[sytWT] and P[sytM-E,D-N,F-E] (p = 0.78, Mann-Whitney test). Error 
bars depict SEM. 
 
 
Quantal size was unaffected  
Each of these stimulation-independent events results from one vesicle fusing with the 
presynaptic membrane, and its response amplitude can be quantified as quantal size, which is 
sensitive to how much neurotransmitter has been loaded into an individual vesicle, as well as the 
makeup and density of postsynaptic receptors [32-36]. We calculated the mean amplitudes of 
individual mEJPs, and no significant changes were determined for any genotype (Fig 3.4D,F). 
Mean mEJP amplitude ± SEM for P[sytWT] was 0.93 ± 0.05 mV (n = 100 mEJPs for 15 fibers) 
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when compared to P[sytD-N,F-E], whose mean mEJP amplitude ± SEM was 0.95 ± 0.03 mV (n 
=100 mEJPs for 12 fibers, p = 0.52, Mann-Whitney test). The mean mEJP amplitude ± SEM for 
P[sytWT] was 0.95 ± 0.02 mV (n = 100 mEJPs for 9 fibers) when compared to P[sytM-E,D-N,F-E], 
whose mean mEJP ± SEM was 1.02 ± 0.05 mV (n = 100 mEJPs for 10 fibers, p = 0.78, Mann-
Whitney test). Since quantal size was unchanged, we have no reason to conclude that either 
vesicle loading or postsynaptic receptor density was affected by these mutations. 
 
Hydrophobic mutants exhibited significant decrease in synchronous release.  
As the previously studid P[sytD-N] mutation displayed no decrease in synchronous 
release [30] (also Shields, unpublished), and hydrophobic mutations exhibited significant 
decreases on synchronous release in vivo [26], we tested the effects of the additional 
hydrophobic mutations on evoked synchronous neurotransmitter release. We measured responses 
to single stimulations, or excitatory junction potentials (EJPs), at the larval neuromuscular 
junction. Unlike the P[sytD-N] mutation alone, the addition of hydrophobic mutations 
significantly decreased neurotransmitter release (Fig 3.5B, p < 0.0001, ANOVA, p < 0.0001 for 
all comparisons to control, Dunnett’s correction). The mean EJP ± SEM for P[sytWT] was 29.18 
± 1.39 mV (n = 9) compared to 3.12 ± 0.44 mV and 2.15 ± 0.42 mV in P[sytD-N,F-E] (n = 9) and 
P[sytM-E,D-N,F-E] (n = 10) larvae, respectively. These ~90 % decreases in neurotransmitter 
release are the most severe syt C2A mutations reported to date.  
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Fig 3.5. Hydrophobic mutations exhibited > 90% knockdown of synchronous release. (A) 
Representative EJP traces of P[sytWT] (black), P[sytD-N,F-E] (red), and P[sytM-E,D-N,F-E] (blue). 
Scale bars represent 5 mV, 20 ms. (B) Compared to P[sytWT] (n = 9 fibers), mean EJP amplitude 
was severely impacted in P[sytD-N,F-E] (n = 9 fibers) and P[sytM-E,D-N,F-E] (n = 10 fibers) (p < 
0.0001, ANOVA, p < 0.0001 comparing P[sytWT] to P[sytD-N,F-E]and p < 0.0001 comparing 
P[sytWT] to P[sytM-E,D-N,F-E], Dunnett’s correction). Error bars depict SEM. 
 
 
The size of the readily releasable pool was unchanged  
A decrease in the size of the readily releasable pool could result in decreased NT release. 
Ringer made hypertonic with the addition of sucrose has been shown to stimulate a Ca2+-
independent form of release, which is implicated to correspond to the same pool of releasable 
vesicles as action-potential triggered release [37-39]. We triggered Ca2+-independent fusion 
events using puff application of 0.3 M sucrose directly to third instar larval neuromuscular 
junctions in Ca2+-free saline. During and after sucrose application, increases in mEJP frequency 
for all genotypes were observed relative to basal frequency (Fig 3.6A,B). As the P[sytD-N,F-E] 
mutation resulted in increased mEJP frequency (Fig 3.4C), mEJP frequencies were normalized to 
mEJP frequency before sucrose application (Fig 3.6C). The increases relative to basal mEJP 
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frequency in all genotypes resulted in similar mEJP frequency increases during the sucrose 
response (p = 0.09, ANOVA). Normalized mean mEJP fold-change ± SEM for P[sytWT] (n = 
12) = 2.40 ± 0.16, P[sytD-N,F-E] (n = 14) = 2.33 ± 0.13, and P[sytM-E,D-N,F-E] (n = 13) = 2.74 ± 
0.13). Both P[sytD-N,F-E] and P[sytM-E,D-N,F-E] mutants displayed similar increases to control 
during maximal sucrose response (Fig 3.6C, p = 0.99 comparing P[sytWT] to P[sytD-N,F-E] and p 
= 0.15 comparing P[sytWT] to P[sytM-E,D-N,F-E], Dunnett’s correction). These results cannot 
account for the severe deficits in evoked release.  
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Fig 3.6. The readily releasable pool was unchanged. (A) Representative traces of event frequency 
before (left) and during sucrose-stimulated responses (right) for P[sytWT] (black), P[sytD-N,F-E] 
(red), and P[sytM-E,D-N,F-E] (blue). Scale bar 2 mV, 0.4 s. (B) Plotted mEJP frequencies in 
response to a 5 s application of hypertonic sucrose. The black bar above the traces represents the 
sucrose application. (C) mEJP frequencies over time in response to sucrose application 
normalized to basal mEJP frequency. No statistically significant changes were determined 
between genotypes during sucrose response (p = 0.09, ANOVA). 
 
 
 Probability of release was decreased in hydrophobic mutants 
 A change in release probability could explain the decrease in evoked responses. 
Experiments in which two closely spaced stimuli are administered, or paired pulse experiments, 
are commonly used to moniter changes in release probabilities. The ratio of the second response 
to the first response is called the paired pulse ratio (PPR). PPR decreases as a result of increased 
release probability, and increases as a result of decreased release probability [31, 40]. 
Accordingly, we stimulated each fiber with 2 pulses at 20 ms interpulse intervals. We performed 
a paired pulse analysis in which paired pulse ratios between control (n = 13) and P[sytD-N,F-E] (n 
= 12) were analyzed. Control (n = 12) and P[sytM-E,D-N,F-E] (n = 13) mutants were also 
compared. The P[sytD-N,F-E] mutation exhibits a significantly larger paired pulse ratio when 
compared to control (Fig 3.7B, mean paired pulse ratio ± SEM for P[sytWT] = 1.09 ± 0.02 and 
P[sytD-N,F-E] = 2.50 ± 0.30, p < 0.0001, student t-test). The P[sytM-E,D-N,F-E] mutation also 
displayed a significantly larger paired pulse ratio than control (Fig 3.7D, mean paired pulse ratio 
± SEM for P[sytWT] = 1.08 ± 0.02, and mean paired pulse ratio ± SEM for P[sytM-E,D-N,F-E] = 
1.83 ± 0.10, p < 0.0001, student t-test). These significantly larger paired pulse ratios indicate 
decreased release probability. Therefore, the decreases in synchronous evoked transmission were 
not due to changes in the readily releasable pool (Fig 3.6C) or quantal size (Fig 3.4D,F), but 
instead resulted from decreased release probability. 
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Fig 3.7. Release probability was decreased in hydrophobic mutants. (A) Representative traces 
between P[sytWT] (black) and P[sytD-N,F-E] (red) stimulated with a 20 ms interpulse interval. 
Scale bars represent 5 mV, 50 ms. (B) Paired pulse analysis indicated statistically different 
paired pulse ratios between control (n = 13) and P[sytD-N,F-E] (n = 12, p < 0.0001, student t-
test). Error bars are SEM. (C) Representative responses of P[sytWT] (black) and P[sytM-E,D-N,F-
E] (blue) to paired pulse stimulations. Scale bars represent 5 mV, 50 ms. (D) Paired-pulse 
quantification between control (n = 12) and P[sytM-E,D-N,F-E] (n = 13) indicated a significantly 
larger paired pulse ratio in P[sytM-E,D-N,F-E] (p < 0.0001, student t-test). Error bars are SEM. 
 
 
Asynchronous release was unaffected in hydrophobic mutants 
Asynchronous release is thought to occur for ~300 ms at Drosophila neuromuscular 
junctions [30] (and Shields, unpublished). We assessed asynchronous release events using two 
electrode voltage clamp recordings, as it provides the temporal resolution current clamp cannot. 
We manually counted the number of individual mEJC events 300 ms before and 300 ms after 
each stimulation, and quantified the differences for each trace. These differences were summed, 
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and a ratio of after/before was determined. In this way, a general percentage could be attributed 
to asynchronous release. The synchronous release event upon stimulation was excluded. Control 
traces (n = 85) comparing asynchronous release to P[sytD-N,F-E] mutants exhibited a 23% 
increase in post-stimulation events compared to pre-stimulation events, while the P[sytD-N,F-E] 
mutation (n = 70) exhibited a 35% increase in events. Control traces (n = 75) comparing 
asynchronous release to P[sytM-E,D-N,F-E] mutants exhibited a 29% increase, and P[sytM-E,D-
N,F-E] mutants (n = 80) exhibited a 23% increase.  
To statistically analyze asynchronous events between genotypes, trace differences were 
compared. Mean differences between P[sytWT] (n = 85, mean release event differences ± SEM = 
0.21 ± 0.14 events) and P[sytD-N,F-E] (n = 70, mean release event differences ± SEM = 0.7 ± 
0.23 events) were not statistically different (Fig 3.9C, p = 0.14, Mann-Whitney). Mean 
differences of release events for P[sytWT] (n = 75) are 0.13 ± 0.14 events, and mean differences 
for P[sytM-E,D-N,F-E] (n = 80) were 0.28 ± 0.16 events. These genotypes were also not 
significantly different (Fig 3.9F, p = 0.92, Mann-Whitney). The addition of a second 
hydrophobic mutation in the P[sytM-E,D-N,F-E] mutation seemed to prevent aberrant 
asynchronous release more completely, although this was not determined statistically. Therefore, 
preventing syt from membrane interactions returned asynchronous release to control levels. This 
supports the hypothesis that the P[sytD-N] mutation was mimicking an asynchronous sensor, 
which created artifacts in release events in response to stimulation.  
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Fig 3.9. Hydrophobic mutations did not alter asynchronous neurotransmitter release. (A-B) Left, 
representative voltage traces for P[sytWT] (black) and P[sytD-N,F-E] (red) exhibiting events both 
300 ms before and after single stimulations. Small arrows represent individual events. Scale bars 
represent 0.5 nA, 0.1 s. Right, latencies of mEJCs 0.3 s before and 0.5 s after single stimulations. 
Each mEJC was categorized into a 10 ms bin. (C) Quantification of mean event differences, or 
asynchronous release, between P[sytWT] (n = 85) and P[sytD-N,F-E] (n = 70). No significant 
change was determined between genotypes (p = 0.14, Mann-Whitney). (D-E) Left, representative 
voltage traces for P[sytWT] (black) and P[sytM-E,D-N,F-E] (blue,) exhibiting events 300 ms 
before and after stimulation. Small arrows represent individual events. Right, latencies of mEJCs 
0.3 s before and 0.5 s after single stimulations. Each mEJC was categorized into 10 ms bins. 
Each bin was presented as the number of events/stimulation. (F) Quantification of mean event 
differences between P[sytWT] (n = 75) and P[sytM-E,D-N,F-E] (n = 80) determined no significant 
difference between genotypes (p = 0.92, Mann-Whitney).  
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3.4 Discussion 
 Here we showed that a previously published mutant introduced asynchronous release 
artifacts by mimicking an active asynchronous release Ca2+ sensor. We accomplished this by 
adding additional hydrophobic mutations to the previously published mutation, thus preventing 
presynaptic membrane interactions. If synaptotagmin’s C2A domain was regulating an 
asynchronous sensor, these mutations would not have affected the increase in asynchronous 
release seen in the P[sytD-N] mutant. However, we reported no increase in asynchronous release 
events, providing further evidence that synaptotagmin’s C2A domain is not needed to regulate an 
asynchronous Ca2+ sensor.  
These newly constructed hydrophobic mutations expressed appropriately to the 
neuromuscular junction and exhibited similar protein expression to control. The P[sytD-N,F-E] 
mutation exhibited an increase in mEJP frequency, suggesting interference with only one 
hydrophobic residue was not sufficient to clamp the increase in mEJP frequency seen in the 
P[sytD-N] mutation alone. However, with interference of both C2A domain hydrophobic residues 
in the P[sytM-E,D-N,F-E] mutation, we reported mEJP frequency similar to control. Therefore, the 
interference of both hydrophobic residues were sufficient to re-clamp mEJP frequency induced 
by the P[sytD-N] mutation. Evoked events resulted in a > 90% knockdown of function in the 
hydrophobic mutants. These are the most severe synaptotagmin C2A mutations reported to date. 
We conclude that these deficits were due to release probability and not the size of the readily 
releasable pool or quantal size. Moreover, asynchronous release events were not increased in 
either the P[sytD-N,F-E] mutant or the P[sytM-E,D-N,F-E] mutant. Together, these results are 
inconsistent with the inhibition hypothesis.  
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If synaptotagmin 1’s C2A domain is not actively regulating an asynchronous sensor, 
another mechanism must be present to explain the interplay between synaptotagmin knockouts, 
mutations, and the resultant changes in asynchronous release. One simple explanation may be 
due to a competition for space between synaptotagmin and the asynchronous Ca2+ sensor. This 
competition hypothesis can explain why synaptotagmin 1 null synapses exhibited increased 
asynchronous release increases. Here, a lack of competition would allow the asynchronous 
sensor more access to Ca2+ and result in increased asynchronous release. 
The competition hypothesis is supported by other studies in which researchers used 
alternative synaptotagmin C2A Ca2+ binding mutants where they reported no increase in 
asynchronous release (Shields, unpublished). Synaptotagmin was still present at the active zone 
and Ca2+ binding in C2A was disabled; yet no increase in asynchronous response. Finally, the 
present study shows that the P[sytD-N] mutation was actually mimicking an asynchronous Ca2+ 
sensor. Therefore, although synaptotagmin was still present, the increased asynchronous release 
could be explained by artifacts of the P[sytD-N] synaptotagmin mutant.  
 
3.5 Conclusion 
 This study investigates a previously studied Ca2+-binding mutant in synaptotagmin 1’s 
C2A domain and provides evidence that it mimics an asynchronous sensor due to a mutational 
artifact. This work supports an alternative hypothesis regarding synaptotagmin 1’s affect on 
asynchronous neurotransmitter release. By introducing additional mutations that prevent 
interactions with the presynaptic membrane, we showed these new mutants clamp the previously 
reported increase in asynchronous release. More investigation into this interplay is needed, as 
there is obvious discord on this mechanism. 
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3.6 Materials and methods 
 
Drosophila Genotypes  
The UAS/Gal4 system was used to drive neuronal expression of our syt 1 transgenes [41, 
42]. The UAS promoter provides strong expression of our syt transgenes in any cell expressing 
galactosidase-4 (Gal4). Expression was localized specifically to the nervous system using the 
elav promoter to drive Gal4 expression, and hence syt transgene expression, in all neurons. To 
assess the functional significance of the mutation, all transgenes were expressed in the absence 
of endogenous synaptotagmin expression using the sytnull mutation, sytAD4 [43]. The genotypes 
of experimental larvae were the following: yw; sytnullelavGal4/sytnull; P[UASsytWT]/+ line 1 
(transgenic control, referred to as P[sytWT]), yw; sytnullelavGal4/sytnull; 
P[UASsytD280,282N,F284E]/+ (referred to as P[sytD-N,F-E]), and yw; sytnullelavGal4/sytnull; 
P[UASsytM222E,D280,282N,F284E]/+ (referred to as P[sytM-E,D-N,F-E]) 
 
Transgenic creation  
cDNA of the Drosophila wild type syt1 gene [44], flanked by 5’ EcoRI and 3’ BgLII 
restriction sites, was synthesized by GeneWiz (South Plainfield, New Jersey). GeneWiz 
synthesized cDNA for both hydrophobic mutations, as well. The transgenes were placed under 
the control of the UAS promoter by directional subcloning of the synthesized cDNA into the 
pUAST-attB vector using these unique restriction sites. The mutant transgenes were inserted in 
the attP2 landing site in Drosophila using the PhiC31 targeted insertion system [45] at BestGene 
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Immunoblotting  
Western analysis on individual larval CNS’s was used to determine levels of 
synaptotagmin relative to an actin loading control. Third instar larval CNSs were dissected in 
HL3.1 saline (70 mM NaCl, 5 mM KCl, 4 mM MgCl2, 10 mM NaHCO3, 5 mM Trehalose, 115 
mM sucrose, 5 mM HEPES, pH 7.2 [46]: Individual CNSs were sonified for 5 pulses using a 
Branson Sonifier 450 (VWR Scientific, Winchester, PA) in Laemmli buffer (Bio-Rad, Hercules, 
CA) containing 5% B-mercaptoethanol. Each sample was electrophoresed, transferred to 
Immobilon membranes (Millipore, Bedford, MA), and washed in blocking solution as previously 
described [47]. Membranes were probed with a 1:2500 dilution of anti-syt antibody, Dsyt-CL1 
[48] and 1:10,000 dilution of anti-actin antibody, MAB 1501 (Millipore Bioscience Research 
Reagents, Billerica, MA), overnight at 4 degrees. An Epichemi3 Darkroom and Labworks 
Imaging Software (UVP BioImaging, Upland, CA) were used to visualize the protein bands. 
Quantification of blots: syt:actin ratios were calculated normalized to the mean syt:actin ratios of 
control lanes for each blot to compare syt signals between blots. Outliers in actin levels were 
excluded from the analysis. Statistical significance was determined using a one-way ANOVA 
using Prism 7.  
 
Immunolabeling  
To visualize transgenic synaptotagmin at the larval neuromuscular junction, third instar 
larvae were dissected in HL3.1 saline and fixed in phosphate-buffered saline (PBS, 137 mM 
NaCl, 1.5 mM KH2PO4, 2.7 mM KCl, 8.1 mM Na2HPO4) containing 4% formaldehyde for 1 
hour. Samples were probed overnight in a 1:400 dilution of Dsyt-CL1 in dilution media [PBS 
with 0.1% Triton, 1% bovine serum albumin (Millipore-Sigma, Burlington, MA) and 1% normal 
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goat serum (Fitzgerald Industries International, Acton, MA). The next day, the whole mounts 
were washed in PBS with 0.1% Triton for 1-3 hours, then incubated in dilution media containing 
a 1:400 dilution of Alexa Fluor 488 goat anti-rabbit antibody (Invitrogen, Carlsbad, CA) for 1 
hour at room temperature. Labeled samples were washed in PBS with 0.1% Triton for one 
additional hour, and mounted on microscope slides in Citifluor (Ted Pella, Redding, CA). 
Images of neuromuscular junctions of muscle 6/7 in segments 3 and 4 were acquired using a 
Zeiss 880 light scanning microscope using a 40X objective with Zeiss Zen 2.1 acquisition 
software, version 11,0,3,190. 
 
Electrophysiological experiments and analyses 
All electrophysiological events were collected using an Axoclamp 2B amplifier 
(Molecular Devices, Sunnyvale, CA), digitized using a Powerlab 4/35 A/D converter 
(ADInstuments, Sydney, Australia) and recorded in LabChart software (ADInstruments, Sydney, 
Australia). Intracellular electrodes were pulled using a (Cite puller) to 10-20 MOhms and filled 
with 3 parts 2 M Kcitrate to 1 part 3 M KCl. Third instar larvae were dissected in HL3.1 saline to 
expose the body wall and to remove the CNS. Recordings were made from muscle 6 of 
abdominal segments 3 and 4, and held at -55 mV using up to 1 nA of current. All 
electrophysiological statistical analyses were calculated using Prism 7 software.  
Single EJPs were evoked from in HL3.1 saline containing 1.0 mM Ca2+ as previously 
described [26, 47, 49]. A stimulating electrode was filled with bath solution to directly stimulate 
the motor nerve innervating the muscle fiber. Averages of 10 EJPs collected at 0.04 Hz were 
calculated for each fiber. Statistical significance was determined using student t-tests. 
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Miniature excitatory junction events were acquired for 3 minutes in HL3.1 saline. Events 
were identified manually after recordings had been randomized and blinded to the researcher for 
analysis. To determine mEPSP frequency, total events in each fiber were counted for 1 
consecutive minute, using consistent time periods from each fiber. Statistical significance for 
mEJP frequency was determined using student t-tests. Mean mEJP amplitudes were determined 
from 100 consecutive events/fiber, taken from consistent time periods from each recording to 
eliminate bias. Statistical significance was determined using Mann-Whitney tests. All recordings 
were randomized and blinded to the researcher for analysis 
For paired pulse experiments, a stimulating electrode was filled with bath solution 
(HL3.1 saline with 1.0 mM Ca2+) to directly stimulate the motor nerve innervating the muscle 
fiber. Stimulations were given using a 0.02 s delay between stimulations, and paired pulse ratios 
were determined by dividing the EJP amplitude of the second stimulation by the amplitude of the 
first stimulation. Genotype means of the paired pulse ratios were compared using student t-tests.  
For hypertonic stimulations, a puff application of modified HL3.1 saline containing 0.3 
M sucrose was administered to the junctional region of muscles 6/7 in abdominal segments 3 and 
4 of third instars. The puff application was administered for 5 s at ~5 pounds per square inch. 
Hypertonic stimulation recordings were acquired in a bath solution of Ca2+-free HL3.1 saline. 
All recordings were randomized and blinded to the researcher for analysis. Frequency of mEJP 
events were counted manually into 1 s bins for 60 s, with 10 s prior to sucrose application to 
determine a baseline mEJP frequency, and 50 s to determine each genotype’s response to the 
sucrose up to one minute after puff application. To determine average mEJP frequency during 
sucrose response, 30 s of mEJP events were averaged during the sucrose response, beginning at 
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the initiation of the sucrose application. Statistical significance was determined using a one-way 
ANOVA.  
Synaptic currents were recorded using two-electrode voltage clamp as described [50]. 
Recordings were acquired in HL3.1 saline containing 1.0 mM Ca2+. An additional intracellular 
electrode was pulled with Sutter model P-97’’ to 10-15 MOhm resistance. Upon both 
intracellular electrodes’ insertions, recordings with muscle input resistances < 5 MOhms were 
excluded. Fibers were voltage clamped to -55 mV using no more than 1 nA of current and 
stimulated at 0.2 Hz for 5 stimulations. Rise time constants were quantified by determining rise 
time (time from beginning of current response to peak current response), and then determining 
the time in which the current had reached 63.2% of its max value. Decay time constants were 
determined by determining decay time (the time from peak current response back to baseline), 
and then determining the time for the decay current to decay 63.2% of its peak response. Traces 
that failed to respond to stimulation were not analyzed for release kinetics. Student t-tests were 
used to determine significance. Latency analysis was acquired by manually binning each mEJC 
event into 10 ms bins and presented as the number of events/stimulation for each bin. Statistical 
analyses for asynchronous release events were determined by calculating the differences in 
mEJC frequency 300 ms before and after stimulation for each individual stimulation (# events 
after stimulation - # events prior to stimulation). The synchronous responses found in the first 2 
10 ms bins were not included in the asynchronous analysis. These differences were averaged per 
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CHAPTER 4: DROSOPHILA STUDIES SUPPORT A ROLE FOR A PRESYNAPTIC 




4. 1 Summary 
During chemical transmission, the function of synaptic proteins must be coordinated to 
efficiently release neurotransmitter. Synaptotagmin 2, the Ca2+ sensor for fast, synchronized 
neurotransmitter release at the human neuromuscular junction, has recently been implicated in a 
dominantly inherited congenital myasthenic syndrome associated with a non-progressive motor 
neuropathy. In one family, a proline residue within the C2B Ca2+-binding pocket of 
synaptotagmin is replaced by a leucine. The functional significance of this residue has not been 
investigated previously. Here we show that in silico modeling predicts disruption of the C2B 
Ca2+-binding pocket, and we examine the in vivo effects of the homologous mutation in 
Drosophila. When expressed in the absence of native synaptotagmin, this mutation is lethal, 
demonstrating for the first time that this residue plays a critical role in synaptotagmin function. 
To achieve expression similar to human patients, the mutation is expressed in flies carrying one 
copy of the wild type synaptotagmin gene. We now show that Drosophila carrying this mutation 
developed neurological and behavioral manifestations similar to those of human patients and 
provide insight into the mechanisms underlying these deficits. Our Drosophila studies support a 
role for this synaptotagmin point mutation in disease etiology.  
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4.2 Introduction 
Understanding the mechanisms mediating information transmission across a chemical 
synapse is essential to understanding brain function. During synaptic transmission, membranous 
vesicles filled with neurotransmitter must fuse with the presynaptic membrane in response to 
Ca2+ influx, thereby releasing the transmitter into the synaptic cleft. The synaptic vesicle protein, 
synaptotagmin, is essential for this release [2-4] as it binds the Ca2+ that triggers vesicle fusion 
[5-7]. Synaptotagmin has two Ca2+-binding pockets, C2A and C2B [8-10], which have both been 
extensively studied for their role in synchronizing vesicle fusion in vivo [5, 7, 11-13] and in 
culture [14, 15]. Synaptotagmin 2 is the predominant isoform found at mammalian 
neuromuscular junctions [16, 17], and until recently, has never been linked to disease. However, 
whole-exome sequencing techniques have now identified point mutations in the human 
synaptotagmin 2 (syt2) gene in patients with a disease combining congenital myasthenic 
syndrome and distal motor weakness, suggesting a role for synaptotagmin in neuromuscular 
disease [18, 19]. 
Two independent mutations in the C2B Ca2+-binding pocket of syt2 have been identified: 
one in a United States (US) family and one in a United Kingdom (UK) family. Patients in each 
of the two families exhibit a novel neuromuscular syndrome characterized by foot deformities, 
fatigable ocular movements, lower limb weakness, and potentiation of tendon reflexes following 
exercise [18, 19]. In nerve conduction studies, all patients exhibited normal sensory responses. 
However, motor responses revealed low amplitude compound muscle action potentials (CMAPs) 
that exhibited significantly less amplitude depression following brief maximum voluntary 
contraction [18, 19]. These findings are indicative of a presynaptic deficit of neuromuscular 
junction function.  
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Interestingly, both familial mutations are located in C2B Ca2+-binding pocket of syt2 
within the highly conserved “SDPYVK” residue motif (Fig 4.1) [18, 19]. The US family 
possesses an aspartate 307 (referred to as D2) to alanine substitution within this motif (Fig 4.1D, 
first *). As D2 is one of the well-ordered C2B aspartate residues known to coordinate the binding 
of Ca2+ [10, 20, 21] required for triggering neurotransmitter release [5, 12, 15], the function of 
this residue has been extensively studied. The UK family possesses a proline 308 to leucine 
substitution within this motif (Fig 4.1D, second *). We investigated the anticipated 
conformational changes of the proline to leucine (P-L) substitution by modeling this P-L 
mutation in silico. Simulation of the P-L mutation predicts that replacement of the highly 
conserved proline residue by a leucine would extend β-strand 3 into the Ca2+-binding pocket (Fig 
4.1A,B, small arrow). The extension of β-strand 3 is accompanied by a significant distortion of 
the backbone angles of residues on the amino terminal side of the proline (Fig S4.1). The 
distortion of upstream residues places this critical D2 Ca2+-binding residue in a non-ideal 
conformation for Ca2+ binding (Fig 4.1C, curved arrow and Fig S4.1). Further, the additional 
amide proton from the mutant leucine residue forms a new H-bond with neighboring residues in 
loop 2 (not shown), thereby altering the shape, and likely the flexibility, of the Ca2+-binding 
pocket. A more rigid Ca2+-binding pocket, as well as the sub-optimally positioned D2 Ca2+-
binding residue, predict deficiencies in Ca2+ binding in the P-L mutation. Together, our 
modeling predicts that this mutation would result in conformational changes in synaptotagmin’s 
C2B domain that would impair Ca2+ binding. Although this proline residue is highly conserved 
(Fig 4.1D), its importance for synaptotagmin function has not been investigated previously. 
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Fig 4.1. Predicted conformational changes in synaptotagmin’s C2B Ca2+-binding pocket.  
(A) Molecular model depicting the crystal structure of the synaptotagmin C2B Ca2+-binding 
pocket. Flexible loops 1, 2, and 3 are indicated. The proline residue under investigation (P) and 
the adjacent, Ca2+-coordinating aspartate (D2) are shown as stick models. Note that the proline is 
at one end of β-strand 3 (small arrow) and the aspartate is in loop 1. (B) Predicted structural 
changes induced by the sytP-L substitution. The leucine (L) and the adjacent aspartate (D2) 
residues are shown as stick models and both are now within β-strand 3 (small arrow indicates 
extension of β-strand 3). The large arrow indicates a newly formed β-strand. (C) Overlay of wild 
type (yellow) and sytP-L mutant (turquoise). The curved arrow indicates the displacement of the 
D2 Ca2+-binding residue. (D) Sequence alignment of the highly conserved SDPYVK amino acid 
motif of the synaptotagmin C2B domain from humans, rat, zebra fish, squid, Drosophila, and C. 
elegans. *locations of the point mutations in the US and UK families, respectively. Note: syt1 
and syt2 in mammals are identical in this region. 
 
To directly assess whether the sytP-L point mutation impacts Ca2+-binding resulting in 
synaptic deficits in vivo, we generated a homologous P-L mutation in the synaptotagmin isoform 
expressed at the Drosophila neuromuscular junction (sytP-L). In mammals, the synaptotagmin 1 
gene (syt1) is predominantly expressed throughout the cerebral hemispheres while syt2 is 
predominantly expressed in the brainstem and spinal cord, and hence at the neuromuscular 
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junction [16, 17]. There is no syt2 gene in Drosophila [22, 23]; the syt1 gene is expressed pan-
neuronally [24, 25] and codes for the Ca2+ sensor for fast, synchronous neurotransmitter release 
[5, 6] throughout the nervous system. When the sytP-L mutation is expressed in Drosophila in the 
absence of wild type synaptotagmin, it results in lethality, demonstrating that this proline residue 
is critical for synaptotagmin function. As the human condition presents as a syt heterozygous 
dominant disorder, with patients carrying one copy of the wild type syt gene and one copy of the 
mutated syt gene (sytWT/sytP-L), we simulated this expression pattern by driving pan-neuronal 
expression from one mutant transgene using elavGal4 in syt heterozygotes (+/-;P[sytP-L]/+). 
Physiologically, mutant larvae exhibit decreased evoked transmitter release and less synaptic 
depression during high-frequency stimulus trains, consistent with the human electrophysiological 
deficits. In addition, the decreased Ca2+ affinity of release and the associated decreased release 
probability documented here are consistent with the predicted disruption to the C2B Ca2+-binding 
pocket (Fig 4.1A-C). Behaviorally, mutant adult flies exhibit less overall activity and a marked 
increase in fatigability, also consistent with the human phenotype. Together, these results 
indicate that this proline to leucine substitution impairs Ca2+ binding and support a role for this 
substitution in the etiology of this human neuromuscular disease.  
 
4.3 Results 
In the absence of wild type synaptotagmin, the P[sytP-L] mutation increases the lethality rate 
To assess the effects of the sytP-L mutation in the absence of the wild type protein, we 
drove pan-neuronal expression of syt transgenes in the sytnull background using the elavGal4 
promoter (referred to as -/-;P[sytWT]/+ or -/-;P[sytP-L]/+, see methods for full genotype). Rates 
of survival to the first instar larval stage were also compared to larvae lacking any synaptotagmin 
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1 expression (-/-). Balancer chromosomes used in our crossing scheme result in embryonic 
lethality for any wild type synaptotagmin homozygotes (+/+ for syt, included in Table 4.1 under 
unhatched) due to the presence of a homozygous lethal Cy mutation (see methods and Fig S4.2) 
with an expected frequency of ~25%.  
Table 4.1. The sytP-L mutation negatively impacts survival rate in the absence of native 
synaptotagmin. Table depicts percentages and raw counts (in parentheses) of first instar larvae in 
the sytnull (-/-, top row) and syt heterozygous (+/-, second row) backgrounds and embryonic 
lethality (unhatched) of progeny containing one copy of synaptotagmin transgenes (P[sytWT] or 
P[sytP-L]) or of progeny containing no transgenic syt (last column). All crosses were carried out 
using the CyO second chromosome balancer such that syt homozygotes are lethal (included in 
unhatched) due to the presence of the homozygous lethal Cy mutation (sytWT Cy/sytWT Cy). 
There was a significant decrease in the percentage of first instars expressing one copy of P[sytP-
L] in the absence of any wild type synaptotagmin (-/-;P[sytP-L]/+, 12.0%) compared to control (-
/-;P[sytWT]/+, 25.7%, p < 0.0001, Chi-squared test). There was also a significant decrease in the 
percentage of first instars expressing one copy of the P[sytP-L] transgene (-/-;P[sytP-L]/+, 
12.0%) compared to no synaptotagmin expression at all (-/-; no transgenic syt, 18.0%, p < 
0.0001, Chi-squared test). 
  P[sytWT]  P[sytP-L]  No transgenic syt 
 -/- 25.7% (365)  12.0% (212)  18.0% (231) 
 +/- 48.7% (691)  50.1% (888)  49.8% (640) 
 Unhatched 25.6% (363)  37.9% (671)  32.2% (415) 
 
As expected for a fully functional protein, the wild type transgenic cross resulted in 
progeny where ~25% were sytnull mutants expressing synaptotagmin from the wild type 
transgene (-/-;P[sytWT]/+; Table 1, 25.7%). This is significantly larger than in the P[sytP-L] 
cross, in which only 12.0% of progeny were sytnull mutants expressing the mutated transgene (-/-
;P[sytP-L]/+, Table 1, 12.0%, p < 0.0001). As previously shown, sytnull mutants are viable [26], 
and the cross lacking any source of synaptotagmin resulted in 18.0% of progeny that were sytnull 
mutants (Table 1, no transgenic syt, 18.0%). Yet the expression of the mutant transgene resulted 
in a significant decrease in the rate of survival to the 1st instar larval stage (Table 1, 18.0% down 
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to 12.0%, p < 0.0001). Thus, in the absence of wild type synaptotagmin, the expression of 
P[sytP-L] not only fails to rescue synaptotagmin function, it results in a negative impact on 
survival. This is the first study to show the critical nature of this proline residue for 
synaptotagmin function.  
 
Transgenic synaptotagmin is expressed appropriately 
To verify appropriate transgenic synaptotagmin expression levels for modeling this 
disease in Drosophila, western blot analysis was performed on the central nervous system (CNS) 
of larvae. Comparison of CNS samples from syt heterozygotes (+/-) and syt heterozygotes 
expressing one copy of the mutant transgene (+/-; P[sytP-L]/+, hereafter referred to as P[sytP-L] 
heterozygotes) showed significant differences in the level of synaptotagmin expression with an 
approximate doubling of synaptotagmin levels in the transgenic line (Fig 4.2A, +/- is 46 ± 18% 
of +/-;P[sytP-L]/+, p = 0.0008). This finding indicates approximately equal protein expression 
from the native gene and the transgene. Consistent with this interpretation, CNS samples from 
wild type syt homozygotes (+/+) and from P[sytP-L] heterozygotes showed similar levels of 
synaptotagmin expression (Fig 4.2B, +/-;P[sytP-L]/+ is 94 ± 9.0% of +/+, p = 0.69). Fig 4.2C 
demonstrates approximately equal levels of synaptotagmin in P[sytP-L] heterozygotes and the 
P[sytWT] heterozygous controls (+/-; P[sytP-L]/+ is 121 ± 8.1% of +/-;P[sytWT]/+, p = 0.25). 
Thus, our heterozygous transgenic control also expresses appropriate levels of synaptotagmin. 
Finally, both the transgenic wild type and transgenic mutant protein are appropriately targeted to 
the synapse (Fig 4.2D-G). As seen in wild type Drosophila [24, 25], synaptotagmin staining in 
muscles is restricted to the neuromuscular junction in third instar larvae of both the P[sytWT] 
heterozygote controls and the P[sytP-L] heterozygotes (Fig 4.2D,E, respectively). Staining of 
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first instar larvae expressing the syt transgenes in the absence of native synaptotagmin also 
revealed that the transgene is appropriately expressed at the neuromuscular junction (Fig 4.2F,G, 
-/-;P[sytWT]/+ and -/-;P[sytP-L]/+).  
 
Fig 4.2. Transgenic synaptotagmin is expressed at appropriate levels and exhibits appropriate 
localization. (A-C) Representative western blots above and average synaptotagmin expression 
normalized to actin levels below. Syt heterozygotes expressing one copy of the mutant transgene 
(+/-;P[sytP-L]/+, n = 6, 5, and 7, respectively) are compared to syt heterozygotes (+/-, n = 5, A), 
syt homozygotes (+/+, n = 5, B), and syt heterozygotes expressing one copy of the wild type 
transgene (+/-;P[sytWT]/+, n = 8, C). The P[sytP-L] heterozygotes had approximately twice as 
much synaptotagmin expression as syt heterozygotes (p = 0.0008, student t-test), while there was 
no significant difference in expression between the other lines compared (Fig 4.2B, p = 0.69 and 
Fig 4.2C, p = 0.25). Error bars depict SEM. (D, E) Third instar larvae stained with antibodies 
against horseradish peroxidase (HRP) as a general axonal stain (red) and synaptotagmin (green). 
Scale bars represent 10 µm. (F, G) First instar larvae stained with antibodies against 
synaptotagmin. Scale bars represent 20 µm.  
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Lifespan is decreased in P[sytP-L] heterozygotes 
 While P[sytP-L] heterozygotes are easily generated and maintained throughout all larval 
and adult stages, we wanted to ascertain whether this mutation had any impact on lifespan in 
heterozygotes. Therefore, we performed a longevity assay. Lifespans between P[sytWT] 
heterozygotes (51.4 ± 1.50 days, mean lifespan ± SEM, n = 151) and P[sytP-L] heterozygotes 
(39.2 ± 1.25 days, mean lifespan ± SEM, n = 149) are significantly different (Fig 4.3, p < 0.0001, 
Wilcoxon Rank-Sum test). However, this does not relate directly to the human condition, who 
show no indication of this P-L mutation impacting longevity, as these flies do not receive any 
medical intervention. These results support a detrimental role of the proline to leucine mutation 
in survival.  
 
Fig 4.3. Lifespan is decreased in P[sytP-L] heterozygotes. (A) Adult lifespan curves of +/-
;P[sytWT]/+ (n = 151, black ) and +/-;P[sytP-L]/+ (n = 149, red). (B) Mean lifespan is 
significantly decreased in +/-;P[sytP-L]/+ adults (p < 0.0001, Wilcoxon Rank-Sum test). 
 
 
The sytP-L mutation disrupts evoked transmitter release  
In human motor nerve conduction studies, the summated response of all muscle fibers 
supplied by a particular motor nerve can be measured as a CMAP. The sytP-L-affected family 
members present with decreased CMAP amplitudes [18, 19], consistent with a decrease in 
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evoked transmitter release. To test evoked release in Drosophila P[sytP-L] heterozygotes, we 
measured excitatory junction potentials (EJPs) at the larval neuromuscular junction. Upon nerve 
stimulation, P[sytP-L] heterozygotes exhibited a significant decrease in the amount of 
neurotransmitter released (Fig 4.4A,B). Average EJP ± SEM for +/-;P[sytWT]/+ was 34.8 ± 0.83 
mV, and for +/-;P[sytP-L]/+ was 29.6 ± 1.5 mV (p = 0.002, student t-test). This decrease in 
release is consistent with the decrease in baseline amplitude in the human motor nerve 
conduction studies.  
 
Fig 4.4. Synchronous evoked release is impaired in P[sytP-L] heterozygotes, but quantal content 
is unchanged. (A) Representative EJP traces for control and P[sytP-L] heterozygotes. Scale bars 
represent 10 mV, 0.2 s. (B) Mean EJP amplitude is significantly less in P[sytP-L] heterozygotes 
(n = 19) compared to control (n = 12, *p = 0.002). Error bars depict SEM. (C) Representative 
consecutive 3 second mEJP traces for control and P[sytP-L] heterozygotes. Scale bars represent 1 
mV, 0.2 s. (D, E) Neither mean mEJP amplitude (p = 0.09, Wilcoxon Rank-Sum Test, D) nor 
mean mEJP frequency (p = 0.18, student t-test, E) is significantly different between P[sytP-L] 
heterozygotes (n = 12 fibers) and control (n = 19 fibers). Error bars depict SEM. 
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One potential explanation for this observed 20% decrease in evoked response could be a 
decrease in quantal content. To determine quantal size, we calculated the mean amplitudes of 
Ca2+-independent spontaneous miniature EJPs (mEJPs) in both P[sytP-L] heterozygotes and their 
controls. Each mEJP results from one vesicle fusing with the presynaptic membrane. Thus, the 
amplitude of the response is an indication of the amount of neurotransmitter loaded into each 
vesicle. Neither the mean amplitude nor frequency of mEJPs in controls and P[sytP-L] 
heterozygotes were significantly different (Fig 4.4C-E). Mean mEJP amplitude ± SEM for 
P[sytWT] heterozygotes was 0.96 ± 0.03 mV (n = 50 mEJP events from 19 fibers), and for 
P[sytP-L] heterozygotes was 1.06 ± 0.05 mV (n = 50 mEJP events from 12 fibers, p = 0.09, 
Wilcoxon Rank-Sum Test ). Mean mEJP frequency ± SEM for P[sytWT] heterozygotes was 1.55 
± 0.15 Hz (n = 19 fibers), and for P[sytP-L] heterozygotes was 1.94 ± 0.26 Hz (n = 12 fibers, p = 
0.18, student t-test). These results demonstrate that the decrease in evoked release is not due to a 
change in quantal content.  
Transmitter release from an activated nerve terminal is a Ca2+-dependent, cooperative 
process [27]. Evoked release was measured at a variety of extracellular [Ca2+], ranging from 0.05 
mM to 5 mM, to assess whether the Ca2+ dependence of release was altered in P[sytP-L] 
heterozygotes. At all [Ca2+] above 0.1 mM, P[sytP-L] heterozygotes exhibit a decrease in evoked 
release compared to controls (Fig 4.5A). A nonlinear regression analysis determined a change in 
the Ca2+ dependence of P[sytP-L] heterozygotes. The extracellular [Ca2+] at which a 50% 
maximum response is reached (EC50) is statistically shifted in P[sytP-L] heterozygotes compared 
to controls. In +/-;P[sytWT]/+ EC50 = 0.33 mM Ca2+ (95% confidence intervals from 0.30-0.36 
mM Ca2+) and in +/-;P[sytP-L]/+ EC50 = 0.44 mM Ca2+ (95% confidence intervals from 0.41-
0.48 mM Ca2+, Fig 4.5B). The non-overlapping confidence intervals demonstrate that the proline 
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to leucine substitution in synaptotagmin results in a significant decrease in the Ca2+ affinity of 
release.  
 
Fig 4.5. The P[sytP-L] mutation decreases the Ca2+ affinity of release and vesicular release 
probability, but the readily releasable pool is unchanged. (A) Mean EJP amplitudes from +/-
;P[sytWT]/+ (filled black circles) and +/-;P[sytP-L]/+ (filled red circles) larvae at Ca2+ levels 
ranging from 0.05 mM - 5.0 mM. At [Ca2+] above 0.1 mM, statistical differences are seen 
between the two genotypes (*p < 0.05 for indicated [Ca2+], see Table S4.1 for specific n’s and p-
values, student t-tests). Lines of best fit were determined using non-linear regression analyses. 
(B) Graph depicting normalized EJP responses at log [Ca2+]. EC50 values were determined using 
the line of best fit determined by nonlinear regression analyses. Dotted lines depict the shift in 
the EC50 value. (C) Application of hypertonic 0.5 M sucrose to +/-;P[sytWT]/+ (n = 11 fibers, 
filled black circles) and +/-;P[sytP-L]/+ (n = 11 fibers, filled red circles) results in increases in 
mEJP frequency. Black bar below the traces represents the duration of the 10 s application of 0.5 
M sucrose or saline solution. Black bars above the mEJP responses indicate three consecutive 
seconds of individual traces either before sucrose application (left inset) or during peak sucrose 
response (right inset). Similar frequencies between +/-;P[sytWT]/+ and +/-;P[sytP-L]/+ are 
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observed both before and during sucrose response (n = 11 fibers for both genotypes, p = 0.28 
before sucrose application, p = 0.23 during maximum sucrose response). Application of bath 
solution does not result in an increase in mEJP frequency in either genotype (open circles) (p = 
0.57 for +/-;P[sytWT]/+ and p = 0.83 for +/-;P[sytP-L]/+, student t-test). Scale bar 2mV, 3s. (D) 
Paired pulse analysis indicates a decrease in release probability in +/-;P[sytP-L]/+. Left, 
representative traces of responses stimulated with a 20 ms interpulse interval. Scale bar 5 mV, 40 
ms. Right, in P[sytP-L] heterozygotes, the paired pulse ratio is significantly increased (+/-





Release probability is decreased in P[sytP-L] heterozygotes 
A decrease in the size of the readily releasable pool and/or a decrease in release 
probability for individual vesicles could result in decreased evoked transmitter release. To 
determine whether P[sytP-L] heterozygotes exhibit alterations in the size of their readily 
releasable pool of synaptic vesicles, we triggered Ca2+-independent vesicle fusion events using a 
hypertonic solution (0.5 M sucrose). Before sucrose stimulation, mEJP frequency is similar 
between both P[sytWT] and P[sytP-L] heterozygotes [Fig 4.5C, filled symbols, +/-;P[sytWT]/+ 
(black), 1.95 ± 0.07 Hz and +/-;P[sytP-L]/+ (red), 1.81 ± 0.10 Hz, mean mEJP frequency ± 
SEM, n = 11 fibers for both genotypes, p = 0.28, student t-test). Increases in mEJP frequencies 
are observed in both controls (p < 0.0001, student t-test) and P[sytP-L] heterozygotes (p < 
0.0001, student t-test) upon sucrose stimulation. These mEJP frequencies are also similar 
between genotypes during the maximum sucrose response period (Fig 4.5C, filled symbols, +/-
;P[sytWT]/+, 5.62 ± 0.23 Hz and +/-;P[sytP-L]/+, 5.32 ± 0.23 Hz, mean mEJP frequency ± 
SEM, p = 0.23, student t-test). When HL3.1 solution is puff applied, mEJP frequency remains 
similar between P[sytWT] and P[sytP-L] heterozygotes (Fig 4.5C, open symbols, +/-;P[sytWT]/+, 
1.71 ±.0.10 Hz and +/-;P[sytP-L]/+ = 1.96 ± 0.10 Hz, mean mEJP frequency ± SEM, p = 0.23, 
student t-test, n = 11 for both genotypes). Moreover, no increase is observed for either genotype 
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during or after saline stimulation (Fig 4.5C, open circles, +/-;P[sytWT]/+ p = 0.57 and +/-
;P[sytP-L]/+ p = 0.83, student t-test), indicating the increases in mEJP frequencies observed 
during sucrose stimulation result from hypertonic solution directly, and not a mechanical 
stimulation due to the puff application. Thus, the size of the readily releasable pool is not 
significantly altered in P[sytP-L] heterozygotes.  
To address release probability, we used a paired pulse analysis examining the ratio of the 
second response divided by the first response using a 20 ms interpulse interval. P[sytWT] 
heterozygotes (n = 18) and P[sytP-L] heterozygotes (n = 24) result in significantly different 
paired pulse ratios [Fig 4.5D, +/-;P[sytWT]/+ = 1.02 ± 0.02 (first pulse = 34.4 ± 0.84 mV, 
second pulse = 35.2 ± 0.89 mV, EJP amplitude ± SEM), compared to +/-;P[sytP-L]/+ = 1.27 ± 
0.06 (first pulse = 25.1 ± 1.02 mV, second pulse = 30.6 ± 0.84 mV, EJP amplitude ± SEM), p = 
0.0008, student t-test]. The significantly larger paired pulse ratio indicates a decrease in release 
probability in P[sytP-L] heterozygotes. Thus, our electrophysiological analysis of P[sytP-L] 
heterozygotes indicates the decrease in evoked transmitter release is not due to changes in the 
readily releasable pool, but rather results from a decrease in vesicular release probability.  
 A distinctive feature of the human condition is that following brief maximal voluntary 
muscle contraction, the CMAP amplitude is less depressed, typically for several minutes [18, 
19]. Since a decrease in release probability could result in less depression, we assessed this 
unique phenotype in Drosophila. We measured the amplitude of evoked release at the larval 
neuromuscular junction following a 10 Hz stimulation for 2 seconds. Responses were normalized 
to the initial EJP response to account for the decrease in EJP amplitude seen in the P[sytP-L] 
heterozygotes. Beginning at the fourth pulse of this stimulation period, P[sytP-L] heterozygotes 
exhibited a significant 5-10% decrease in synaptic depression relative to control (Fig 4.6, Table 
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S4.2). However, when a test stimulation was applied 1 minute after the end of the stimulus train, 
this effect was no longer observed; the amplitude of the evoked response in both the P[sytP-L] 
heterozygotes and the controls had returned to resting levels (Fig 4.6, Table S4.2).  
 
Fig 4.6. P[sytP-L] heterozygotes exhibit less depression throughout the course of high frequency 
stimulation, but fail to maintain this relatively increased response upon cessation of stimulation. 
(A) Representative traces from control and P[sytP-L] heterozygotes during a 2 second, 10 Hz 
stimulation train, and a single stimulus 1 minute following cessation of the train. Dotted line 
represents the amplitude of the initial response. Scale bar represents 10 mV, 0.2 s. (B) Mean EJP 
amplitudes of P[sytP-L] heterozygotes (n = 17) showed less depression compared to control (n = 
14, *indicates p < 0.05, and **indicates p < 0.001). However, this relative increase in release is 
not maintained upon cessation of the stimulus train (p = 0.87). Error bars depict SEM. 
 
Since maximum voluntary contraction can produce motor nerve firing rates in excess of 
50 Hz [28], larval preparations were stimulated at 50 Hz for 2 seconds in an attempt to more 
closely approximate the stimulus that results in the prolonged increase in release seen in the 
affected family members. Normalized post-stimulus train responses were tested at 1 second and 
then at 30-second intervals out to 4 minutes. This protocol displayed similar results to the 10 Hz 
stimulation experiment. Both at the end of the stimulus train and at 1 second post-stimulation, 
there is no synaptic depression in the P[sytP-L] heterozygotes, unlike in the control (Fig 4.7, 
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Table S4.3). However, normalized responses to test stimulations at 30 seconds or longer after 
cessation of the stimulation train showed no significant differences in release between the 
P[sytP-L] heterozygotes and controls (Fig 4.7, Table S4.3). Thus, our transgenic model system 
cannot provide insight into the prolonged increase of the CMAP amplitude following maximal 
voluntary contraction, which can last 10 minutes or longer in humans [18, 19]. 
 
Fig 4.7. The sytP-L mutation does not result in synaptic depression during and shortly after a high 
frequency 50 Hz stimulation, but this relative increase in release is short-lived. (A) 
Representative traces for control and P[sytP-L] heterozygotes showing the initial 2 second 50 Hz 
train, followed by each post-train pulse at 1 second, then every 30 seconds thereafter for 4 
minutes. Dotted line represents the amplitude of the initial response. Scale bar represents 10 mV, 
0.1 s. (B) Average EJP amplitude during and after 50 Hz stimulation in control (n = 18) and 
P[sytP-L] heterozygotes (n = 24). Responses were normalized to the amplitude of the initial 
response. Unlike controls, P[sytP-L] heterozygotes do not exhibit synaptic depression at the end 
of the stimulus train (p << 0.0001) and 1 second after cessation of the train (p = 0.0012). Error 
bars depict SEM. 
 
 
Basal levels of locomotor activity are decreased in P[sytP-L] heterozygotes. 
The P-L familial condition presents with distal limb deformities, muscle wasting, and 
difficulty walking [18, 19]. To assess the impact of this mutation on overall motor function in 
our model system, the Drosophila activity-monitoring (DAM) assay was performed to quantify 
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basal locomotor activity levels. This assay determines total activity over time. However, as 
activity levels in Drosophila males and females are known to have different circadian cycles [29, 
30], males and females were tested separately. Activity level was determined by monitoring 
individual flies for 6 days in a 12hr light: 12hr dark cycle (Fig 4.8A,B) in age- and sex-matched 
adult Drosophila P[sytWT] or P[sytP-L] heterozygotes. 
 
Fig 4.8. The sytP-L mutation affects locomotor activity in Drosophila. (A, B) Average activity 
per 30 minutes for an averaged 24-hour day in a 6-day Drosophila Activity Monitoring Assay in 
5-7 day old females (A) and males (B). (C, D) Distinct activity periods (AP) were averaged for 
females (C, n = 48 for each genotype) and males (D, n = 48 for +/-;P[sytP-L]/+, n = 45 for 
control). P[sytP-L] heterozygotes were significantly less active than controls during all activity 
periods in both males and females (* indicates p < 0.001, student t-tests). Error bars depict SEM. 
 
Drosophila are typically active during periods of light and inactive during periods of 
dark. Furthermore, flies have an increase in locomotor activity in anticipation of the transition 
between dark to light and light to dark. We analyzed the locomotor activity at the two 
anticipatory peaks of activity (Active 1 and 2, respectively), the non-peak period during lights on 
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(Active 3) and the inactive period approximately corresponding to lights off (Inactive). We find 
distinct periods of activity between males and females, consistent with published data [29, 30]. 
During all activity periods, both male and female P[sytP-L] heterozygotes displayed significantly 
less movement (Fig 4.8C,D, Table S4.4).  
 
The rate of muscle fatigue is faster in P[sytP-L] heterozygotes. 
Affected individuals with the human disease also present with cramping and pain upon 
physical exertion, difficulty with sports, and some fatigable eye movements [19]. Since these can 
all be associated with fatigability in muscle, we analyzed fatigue rate in adult Drosophila using a 
modified climbing assay [31]. Flies were repetitively knocked to the bottom of a vial. This 
stimulates negative geotaxis, an innate escape response in which flies climb up the vial wall. 
Vials were dropped (see methods) every 10 seconds for 30 minutes. After each drop, the distance 
each fly climbed upward within 5 seconds was measured and averaged. As with the DAM assay, 
we tested age-matched female and male adult flies separately. Differences were observed as 
early as the first drop for both males and females of P[sytP-L] heterozygotes and controls (female 
+/-;P[sytWT]/+ = 6.49 ± 0.60 cm, female +/-;P[sytP-L]/+ = 3.67 ± 0.91 cm, p = 0.017, student t-
test, male +/-;P[sytWT]/+ = 6.99 ± 0.45 cm, and male +/-;P[sytP-L]/+ = 4.68 ± 0.64 cm, p = 
0.009, student t-test, average distance traveled ± SEM after the first drop). To specifically 
measure fatigue, we controlled for the decreased overall activity in the mutants by normalizing 
all measurements to the distance traveled after the initial drop. The normalized data was then 
graphed over time for both females and males (Fig 4.9A,B, respectively). As a measure of the 
rate of fatigue, we calculated the log of the raw data and used linear regressions to provide 
predicted lines of best fit (not shown). The slopes of these lines were statistically significantly 
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different between mutants and controls in both females and males (slopes for female +/-
;P[sytWT]/+ = -0.013, female +/-;P[sytP-L]/+ = -0.039, male +/-;P[sytWT]/+ = -0.011, and male 
+/-;P[sytP-L]/+ = -0.069, p < 0.0001 for both females and males, see methods). These results 
demonstrate a faster rate of fatigue in the P[sytP-L] heterozygotes, consistent with the muscle 
fatigability seen in the affected family members.  
 
Fig 4.9. The sytP-L mutation increases the rate of fatigue in Drosophila. (A, B) Normalized 
values of distance traveled up a vial wall after repetitive drops over time for 5-7 day old females 
(A) and males (B). Each point is a binned 1 minute average of 6 drops (1 drop every 10 seconds) 
normalized to the percentage of the distance traveled after the first drop. Statistical analysis 
indicates different rates of fatigue (see methods) between the two genotypes for both females (p 
< 0.0001) and males (p < 0.0001), indicating the P[sytP-L] heterozygotes (n = 10) fatigued 




4.4 Discussion  
In this study we have investigated a synaptotagmin point mutation that was implicated in 
the etiology of a congenital myasthenic syndrome found in a single family. By modeling this 
 
	   	   	  110	  
point mutation in silico, we predict significant conformation changes to a key, well-ordered 
Ca2+-binding residue essential for fast, synchronous neurotransmitter release. The role of this 
conserved proline residue in these C2 domains could be to punctuate the end of the β-strand 
leading into the Ca2+-binding pocket thereby providing maximum Ca2+ binding volume 
optimizing Ca2+ sensitivity. 
We expressed the homologous mutation in Drosophila and documented several similar 
deficits to those seen in the affected patients. In addition, we found a decreased Ca2+ affinity for 
release and decreased release probability that are consistent with the conformational changes 
predicted by our in silico analysis. Notably, this sytP-L mutation not only fails to rescue 
synaptotagmin function, it has a negative impact on survival when expressed as the sole source 
of synaptotagmin (-/-;P[sytP-L]/+); the survival rate is significantly lower than that of larvae 
with no synaptotagmin expression (-/-). This finding demonstrates for the first time that this 
proline residue in the C2B Ca2+-binding pocket is essential for synaptotagmin’s Ca2+-sensing 
function. By driving expression of the mutant transgene in syt heterozygotes (+/-;P[sytP-L]/+), 
we were able to achieve expression levels of sytWT and sytP-L similar to that in the human 
disease.  
Electrophysiological analyses demonstrated deficits that may help inform the human 
condition. Consistent with the human nerve conduction tests, the EJP amplitude at the larval 
neuromuscular junction in P[sytP-L] heterozygotes is significantly decreased. This decrease in 
the initial evoked response is not due to a decrease in quantal size or the readily releasable pool. 
P[sytP-L] heterozygotes exhibit a decreased Ca2+ affinity, as documented by the increased EC50 
for Ca2+, which resulted in a decreased release probability, as documented by the facilitated 
responses in paired pulse experiments, and either no, or less, depression during high frequency 
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stimulations. This decreased probability of release could account for an increased failure rate at 
the neuromuscular junction, consistent with the decreased CMAP seen in humans.  
The P[sytP-L] mutation resulted in significant electrophysiological deficits when 
expressed in a heterozygous background. This is notable, as synaptotagmin heterozygotes 
previously have been shown to exhibit no significant changes in electrophysiological responses 
compared to synaptotagmin homozygotes [32]. Although we did not express this mutation in an 
otherwise wild type background, this would be consistent with a dominant negative phenotype.  
This proline to leucine mutation presents with behavioral deficits similar to those in 
patients, most notably decreased movement and increased fatigability. This similarity of multiple 
deficits found in the familial disease strongly supports a role for this residue in the etiology of 
this form of congenital myasthenic syndrome. It is only recently that mutations in the syt1 and 
syt2 genes have been implicated in human disease [18, 19, 33]. A patient with a de novo 
mutation in the human syt1 gene presented with an early onset dyskinetic movement disorder, 
severe motor delay, and profound cognitive deficits attributed to a single amino acid substitution 
in the C2B Ca2+-binding pocket: an isoleucine to threonine (I-T) substitution [33]. This 
hydrophobic isoleucine residue had been shown previously to mediate Ca2+-dependent 
membrane penetration by synaptotagmin [34-37]: an effector interaction critical for coupling 
Ca2+ influx with neurotransmitter release from neurons [38, 39]. Since this syt mutation results in 
the most severe deficits in an animal system [38] and is located in the syt1 gene, which is 
preferentially expressed in the cerebral hemispheres [16, 17], it is not surprising that this patient 
experienced extreme cognitive deficits as well as the most severe motor deficits observed in a 
synaptotagmin human disease to date [33]. 
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Herrmann et al, 2014 reported two mutations in the human syt2 gene implicated in the 
etiology of congenital myasthenic syndrome patients: the proline to leucine (sytP-L) mutation 
analyzed in this paper and an adjacent aspartate to alanine (sytD-A) mutation. Both of these 
highly conserved residues are located in synaptotagmin’s C2B Ca2+-binding pocket [10, 20, 40]. 
While the function of this proline residue had not been previously studied in animal models, 
previous studies have demonstrated that the Ca2+-binding aspartate residues of the C2B domain 
are essential for synaptotagmin function [5, 15, 18, 36], at times resulting in lethality in animal 
models [5, 18]. The single viable Drosophila line from our lab investigating C2B aspartate 
mutations had somewhat reduced expression of the mutant transgene [5]. Since these mutations 
result in a dominant negative decrease in evoked transmitter release (worse than no 
synaptotagmin at all) [5], the decreased expression level in our line may have contributed to its 
viability. When driven in the presence of native synaptotagmin, our Drosophila lines that 
disrupted Ca2+ binding by C2B were viable, but they did result in a significant dominant negative 
knockdown in function [5]. For the sytD-A familial mutation, expression of the mutant syt from a 
transgene in syt heterozygotes resulted in lethality in 4 of 6 independent transgenic lines. There 
was a dramatic decrease in the evoked response in the remaining two lines [18]. The sytP-L 
mutation investigated here, however, resulted in no viability issues in the heterozygous 
background, and only a 20% decrease in the evoked response. Thus, it is surprising that both the 
sytP-L and the sytD-A human families present with such similar symptoms [18, 19]. Given the 
severe consequences of mutating the C2B Ca2+-binding aspartate residues in animal models, it is 
noteworthy that the deficits seen in the affected human family are comparatively mild [18, 19].  
It has been shown that Ca2+-binding by the aspartate residues [10, 20, 36] as well as 
membrane penetration by the hydrophobic residue [34-37], both located in the C2B domain of 
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synaptotagmin, are of critical importance for proper synchronous transmitter release [5, 15, 18, 
19, 33, 38]. Interestingly, the proline residue investigated in this study is located directly adjacent 
to one of these aspartates residues. We speculate that this proline residue may provide 
conformational rigidity important for stabilizing the C2B Ca2+-binding pocket. By mutating the 
proline to a leucine, the rigid R group found in the proline residue would be lost, potentially 
affecting the precise conformation of the pocket and impacting the ability of the adjacent 
aspartate to bind Ca2+. Such a mechanism could result in a decreased, albeit not demolished, 
ability of the C2B domain to bind Ca2+, resulting in the less severe phenotype documented here 
compared to both the aspartate and isoleucine mutations in vivo [5, 12, 18, 19, 33, 38].  
In our Drosophila P[sytP-L] heterozygotes, the impact of high frequency stimulation on 
EJP amplitude was short-lived. Thus our model system cannot provide insight into the long-
lasting decrease in depression of the CMAP seen in the human patients following maximal 
voluntary contraction. The initial facilitation and following lack of depression observed in our 
P[sytP-L] heterozygotes during and immediately after high frequency stimulation is predicted by 
the residual Ca2+ hypothesis for short-term plasticity [41-43]. The increase in paired pulse 
facilitation (Fig 4.5D) and lack of depression observed during high frequency stimulation (Fig 
4.6 and 4.7) demonstrates that the sytP-L mutation decreased release probability compared to 
wild type. Accordingly, the build-up of Ca2+ that occurs during high-frequency stimulation is 
predicted to contribute to a relatively increased release probability during and shortly after the 
stimulus train. As this sytP-L mutation is predicted to disrupt the critical C2B Ca2+-binding 
pocket of synaptotagmin (Fig 4.1A-C), which is the Ca2+ sensor for fast, synchronous 
neurotransmitter release, a decrease in release probability was not unexpected. The note-worthy 
long-lasting potentiation of the CMAP, which can last up to 60 minutes in human sytP-L patients 
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[19] remains unexplained; mutation of the Ca2+ sensor would not be predicted to cause such a 
long-lasting effect.  
The decreasing cost and increasing availability of DNA sequencing has led to an 
increased incidence of genomic sequencing during patient diagnoses. This ever-increasing 
process will undoubtedly lead to the discovery of additional synaptic mutations and associated 
genetic disorders. The need for a relatively quick and cost effective method to begin elucidating 
the molecular mechanisms underlying these synaptic disorders is vital. Using Drosophila to 
model these newly discovered conditions in highly conserved pathways like synaptic 
transmission is ideal for elucidating their underlying mechanisms, as Drosophila provide a cost-
effective and rapid mechanism for analysis.  
In summary, we have identified the functional role of a predicted leucine-induced 
conformational change in the C2B Ca2+-binding pocket of synaptotagmin. Expression of the 
homologous human mutation in Drosophila resulted in deficits similar to many of the human 
symptoms. Thus, this work supports a role for this synaptotagmin point mutation in disease 
etiology and elucidates the molecular mechanisms responsible.  
 
4.5 Conclusion 
In this study, we investigate the functional role of a synaptotagmin 2 residue implicated 
in disease. Recently, a neuromuscular disorder has been reported in which a highly conserved 
proline residue is mutated to a leucine within synaptotagmin. The functional importance of this 
residue was unknown. Here we model the impact of this mutation on the structure of 
synaptotagmin and examine the effects of a homologous mutation in vivo using Drosophila. We 
found that this mutation is predicted to produce a conformational change in the C2B domain of 
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synaptotagmin that would decrease Ca2+ binding. When expressed in flies containing no 
synaptotagmin, this mutation was lethal, demonstrating the critical nature of the examined 
residue. When expressed in combination with wild type synaptotagmin, we demonstrated a 
decreased Ca2+ affinity for neurotransmitter release and a decreased release probability. These 
deficits can account for the defects in neuromuscular function and behavior, which are similar to 
those of the human patients. Thus, these results support a role for this amino acid substitution in 
human disease etiology.  
 
4.6 Materials and Methods 
Mutagenesis 
In Drosophila, the syt1 gene is expressed in all neurons [24, 25] and is homologous to 
both syt1 and syt2 in mammals [22]. Proline residue 363 of Drosophila syt1 is homologous to 
proline 308 in human syt2, implicated in the human disease, and proline 310 in rat syt1, modeled 
in Fig 4.1. Using the Drosophila syt1 coding sequence [44, 45], both a wild type control and a 
P363L mutant cDNA flanked by EcoRI and BglII restriction sites were synthesized by GeneWiz 
(La Jolla, CA). The synthesized cDNAs were then subcloned into the PUAST-attB vector to 
place the transgenes under the control of the UAS promoter and the PhiC31 targeted insertion 
system was used to target the transgene containing vectors to the attP2 landing site on the 
Drosophila third chromosome [BestGene, Chino Hills, CA; [46, 47]]. We refer to the mutant 
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Fly lines  
Expression of the UAS-driven syt transgenes was localized to the nervous system using a 
pan-neuronal source of GAL4 [elavGAL4 [48, 49]]. SytAD4 was the sytnull mutation used [45]. 
Synaptotagmin is found natively on the second chromosome, and the syt transgene used was 
incorporated into a third chromosome landing site. To directly assess the function of the sytP-L 
mutation, the impact of transgene expression on survival was assessed in the sytnull background. 
For these experiments, the following genotype yw;sytnullP[elavGal4w+]/CyO,GFPw+ was 
crossed to yw;sytnull/CyO,GFP;P[UASsytWT,y+w+] or yw;sytnull/CyO,GFP;P[UASsytP-L y+w+] 
or yw;sytnull/CyO,GFP to generate: 1) the transgenic control in the sytnull background 
yw;sytnullP[elavGAL4w+]/sytnull;P[UASsytWTy+w+]/+ (referred to as -/-; P[sytWT]/+), 2) the 
transgenic mutant in the sytnull background, yw;sytnullP[elavGAL4w+]/sytnull;P[UASsytP-
Ly+w+]/+ (referred to as -/-;P[sytP-L]/+), and 3) sytnull mutants, yw; 
sytnullP[elavGAL4w+]/sytnull (referred to as -/-), respectively. Expression of the mutant transgene 
resulted in embryonic or first instar lethality. Therefore, for most experiments, the P[sytP-L] 
transgene was expressed in a syt heterozygous background in order to mimic the heterozygous 
nature of the affected human population (sytP-L/sytWT). This results in synaptotagmin expression 
from a single copy of the endogenous syt gene and from a single copy of the mutant syt 
transgene. For these experiments, the following genotype yw;sytnullP[elavGal4w+]/CyO,GFPw+ 
was crossed to yw;+;P[UASsytP-Ly+w+] or yw;+;P[UASsytWT y+w+] (note: both of these 
transgenic lines are homozygous for sytWT on the second chromosome) to generate: 4) the 
transgenic mutant in the syt heterozygous background, yw; 
sytnullP[elavGAL4w+]/sytWT;P[UASsytP-Ly+w+]/+ (labeled as +/-;P[sytP-L]/+ in the figures and 
referred to as P[sytP-L] heterozygotes in the text), and 5) the transgenic control in the syt 
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heterozygous background, yw;sytnullP[elavGAL4w+]/sytWT;P[UASsytWTy+w+]/+ (labeled as +/-
;P[sytWT]/+ in the figure legends and referred to as P[sytWT] heterozygotes in the text). For 
western analyses, the additional genotypes used for comparisons were: 6) syt heterozygotes, yw; 
sytnull/sytWT;P[UASsytP-Ly+w+]/+ (labeled as +/- in Fig 4.2A), and 7) syt homozygotes, yw; 
sytWT/sytWT;P[UASsytP-Ly+w+]/+ (labeled as +/+ in Fig 4.2B). The experimental syt 
heterozygotes (+/- in Fig 4.2A) and homozygotes (+/+ in Fig 4.2B) both contained the P[sytP-L] 
transgene but lack the elavGal4w+ driver, so the transgene was not expressed.  
 
Molecular Dynamics  
As the crystal structures of mammalian synaptotagmin 2 proteins have not been solved, 
we obtained the crystal structures of rat syt1 C2B (PDB file 1TJX) [21] from the Protein Data 
Bank. The C2B domains of mammalian synaptotagmin 1 and synaptotagmin 2 are >90% 
identical (8 substitutions in the core of 93 C2B residues) and most of these substitutions are 
conservative. We generated models of the P-L mutation using the mutagenesis wizard in Pymol 
Molecular Graphics System, Version 1.8, Schrödinger, LLC. The QuikMD utility in NAMD [50] 
was used for the simulation. The structures were solvated using the solvate TCL utility in a cube 
of approximately 7,000 water molecules (TIP3) with a positive and negative padding of 10 Å on 
each axis. Residue 359 in C2B was restrained with harmonic constraints to dampen coordinate 
drift within the simulation box. Both wild type and mutant C2B models were simulated using 
NAMD [50] with different random seeds for 50,000,000 frames with a time step of two 
femtoseconds (total of 100 ns) and a write frequency of 25,000. Periodic boundary conditions 
were used with PME and a grid spacing of 1.0. We used rigid bonds and constant group pressure 
control. The pressure was controlled with a Langevin piston set at 1.01325 bar (atmospheric 
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pressure). The temperature was controlled at 310 K with Langevin dynamics and a dampening 
coefficient of 5 ps-1 was applied to each trajectory. We validated that the trajectories reached 
equilibrium by calculating the root mean squared displacements of all atoms in the protein after 
alignment over the course of the run. Each unique simulation setup was run three times. 
 
Lethality assay  
The only source of synaptotagmin from the native locus (sytWT) in the crosses used to 
assess the effect of transgene (P[syt]) expression was located on the CyO,GFP balancer 
chromosome (see fly lines section above). Therefore, any progeny that were homozygous for 
native synaptotagmin are categorized as unhatched since they are also homozygous for Cy, 
which is embryonic lethal (Table 1, S1 File). Based on Mendelian genetics, the expected 
frequency is ~25% (S1 File). At least three bottle crosses using at least 50 virgin females each 
were fed on molasses plates supplemented with a dab of yeast/baby food mixture and were left to 
mate for two days. A fresh molasses plate dabbed with yeast/baby food mixture was then 
provided and the flies were allowed to lay eggs for 6 hours to provide age-matched progeny. A 
total of 4476 eggs were collected and observed. First instar progeny were then scored by 
phenotype, and the number of unhatched eggs was counted. The plates were observed daily for 
three consecutive days to control for any developmental delays. A chi-squared test between the 
three genotypes was applied to reject the test of independence. Additional chi-square tests were 
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Immunoblotting  
Western analysis of larval CNSs was used to determine relative levels of synaptotagmin 
expression. The CNS was isolated from third instars dissected in Ca2+-free HL3.1 containing 70 
mM NaCl, 5 mM KCl, 4 mM MgCl2, 10mM NaHCO3, 5 mM Trehalose, 115 mM sucrose, 5 mM 
HEPES, pH 7.2 [51]. Samples were sonified for 10 pulses using a Branson Sonifier 450 (VWR 
Scientific, Westchester, PA) in Laemmli buffer (Bio-Rad, Hercules, CA) containing 5% 2-
mercaptoethanol. The indicated genotype was loaded one CNS per lane. Samples were 
electrophoresed, transferred to Immobilon membranes (Millipore, Bedford, MA), and washed in 
blocking solution according as described [32]. Blots were probed overnight at 4°C with an anti-
synaptotagmin antibody, Dsyt-CL1 [5], diluted 1:2500 and an anti-actin antibody, MAB 1501 
(Millipore Bioscience Research Reagents, Billerica, MA), diluted 1:10,000. Actin levels were 
used to normalize for equal protein loading. Blots were visualized using an EpiChemi3 Darkroom 
and Labworks Imaging software (UVP BioImaging, Upland, CA). The synaptotagmin:actin ratio 
was determined for each lane, then normalized to the mean synaptotagmin:actin ratio of all 
control lanes on an individual blot to allow comparison of signal between multiple blots. Outliers 
in total protein loaded (as indicated by actin levels) were not included in the analysis. Statistical 
significance for each comparison was determined using a student’s t-test.  
 
Immunolabeling  
For immunolabeling of the neuromuscular junction, third instars of P[sytWT] 
heterozygotes and P[sytP-L] heterozygotes were dissected in Ca2+-free HL3.1 saline to expose 
their body wall muscles and fixed in phosphate-buffered saline (PBS, 137 mM NaCl, 1.5 mM 
KH2PO4, 2.7 mM KCl, 8.1 mM Na2HPO4) containing 2% formaldehyde for 1 hour. Whole-
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mounts were incubated overnight in Dsyt-CL1 diluted 1:400 in dilution media [PBS with 0.1% 
Triton, 1% bovine serum albumin, and 1% normal goat serum (NGS from Jackson 
ImmunoResearch, West Grove, PA)], washed in PBST (PBS with 0.1% Triton) for 3 hours, 
incubated in Alexa Fluor 488 goat-anti-rabbit antibody (Invitrogen, Carlsbad, CA) diluted 1:400 
and Texas Red anti-HRP (Jackson ImmunoResearch, West Grove, PA) diluted 1:50 in dilution 
media for 1 hour, washed in PBST for 1 hour, and mounted in Citifluor (Ted Pella, Redding, 
CA). To label transgenic synaptotagmin expressed in the sytnull background, the above protocol 
was applied to first instars rather than third instars with the following changes: first instars were 
fixed in PBS containing 4% formaldehyde for 2 hours and Texas Red anti-HRP was omitted. 
Neuromuscular junctions at the muscle 6/7 junction were imaged for both first and third instars 
with a Zeiss 880 light scanning microscope using a 40X objective, and acquired using Zeiss Zen 
2.1 acquisition software, version 11,0,3,190.  
 
Longevity Assay  
Lifespans between +/-;P[sytWT]/+ and +/-;P[sytP-L]/+ were recorded from at least three 
separate crosses using at least 50 virgins in each cross. Lenth’s analysis was used to determine 
adequate sample size. N = 151 for +/-;P[sytWT]/+ and n = 149 for +/-;P[sytP-L]/+. Ten newly 
hatched adult flies/vial were observed/flipped into fresh food every Monday/Wednesday/Friday 
and number of living or dead flies were recorded. Flies that were found alive but stuck in the 
food were omitted from analysis. Any flies that escaped during flipping were also omitted from 
analysis, as there was no way to determine the length of natural life. The Wilcoxon (two-sample) 
Rank-Sum test was used to determine significance between genotypes.  
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Excitatory Junction Potentials  
Third instars were dissected in Ca2+-free HL3.1 saline. EJPs were evoked from muscle 
fiber 6 of abdominal segments 3 and 4 in HL3.1 containing 1.0 mM Ca2+ using standard 
techniques [26, 32, 38]. Intracellular electrodes of 10–25 MΩ contained 3 parts 2M potassium 
citrate to 1 part 3M potassium chloride. The resting membrane potential of each fiber was 
maintained at -55 mV by passing no more than 1 nA of current. Nerves were stimulated with a 
suction electrode filled with HL3.1 containing 1.0 mM Ca2+. All events were collected using an 
AxoClamp 2B (Molecular Devices, Sunnyvale, CA) amplifier and digitized using a Powerlab 
4/35 A/D converter (ADInstruments, Sydney, Australia). EJPs were recorded in LabChart 
software (ADInstruments, Sydney, Australia). For single evoked responses, averages of 10 EJPs 
collected at 0.04 Hz were calculated for each individual fiber. Statistical significance was 
determined using a student’s t-test. Spontaneous events were identified manually after recordings 
had been randomized and blinded to the researcher. Average mEJP amplitudes were determined 
from 50 consecutive mEJP events/fiber, taken from consistent time periods across fibers. 
Statistical significance for mEJP amplitude was determined by the Wilcoxon Rank-Sum test. 
Frequency of spontaneous events was determined by manually counting number of mEJP events 
during one minute of baseline activity/fiber. Each fiber was analyzed for the same time period 
during the recording to eliminate bias.  
 
Ca2+ dependence of release 
Individual fibers were bathed in HL3.1 saline containing Ca2+ levels varying from 0.05 
mM – 5.0 mM. Each fiber was recorded in at least three different [Ca2+] to be included in 
analysis. At each [Ca2+], the mean response of 5 EJPs collected at 0.5 Hz were calculated. Lines 
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of best fit were calculated using a nonlinear regression analysis, which provided EC50 values and 
their confidence intervals for each genotype.  
 
Paired pulse 
Experiments were conducted using a 0.02 second delay between stimulations, and 
averages of EJP responses were normalized to the first stimulation. Statistical significance was 
determined using a student t-test.  
 
High frequency stimulation 
Assays to observe depression or facilitation were first assessed by stimulating the nerve 
at 10 Hz for 2 seconds followed by a test pulse 60 sec post-stimulus train. EJP amplitudes were 
normalized to that of the first EJP prior to calculating the average response within a genotype. A 
repeated measures analysis of variance was used to compare the two genotypes at each stimulus. 
Post-hoc t-tests were then used to determine significance. To more closely mimic maximal 
voluntary contraction at the human neuromuscular junction, another protocol was designed using 
50 Hz stimulation for 2 seconds, followed by test pulses at 1 second post-stimulus train, and then 
at 30 second intervals to 4 minutes. Similar statistical methods as above were applied to 
determine significant differences between amplitudes at each individual time point.  
 
Hypertonic solution stimulations 
A PicoSpritzer III was used to administer a puff application of either 0.5M sucrose or 
HL3.1 bath solution to the junctional region of muscle fibers 6 at 5 pounds per square inch (psi) 
for 10 seconds. Hypertonic stimulations were conducted in Ca2+-free HL3.1. mEJP events were 
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counted manually for all time points analyzed. To determine baseline mEJP frequency, 10 
seconds of mEJP events immediately prior to sucrose or HL3.1 application were analyzed. To 
determine average mEJP frequency during maximum sucrose stimulation, 15 seconds of mEJP 
events were analyzed, beginning 5 seconds into the sucrose or HL3.1 application. Statistical 
significance was determined by student t-tests.  
For all electrophysiological experiments, post-hoc Lenth’s analyses were performed to 
ensure adequate sample size. If fibers were unable to maintain a physiological potential when 
injected with a maximum of 1 nA of current, they were excluded. 
 
Drosophila Activity Monitoring 
The basal locomotor activity of adult Drosophila was assessed using the TriKinetics 
Locomotor Activity Monitoring System (Trikinetics, Waltham, MA). Age-matched 5-7 day old 
adult flies of the indicated genotypes were loaded into DAM2 Drosophila activity monitors. 
Males and females were tested separately to control for sex differences in circadian rhythms [29, 
30]. Animals were placed on a 12hr light: 12hr dark cycle on standard fly food media and 
activity was recorded for 7 days using DAM system Acquisition Software. Data from the first 
day were not included in the analysis to allow flies to acclimate to their new environment. 
Activity levels were binned into 30-minute intervals and uploaded into Microsoft Excel using 
DAM Filescan software. Using these 30-minute intervals, an averaged 24-hour day was created 
for each genotype and sex. Four distinct activity periods were determined post-hoc that 
correspond to Drosophila’s two anticipatory peaks (Active 1 and 2), a lights-on active period 
(Active 3), and a lights off-inactive period (Inactive). T-tests were performed to compare 
genotypes during each activity period for both males and females. Flies that died during the 
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course of the experiment were excluded from the analysis. Post-hoc Lenth’s analysis was 
performed to ensure adequate sample size.  
 
Fatigability assay 
To assess fatigue, a modified negative geotaxis assay was used [31]. For each genotype, 
10 un-anesthetized, sex- and age-matched 5-7 day old adult flies were loaded by aspiration into a 
9 cm tall standard Drosophila vial. Flies were not exposed to CO2 to avoid possible side effects 
and were left to acclimate for 1 hour. Experimental and control vials were secured side by side in 
a vial rack, raised 6-8 inches above a table, and then dropped, causing all flies to fall to the 
bottom of the vial. Vials were dropped every 10 seconds for 30 minutes, and a picture was 
recorded 5 seconds after every drop. Each picture was analyzed in ImageJ for the distance each 
fly had traveled up the side of the vial. The average for each sex and genotype was calculated for 
each picture, and the data was binned into 1 minute averages. To control for any genotype-
dependent decrease in mobility and thereby specifically assess fatigue, all average distances were 
normalized to the average distance traveled after the first drop. Linear regressions of the log of 
the raw data provided predicted lines of best fit for each sex and genotype. A significant 
interaction between time and genotype (for both sexes) in the log of the raw data indicates that 
there is a difference between the slopes for the two genotypes. Fitted curves, after back 
transformation, are shown in Fig 4.9. Post-hoc Lenth’s analysis was performed to ensure 
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Fig S4.1. Molecular modeling predicts conformational changes in the C2B Ca2+-binding domain 
of synaptotagmin. (A) Dynamic Ramachandran Plot of the residues surrounding the P-L 
mutation in syt C2B. The top panels are taken from the trajectories from the P-L simulations. The 
bottom panels are taken from the wild type syt1 C2B simulations. Each dot in each plot 
represents a time progression from 0 – 100 ns. Zero ns being the darkest spot and 100 ns being 
the bluest. Standard Ramachandran boundaries for alpha and beta secondary structure are 
provided. (B) Histogram showing the range and variation of phi angles of the D2 aspartate 
residue in wild type and the P-L mutation throughout the 100 ns molecular dynamics trajectories. 
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Fig S4.2. Example cross used for lethality assay in sytnull background. Potential F1 progeny are 
shown with the expected Mendelian distribution of each genotype, and identification of null, 
heterozygotes, and homozygotes at the native locus. Due to the use of the CyO balancer, ~25% 
of F1 progeny in control crosses (syt homozygotes at the native locus) are expected to remain 
unhatched, as they are also homozygous for Cy, which is embryonic lethal. The remaining 
progeny should present as ~25% lacking GFP (sytnull at the native locus) and ~50% GFP (syt 
heterozygotes at the native locus).  
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APPENDIX 2: SUPPLEMENTAL TABLES 
 
Table S4.1. P[sytP-L] heterozygotes exhibit decreased EJP amplitudes at most [Ca2+]. Table 
providing p-values for each [Ca2+] tested in Fig 4.5. *depicts statistical significance.  
 +/-;P[sytWT]/+ +/-;P[sytP-L]/+  
[Ca2+] (mM) Mean EJP (mV) SEM n = Mean EJP (mV) SEM n = p = 
0.05 0.32 0.04 12 0.28 0.06 12 0.60 
0.1 2.86 0.95 12 1.81 0.63 12 0.37 
0.25 15.70 1.53 16 10.10 1.74 16 0.02* 
0.5 27.17 0.98 23 18.16 1.60 22 <0.0001* 
0.75 31.09 0.95 12 23.88 2.12 10 0.003* 
1.0 35.52 0.50 15 28.40 1.08 16 <0.0001* 
2.5 37.05 0.81 11 31.99 2.43 11 0.05* 
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Table S4.2. P[sytP-L] heterozygotes exhibit less synaptic depression relative to the control 
throughout a 10 Hz stimulation, but fail to maintain this relative increase in release upon 
cessation of the stimulus train. Table providing normalized mean responses, SEM, and p-values 
for all points tested during and after a 10 Hz stimulation train (Fig 4.6), where *p < 0.05, and **p 
< 0.001.  
 +/-;P[sytWT]/+ +/-;P[sytP-L]/+  
Time 
(s) 
Normalized Mean SEM Normalized Mean SEM p-value 
0.1 1.00 0.00 1.00 0.00 1.0 
0.2 0.97 0.01 1.01 0.02 0.28 
0.3 0.95 0.01 1.00 0.01 0.13 
0.4 0.93 0.01 0.99 0.02 0.033* 
0.5 0.92 0.01 1.01 0.03 0.0013* 
0.6 0.91 0.01 0.95 0.02 0.10 
0.7 0.90 0.01 0.98 0.02 0.0030* 
0.8 0.89 0.01 0.96 0.03 0.0071* 
0.9 0.88 0.02 0.97 0.02 0.0004** 
1.0 0.87 0.02 0.94 0.03 0.0083* 
1.1 0.87 0.01 0.96 0.02 0.0010* 
1.2 0.88 0.01 0.97 0.03 0.0007** 
1.3 0.87 0.01 0.96 0.03 0.0008** 
1.4 0.87 0.01 0.95 0.02 0.0046* 
1.5 0.87 0.01 0.95 0.03 0.0029* 
1.6 0.87 0.01 0.96 0.03 0.0005** 
1.7 0.88 0.01 0.96 0.03 0.0012* 
1.8 0.88 0.01 0.95 0.03 0.0037* 
1.9 0.88 0.01 0.95 0.03 0.0063* 
2.0 0.87 0.01 0.96 0.03 0.0005** 
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Table S4.3. P[sytP-L] heterozygotes do not exhibit synaptic depression during and shortly after 
50 Hz stimulation, but this increase in release relative to controls is not prolonged. Table 
providing normalized mean responses, SEM, and p-values during and after a 50 Hz stimulation 
train (Fig 4.7), where **p << 0.0001, and *p < 0.01.  
 +/-;P[sytWT]/+ +/-;P[sytP-L]/+  
Time Normalized Mean SEM Normalized Mean SEM p-value 
0 1.00 0.00 1.00 0.00 1.00 
2 0.74 0.04 1.03 0.07 <<0.0001** 
3 0.81 0.05 1.06 0.07 0.0012* 
33 0.89 0.04 0.93 0.07 0.50 
63 0.91 0.04 0.93 0.06 0.54 
93 0.91 0.04 0.94 0.06 0.62 
123 0.86 0.04 0.96 0.05 0.19 
153 0.87 0.03 0.91 0.06 0.60 
183 0.88 0.02 0.90 0.05 0.73 
213 0.86 0.03 0.90 0.05 0.52 
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Table S4.4. P[sytP-L] heterozygotes display decreased motor output compared to controls. Table 
providing mean sensor crossings and SEM acquired during the Drosophila Activity Monitoring 
assay (Fig 4.8).  
  +/-;P[sytWT]/+ +/-;P[sytP-L]/+ 
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APPENDIX 3: SYNAPTIC TRANSMISSION CHAPTER IN CELL PHYSIOLOGY SOURCE 
BOOK, 5TH EDITION4 
 
I. Summary 
 Most communication between neurons is mediated by release of chemical signals. This 
release takes place at specialized structures called synapses, consisting of a presynaptic element, 
a synaptic cleft, a postsynaptic element, and surrounding glial cells. Presynaptic cells are 
specialized to transduce an electrical signal into a chemical signal through the synthesis, 
packaging and release of neurotransmitter. The synaptic cleft contains molecules that direct the 
formation of synaptic specializations, enzymes that break down neurotransmitter, and scaffolding 
proteins that maintain the synaptic superstructure. The postsynaptic cell is responsible for 
transducing the chemical signal back into an electrical response. Chemical synapses can be 





Nervous system function relies upon the transmission of signals between neurons. 
Neurons transmit information across long distances through the nervous system by sending an 
electrical impulse, known as an action potential, down its axon. However, these electrical signals 
generally do not propagate between spatially distinct cells. To cross the gap between nerve cells, 
the majority of cell-to-cell signaling relies on small diffusible chemicals known as 
neurotransmitters. These neurotransmitters are released from active neurons in a calcium 
dependent manner at specialized cell-to-cell contact sites called synapses. It is important to note 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4	  Authors: Mallory Shields*,1,2, Matthew Bowers*,1,2, Noreen Reist1,2 *equally contributing  
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that direct electrical communication can occur between nerve cells through specialized structures 
called gap junctions. Chemical synaptic transmission is primarily unidirectional. Thus, the 
transmission of information required for canonical neuronal processes, such as sensation, 
movement, and thought, is primarily from the presynaptic cell to the postsynaptic cell. 
Retrograde signaling from the postsynaptic cell back to the presynaptic cell occurs, but will not 
be addressed in this chapter. Slower and less-directed release of chemical transmitters occurs in 
the autonomic nervous system and neuroendocrine pathways, including release of proteinaceous 
signals from large dense core vesicles. These mechanisms will not be addressed here. This 
chapter is focused on the Ca2+-dependent, release of classical chemical neurotransmitters from 
an activated presynaptic neuron and their effects on their postsynaptic target.  
Pioneering studies by Bernard Katz and colleagues in the 1950s first identified that the 
release of neurotransmitters from nerve cells at the frog neuromuscular junction occurrs via 
unitary packets [1-3]. These studies were foundational to the modern understanding of chemical 
synaptic transmission (section IV.b). In the 1960s and 1970s, experiments in rabbits and Aplasia 
demonstrated that synaptic transmission was highly plastic in response to activity by 
documenting changes in synaptic strength underlying changes in behavior [4-6] (section VIII). In 
the 1970s, extracellular molecules located in the synaptic cleft were discovered to direct the 
differentiation of synaptic contacts [7, 8]. Throughout the 1970-1980s, many postsynaptic 
receptor proteins were identified [9-15]. Essential players in the synaptic cleft began to be 
identified throughout the 1980s and 1990s. These include extracellular molecules such as agrin, 
the neural cadherins, and others [16-24]. Also in the 1980s and 1990s, the molecular identity of 
the presynaptic neurotransmitter release machinery was identified using a combination of 
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purification and cloning techniques in conjunction with clostridial neurotoxin studies [25-29]. 
Since then, these mechanisms have been found to be conserved at the majority of synapses.  
 
III. Structure of the Chemical Synapse 
While synaptic structure varies between cell types, many basic features are relatively 
conserved. This chapter will focus on generalized neuron-to-neuron synapses in the central 
nervous system (AF 1.1A,B) and neuron-to-muscle synapses peripherally (AF 1.1C,D). 
Chemical synapses possess a pool of small, clear synaptic vesicles clustered around electron 
dense synaptic machinery in the presynaptic cell. The pre- and postsynaptic cells are separated 
by a narrow space, the synaptic cleft, and are insulated by glial cells. Finally, the postsynaptic 
cells have defined, electron-dense domains containing receptors positioned opposite release sites.  
 
 
AF 1.1. Synaptic structure. (A) Electron micrograph of a synapse in the central nervous system 
(CNS). (B) The presynaptic (PRE) and postsynaptic (POST) neurons of a CNS synapse 
mediating fast synaptic transmission showing mitochondria (M) and a population of small, clear 
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synaptic vesicles (SV) containing neurotransmitter. Some vesicles are docked on the presynaptic 
membrane adjacent to dense material containing the protein machinery for vesicle fusion, active 
zone material (AZM). Opposite the docked vesicles and AZM, the membrane of the postsynaptic 
neuron appears thickened due to the presence of neurotransmitter receptors and scaffolding 
proteins, referred to as the postsynaptic density (PSD). Glial cells (GC) envelop and insulate the 
synapse. (C) Electron micrograph of a neuromuscular junction. (D) The presynaptic neuron 
(PRE) and postsynaptic striated muscle fiber (POST) of a neuromuscular junction showing 
similar mitochondria and neurotransmitter filled SVs with a subset docked adjacent to AZM. 
Invaginations of the postsynaptic membrane, junctional folds (JF), are found immediately 
opposite the AZM. Receptors for neurotransmitter and scaffolding proteins are especially 
concentrated near the tops of the JFs. The insulating glial cell is a Schwann Cell (SC). 
(Micrographs courtesy of John Heuser). 
 
 
III.a. Presynaptic Structure 
 The presynaptic terminal is generally a distinct bouton or varicosity filled with synaptic 
vesicles containing small, fast-acting chemical neurotransmitters (section IV.a). Synaptic 
vesicles must fuse with the presynaptic membrane to release their neurotransmitters into the 
synaptic cleft and initiate synaptic transmission. Thus, presynaptic terminals contain the 
machinery required to: 1) synthesize neurotransmitter, 2) package neurotransmitter into vesicles, 
3) couple incoming electrical signals with an increase in cytosolic [Ca2+], 4) fuse the vesicles 
with the presynaptic membrane in response to this Ca2+ influx, and 5) recycle the vesicle 
membrane and associated proteins back into the presynaptic terminal to make new synaptic 
vesicles.  
 Within presynaptic terminals, vesicles are clustered at specialized fusion sites along the 
presynaptic membrane, called active zones [30]. Active zones consist of specialized scaffolding 
proteins that organize the presynaptic machinery required for the Ca2+-dependent, vesicular 
fusion events that release neurotransmitter. Electron microscopy has shed light onto the precise 
structural organization at the active zone (section V.a). This organization provides precise 
alignment of synaptic vesicles with the fusion machinery complex and Ca2+ channels. This 
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highly ordered structure is critical for proper triggering of neurotransmitter release in response to 
action potentials. 
 
III.b. Synaptic Cleft Structure  
 The synaptic cleft contains structural proteins that control the surface area of the synaptic 
interface and the proximity between the pre- and postsynaptic membranes. Synaptic cleft width 
is related to the type of transmission at the synapse. Small synapses, with closer apposition of the 
pre- and post-synaptic cells (20-50 nm), are fast acting with localized effects. Larger synapses 
with wide synaptic clefts can have slower time scales and a wider range of postsynaptic targets 
[31]. Cell-adhesion molecules and scaffolding proteins control cleft width [32]. Regulatory 
proteins align domains on the pre- and postsynaptic membranes and direct the organization of the 
pre- and postsynaptic specializations required for efficient synaptic communications [18, 33]. 
 Other synaptic cleft molecules provide clearance of neurotransmitter. Following release, 
neurotransmitters must be efficiently removed to terminate the signal from the pre- to the 
postsynaptic cell. Neurotransmitter may be enzymatically cleaved within the cleft or removed by 
uptake machinery on the surface of the surrounding glial cells, the presynaptic terminal, or the 
postsynaptic cell (section VI). 
 
III.c. Postsynaptic Structure 
 The postsynaptic cell must transduce the chemical signal of the neurotransmitter back 
into an electrical signal. Required specializations within the postsynaptic membrane include a 
high concentration of neurotransmitter receptors, regulatory molecules, and ion channels to 
produce the electrical signal (reviewed in [34]). The postsynaptic response may be a fast, specific 
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response or a slower, more generalized response. It can be excitatory (depolarizing) or inhibitory 
(hyperpolarizing). The postsynaptic response depends on the specific neurotransmitter receptors 
present in the postsynaptic membrane, which are highly variable between cell populations, but 
generally fall into two main categories: ionotropic and metabotropic (section VII.a). Ionotropic 
receptors are ligand-gated ion channels; the binding of neurotransmitter opens the channel 
allowing specific ions to cross the membrane. The selective permeability for specific ions 
determines whether the cell is depolarized or hyperpolarized. Metabotropic receptors are integral 
membrane proteins that bind G-proteins, called G-protein coupled receptors (GPCRs). 
Neurotransmitter binding to GPCRs results in activation of the coupled G-protein, triggering 
second messenger cascades that cause downstream secondary effects. These include opening of 
ion channels, posttranslational modification of proteins, or transcriptional changes.  
 
IV. Neurotransmitters  
 The presynaptic element is specialized to synthesize and release neurotransmitters. The 
type of neurotransmitter released varies between neuron types, with many neurons releasing 
more than one kind of neurotransmitter. During synaptic transmission, neurotransmitter-filled 
synaptic vesicles undergo a stereotypical cycle: docking at active zones, priming, Ca2+-triggered 
fusion, vesicle reformation, refilling with neurotransmitter, and trafficking back to the active 
zone (AF 1.2). This continuous cycle provides a constantly replenished supply of 
neurotransmitter ready for release.  
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AF 1.2. The synaptic vesicle cycle. (A) Schematic of the synaptic vesicle cycle depicting vesicle 
loading with neurotransmitter (a), vesicle docking (b), variable vesicle priming (c), maximally-
primed, docked vesicle (d), depolarization-triggered Ca2+ entry (e), vesicle fusion with 
presynaptic membrane (f), vesicle membrane collapse (g), endocytosis (h), and recycling 
endosome (i). (B) Electron micrograph showing docked vesicles (b) at a neuromuscular junction. 
(C) Electron micrograph showing fusing vesicles with omega morphology (f) and vesicle 
membrane collapse (g). (Micrographs courtesy of John Heuser). 
 
 
IV.a. Neurotransmitter Synthesis, Loading and Clearance 
 To be classified as a neurotransmitter, a chemical must meet several criteria. There must 
be enzymatic machinery located at the synapse to synthesize the neurotransmitter. It must be 
released from the terminal in response to an electrical signal. Finally, there must be machinery to 
degrade or clear the neurotransmitter from the synaptic cleft. 
 The small, fast-acting neurotransmitters, shown in AT 1.1, can be grouped into a few 
general classes: cholinergic, amino acidergic, monoaminergic, and purinergic. While each has its 
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own specific synthesis, loading, and clearance machinery (reviewed in [35]), they share many 
common characteristics.  
Vesicle loading for these neurotransmitters relies on a proton (H+) gradient driving force. 
A proton pump, or vesicular-ATPase, hydrolyzes ATP to transport H+ ions into the vesicles. 
Transporters for specific neurotransmitters rely on the resultant proton gradient to move 
neurotransmitter into the vesicle in exchange for allowing protons to exit (reviewed in [36, 37]). 
 
AT 1.1. Table title and caption go here above the table.  
Neurotransmitters and receptors  
Category Neurotransmitter Ionotropic receptors Metabotropic 
receptors 
Cholinergic  Acetylcholine nAChR mAChR 
Amino 
Acidergic 
Glutamate Kainate, AMPA, 
NMDA 
mGluR 
 Glycine Gly-R  
 GABA GABAa, GABAc GABAb 
Monoaminergic Dopamine  D1, D2 
 Norepinepherine  α1, α2, β1, β2 
 Serotonin 5-HT3 5-HT1, 5-HT2 





 Cholinergic neurons synthesize and release the neurotransmitter acetylcholine (ACh). In 
mammals, ACh is present in the central, peripheral and autonomic nervous systems. ACh is the 
neurotransmitter in motor neurons that innervate skeletal muscle, making it essential for 
movement. It is one of two predominant transmitters in the parasympathetic division of the 
autonomic nervous system and is increasingly thought to play an important role in cognition. 
ACh is synthesized by choline acetyltransferase, which attaches choline to acetyl coenzyme A. 
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Acetyl coenzyme A and choline acetyltransferase are synthesized in cholinergic neurons, but 
choline must be transported into these neurons by a Na+-dependent carrier. Following synthesis 
of ACh, the neurotransmitter is loaded into vesicles by the vesicular acetylcholine transporter 
using the proton gradient mentioned above. Once released, ACh is cleared from the synaptic cleft 
by acetylcholinesterases that hydrolyze ACh. This produces acetate and choline, much of which 
is recaptured by the presynaptic terminal for synthesis of new ACh (reviewed in [38, 39]). 
 
Amino Acidergic Neurons 
 Amino acidergic neurons release glycine, glutamate, or gamma-aminobutyric acid 
(GABA), which are common neurotransmitters released broadly throughout the CNS. Neurons 
synthesize glycine from serine using the enzyme serine hydroxymethyltransferase. Glycine can 
have excitatory or inhibitory effects on the postsynaptic cell depending on the receptor types 
present. Following release, specific transporters sequester it into glia or back into nerve 
terminals. Neurons are unable to synthesize glutamate or GABA de novo from glucose. They 
rely on glutamine production in surrounding glia as sources of the precursors for 
neurotransmitter production and reuptake of released neurotransmitter. In glia, alpha-ketoglutaric 
acid of the tricarboxylic acid cycle is converted to glutamate by the enzyme transaminase. This 
glutamate is then converted to glutamine, which is transported to the nerve terminal. Once there, 
the enzyme glutaminase catalyzes the conversion of glutamine back to glutamate. GABA is 
generated from glutamate by the enzyme glutamic acid dehydrogenase. Once synthesized, each 
is loaded into synaptic vesicles, again utilizing the proton gradient. Following release, they are 
transported from the cleft back into the nerve terminal for reuse or into surrounding glial cells. In 
glial cells, the neurotransmitter is converted back to glutamine for transport back to the 
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presynaptic cell. This glutamine-glutamate cycle between the neuron and glial cell provides the 
synapse with the necessary pool of neurotransmitter (reviewed in [40, 41]).  
 
Monoaminergic Neurons  
Monoaminergic neurons release a wide array of neurotransmitters (reviewed in [42, 43]). 
One class, known as catecholaminergic neurons, release dopamine, norepinephrine, or 
epinephrine. The catecholamines are synthesized from tyrosine through multiple intermediaries. 
Tyrosine is initially converted to L-dihydroxyphenylalanine (L-DOPA) by tyrosine hydroxylase, 
the rate-limiting step in catecholamine production. L-DOPA is decarboxylated to dopamine by l-
amino acid decarboxylase. In dopaminergic neurons, dopamine is loaded into vesicles via its 
specific monoamine transporter. In neurons that release norepinephrine, dopamine is loaded into 
vesicles containing the enzyme dopamine-β-hydroxylase which converts the dopamine into 
norepinephrine. In epinephrine-releasing neurons, norepinephrine leaks out of vesicles, where it 
is converted to epinephrine by the cytosolic enzyme phenolethanolamide-N-methyltransferase. 
This epinepherine is then loaded into its own vesicle population. Following release, dopamine, 
norepinephrine and epinephrine are cleared from the cleft by Na+- and Cl--dependent monoamine 
transporters that move them back into nerve terminals. In the terminal, these monoamines are 
either broken down by mitochondrial monoamine oxidase (MAO) or reloaded into new synaptic 
vesicles.  
 Other monoaminergic neurons release the indoleamine, serotonin. In serotonergic 
terminals, tryptophan-hydroxylase converts the amino acid tryptophan into 5-hydroxytryptophan, 
which is decarboxylated by 5-hydroxytryptophan decarboxylase to serotonin (5-
hydroxytryptamine or 5-HT). Serotonin is loaded into vesicles via vesicular monoamine 
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transporters. Following release, serotonin is cleared from the cleft and degraded in the cytosol of 
the presynaptic terminal by MAO or reloaded into synaptic vesicles.  
 
Purinergic Neurons  
Purinergic neurons synthesize and release the nucleotides ATP and adenosine (reviewed 
in [44, 45]). ATP and adenosine are important for numerous cellular processes, and are therefore 
sequestered into different populations. At the synapse, they are loaded into vesicles to prevent 
other cellular processes from depleting the supply necessary for release. This class of 
neurotransmitter is often co-released with other neurotransmitters throughout the peripheral and 
central nervous systems. Once released, ATP and adenosine are degraded in the cleft by cell 
surface enzymes known as ectonucleotidases. 
 
IV.b. Quantal Release Hypothesis  
 Identification of synaptic vesicles as the source of neurotransmitter release was a 
groundbreaking step in our understanding of synaptic transmission. Bernard Katz and his 
colleagues proposed the quantal release hypothesis in the early 1950s [1-3]. In pioneering 
electrophysiological studies at the frog neuromuscular junction, they identified spontaneous, 
small postsynaptic changes (AF 1.3A) that occurred in the absence of neural activity. These 
depolarizations resembled end plate potentials (EPPs) following an action potential (AF 1.3B), 
albeit on a much smaller scale. These small, spontaneous events are referred to as miniature end-
plate potentials (mEPPs). Since mEPPs appeared to be random and similarly-sized (between 0.3 
and 0.5 mV), this suggested neurotransmitter was being released in discrete packets, or quanta. 
When they evoked EPPs with presynaptic action potentials in the presence of excess Mg2+, 
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which decreases Ca2+ entry, the amplitude of the EPP was decreased and highly variable (AF 
1.3C). Importantly, they noticed that the EPP amplitudes fell in roughly even steps, with the step 
height being multiples of the spontaneous mEPP amplitude. These findings led to the hypothesis 
that neurotransmitter was being released in multimolecular quantized packets. Furthermore, an 
action potential causes the synchronous release of a large number of these packets, generating a 
large EPP (AF 1.3B) in the postsynaptic cell. Later studies at the mammalian neuromuscular 
junction clearly demonstrated the step-wise distribution of EPP amplitudes under similar 
conditions (AF 1.3D). 
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AF 1.3. Intracellular recordings at the neuromuscular junction. (A) Spontaneous, mEPPs 
recorded from a resting (not stimulated) frog neuromuscular junction. Note that these small 
depolarizing potentials are less than 1 mV in amplitude and occur randomly. (B) Postsynaptic 
response to a presynaptic action potential. The initial hump on the recorded waveform is the EPP 
elicited by ACh released from the presynaptic terminal. Note that the EPP is a large 
depolarization (> 40 mV), sufficient to bring the end-plate to threshold and trigger a muscle 
action potential (AP) (A,B adapted with permission from [2], ©1952 The Physiological Society). 
(C) Fluctuations in EPPs when neurotransmitter output has been reduced by adding 10 mM Mg2+ 
to the bathing medium. (C adapted with permission from [3] ©1954 The Physiological Society). 
(D) Distribution of EPP amplitudes recorded from a mammalian end-plate under conditions of 
reduced transmitter release in high (12.5 mM) Mg2+. The inset shows a histogram of spontaneous 
mEPPs recorded from a resting junction. Note that EPP amplitudes group around multiples of 
mean mEPP amplitude. The number of experimentally observed failures (0 quanta released) and 
single, double, triple, or more quantal responses, fit the theoretical distribution (solid curve) 
calculated from the Poisson equation. (Adapted with permission from [46] ©1956 The 
Physiological Society). 
 
The concept that synaptic transmission could be explained by the quantized release of 
neurotransmitter was proposed around the same time that small membranous vesicles within 
nerve terminals were first identified by electron microscopy [47, 48]. Together, these findings 
led to the vesicular hypothesis for neurotransmitter release, which states that each synaptic 
vesicle contains a similar amount of neurotransmitter (1 quantum), and that the transmitter 
release following an action potential results from a discrete number of vesicles fusing 
synchronously with the plasma membrane.  
This hypothesis allows for neurotransmitter release at the synapse to be understood in 
terms of the relatively simple equation m=np, where m is the average number of quanta released 
following a single nerve impulse (referred to as quantal content). The parameter m depends on 
the number of vesicles immediately available for release (n) and the probability (p) that any 
given vesicle will fuse with the membrane after a single impulse. This probability depends on 
multiple factors, including how “ready” the vesicle is to fuse, which we will refer to as its degree 
of priming, and the amount of Ca2+ influx into the presynaptic terminal (see sections V.a and 
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V.b). Statistical analysis of neurotransmitter release extends beyond this foundational concept 
(reviewed in [49]). 
 
V. Presynaptic Vesicle Cycle 
 As introduced above, synaptic vesicles must undergo a distinct, tightly regulated series of 
steps. They must be loaded with neurotransmitter (AF 1.2A.a), transported to the active zone, 
and docked to the presynaptic membrane by way of specific molecular interactions (AF 1.2A.b 
and 1.2B.b). The population of docked vesicles at a synapse is thought to constitute a readily 
releasable pool of neurotransmitter. However, only a subset of docked vesicles are fusion 
competent at any given time, namely, those that are maximally primed (AF 1.2A.d). In a resting 
terminal, individual maximally-primed vesicles can spontaneously fuse with the presynaptic 
membrane, resulting in the release of a single quantum of neurotransmitter. In an activated 
neuron, the influx of Ca2+ through voltage-gated Ca2+ channels (AF 1.2A.e) triggers the fusion 
of multiple maximally-primed vesicles with the presynaptic membrane and results in a larger 
release of neurotransmitter (AF 1.2A.f,g and 1.2C.f,g). This is accomplished by Ca2+-sensing 
proteins activating the fusion machinery. Neurotransmitter release occurs in two temporally 
distinct Ca2+-dependent phases: synchronous and asynchronous. After neurotransmitter release, 
the fusion machinery is disassembled and recycled for subsequent use. Concurrently, the 
synaptic vesicle membrane and associated proteins are retrieved through endocytosis (AF 
1.2A.h) to form new synaptic vesicles. These vesicles are reloaded with neurotransmitter and 
transported back to active zones, completing the cycle. The proteins covered in this and 
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AT 1.2. Table title and caption go here above the table.  
Compartment Protein Function 
Presynaptic RIM Active zone material 
 Munc13 Active zone material 
 RIM-BP Active zone material 
 Alpha-liprin Active zone material 
 ELKS/CAST Active zone material 
 Synaptobrevin 2 Fusion machinery 
 SNAP-25 Fusion machinery 
 Syntaxin Fusion machinery 
 Munc18 SM protein 
 Synaptotagmin 1/2 Ca2+ sensor, synchronous 
 Synaptotagmin 7 Ca2+ sensor, asynchronous 
 Doc2 Ca2+ sensor, asynchronous 
 NSF SNARE disassembly 
 Clathrin Endocytosis 
 Dynamin Endocytosis 
Synaptic Cleft Agrin Synaptogenesis 
 MuSK Synaptogenesis 
 LRP4 Synaptogenesis 
 Neuroligins Synaptogenesis/plasticity 
 Neurexins Synaptogenesis/plasticity 
 Cadherins Scaffolding/plasticity 
 Eph Tyrosine Kinases Scaffolding/plasticity 
 Epherins Scaffolding/plasticity 
Postsynaptic Ionotropic receptors Changes in postsynaptic potential 
 Metabotropic receptors Changes in postsynaptic potential/ 
second messenger cascades 
 
 
V.a. The Active Zone 
Functionally, the role of the active zone is to transduce an electrical nerve terminal 
depolarization into neurotransmitter release. Couteaux and Pecot-Dechavassinein coined the term 
“active zone” in 1970 when they noticed synaptic vesicles at the frog neuromuscular junction 
docked to the presynaptic membrane adjacent to electron dense material in electron micrographs 
[30]. Subsequent ultrastructural studies revealed similar morphologies across organisms. The 
structure of this active zone material (AZM) varies among different types of synapses, but must 
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include the requisite protein machinery for vesicle docking, priming, and fusion. The major 
constituents of active zones include: active zone core proteins, essential fusion machinery, 
Sec1/Munc18-like (SM) proteins, Ca2+ channels, and Ca2+ sensors. The core proteins covered in 
this chapter are Rab3-interacting molecules (RIM), Munc13, RIM binding protein (RIM-BP), 
alpha-liprin, and ELKS/CAST [50]. The essential fusion machinery consists of the soluble N-
ethlymaleimide sensitive factor adaptor protein receptors, or SNAREs. The Ca2+-sensing 
proteins covered in this chapter that trigger evoked neurotransmitter release are synaptotagmin 1, 
2, 7, and double C2 containing protein (Doc2). Numerous additional regulatory and adaptor 
molecules are present at or near active zones, but are not covered.  
The AZM holds a cluster of synaptic vesicles near release sites, including those docked 
against the presynaptic membrane. The precise structure of the AZM can vary in size and shape, 
depending on synaptic type and/or organism. In certain visual and auditory neurons, ribbon-like 
structures have been observed across several species. In contrast, neuromuscular junction 
ultrasturcture varies across organisms. In Drosophila, the neuromuscular AZM has a “T-bar” 
shape surrounded by synaptic vesicles. At mammalian neuromuscular junctions, the AZM 
contains short bars of electron-dense material located on either side of two adjacent docked 
vesicles with additional associated vesicles above. Frog neuromuscular junctions exhibit a long 
midline AZM with two rows of docked vesicles on either side (see AF 1.6) surrounded by 
additional synaptic vesicles. Despite their differences, Drosophila, frog, and mammalian 
neuromuscular junctions share common synaptic machinery. Recent electron tomography studies 
at the frog and mouse neuromuscular junctions reveal similar ultrastructural AZM components 
[51, 52]. The molecular identity of the individual proteins comprising these structures remains an 
active area of synaptic research.  
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Active Zone Core Proteins 
 Some of the proteins that are located in the core of the active zone include RIM, Munc13, 
RIM-BP, alpha-liprin, and ELKS/CAST. Together with additional adaptor proteins, they recruit 
synaptic vesicles, fusion machinery, and Ca2+ channels to the active zone. RIM and Munc13 
work together to link synaptic vesicles to active zones, as discussed below. In addition, RIM 
binds Ca2+ channels, which are concurrently bound by RIM-BP and ELKS/CAST, creating a 
trimeric complex essential for recruiting Ca2+ channels to active zones. Munc13 is additionally 
involved in enhancing vesicle fusion competence (see section V.b). Alpha-liprins interact with 
multiple proteins that regulate active zone formation [53]. They are scaffold proteins that may 
act as anchors to recruit and stabilize molecules at the active zone, as they are critical for 
recruiting RIM [54, 55] and trafficking synaptic vesicles [56]. Studies in invertebrates suggest a 
role for alpha liprin in active zone morphogenesis as mutants exhibit larger, less dense active 
zones [57]. The invertebrate homolog of ELKS/CAST is implicated in active zone cytoskeletal 
formation [58] and Ca2+ channel recruitment [59]. 
 
Fusion Machinery 
 The minimum machinery required to fuse a vesicle with its target membrane is the 
SNARE fusion complex, which is comprised of a vesicle-associated SNARE protein (vSNARE) 
and target-membrane associated SNARE proteins (tSNAREs). At the synapse, the vSNARE is 
synaptobrevin-2, also known as vesicle-associated membrane protein 2 (VAMP2) and the 
tSNAREs are syntaxin-1 and synaptosomal-associated protein of 25 kDa (SNAP-25) (AF 1.4).  
Each SNARE protein contains at least one SNARE motif of ~65 residues with a 
propensity to form coiled coils [60]. Synaptotobrevin and syntaxin each contain one SNARE 
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motif, and SNAP-25 contains two [61]. Prior to vesicle docking, syntaxin is found in a stable, 
closed conformation, with its SNARE motif bound to an internal three-helix-bundle regulatory 
domain, making it inaccessible for interactions with other SNARE proteins [62]. Syntaxin 
undergoes a conformational change triggered by Munc13 (see section V.b), which allows its 
SNARE motif to interact with the SNARE motifs of synaptobrevin and SNAP-25. This creates a 
trans-SNARE complex which is associated with both the vesicular membrane and the 
presynaptic plasma membrane. On any given vesicle, tight coiling of multiple SNARE 
complexes [63] provides the energy required to drive fusion of the vesicle and target membranes 
(AF 1.4) [64, 65]. Following membrane fusion, all members of the SNARE complex are located 
in the target membrane, and the complex is referred to as a cis-SNARE complex. 
SNARE complexes mediate both constitutive and regulated vesicle fusion events 
throughout cells. At the synapse, multiple regulatory elements suppress constitutive SNARE-
mediated fusion events and facilitate the fast, synchronous fusion of multiple synaptic vesicles 
upon Ca2+ influx. Synchronous fusion of multiple vesicles is essential for neuronal signaling and 
relies on the docking of vesicles at the active zone and their priming to a fusion ready state 
(section V.b).  
The basic concept of the minimal machinery necessary to fuse a vesicular with its target 
membrane is as follows: SNARE proteins on both the vesicular and target membranes associate 
to form tight coiled-coil configurations. When maximally coiled, trans-SNARE complexes force 
the two membranes together, thereby destabilizing the membranes’ natural curvature (AF 1.4). 
The coiling of trans-SNARE complexes all the way into their transmembrane domains provides 
the energy to drive fusion of the membranes [64, 66, 67]. Following fusion, the vSNAREs and 
tSNARES are now in a cis-SNARE complex, and the vesicular contents are released.  
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AF 1.4. Minimal fusion machinery. Schematic of a vesicle just prior to fusion showing two (of 
multiple) maximally-coiled, trans-SNARE complexes pulling the vesicle membrane flat against 
the presynaptic membrane. (Reprinted by permission from [61], Springer Nature: Springer, 
Nature, Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å 




SM Proteins  
SM proteins function during virtually all SNARE-dependent fusion reactions. These 
soluble proteins fold into general “clasp” shapes [68] with a propensity to bind four helix 
bundles. At least one SM protein is necessary for any SNARE-mediated fusion event to occur. 
SM proteins are believed to be essential to stabilize SNARE complexes spatially and support 
SNARE complex assembly. Munc18, a member of the SM protein family, binds the N-terminal 
region of syntaxin in its closed conformation [62, 68, 69]. This SM/SNARE interaction prevents 
SNARE complex assembly, thereby inhibiting fusion events. Once syntaxin undergoes a 
conformational change to its open configuration (see section V.b), Munc18 remains bound but 
alters its binding to interact directly with the four helix bundle of the assembling trans-SNARE 
complex, aiding in fusion [70, 71]. In this way, SM proteins are both negative and positive 
regulators of SNARE-mediated fusion. 
 
Ca2+ Channels  
The presence of voltage-gated Ca2+ channels at active zones is necessary to couple 
neuronal depolarization to vesicle fusion events. Not only do these channels need to be present at 
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active zones, their precise localization within an active zone can have immense effects on the 
efficacy of synaptic transmission. Ca2+ channels are located within 50 nm from docked vesicles 
[72-74]. When the cell is depolarized, the Ca2+ channels briefly open, creating a nanodomain of 
particularly high [Ca2+] immediately adjacent to each channel. This [Ca2+] reaches hundreds of 
µM at the mouth of the channel [75] and drops off rapidly with distance (AF 1.5) [76-79]. As the 
availability of Ca2+ is limited temporally and spatially, the closer the channel is located to the 
Ca2+ sensor, the greater the odds of saturating sensor binding and triggering vesicle fusion. Since 
the sensor for fast, synchronous neurotransmitter release is a low affinity sensor (see below), 
even a 5 nm change in the distance between the channel and the sensor has profound effects on 
vesicle release probability [80].  
 
AF 1.5. Ca2+ nanodomains. Schematic depicting the rapid decay of [Ca2+] with distance from the 
Ca2+ channel. The darker the gradient, the higher the [Ca2+]. A Ca2+ sensor on the left vesicle 
would experience a very high [Ca2+], which would maximize the probability of fusion. A Ca2+ 
sensor on the right vesicle would be exposed to a much lower [Ca2+] and have a correspondingly 





Synaptotagmins 1, 2, and 7, as well as Doc2 regulate two distinct forms of Ca2+-
dependent neurotransmitter release: fast, synchronous release and a longer lasting, asynchronous 
release (section V.c). While other Ca2+ sensors exist, only the previously mentioned proteins will 
be covered as they are currently the best understood. 
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Synaptotagmins are a large family of integral membrane proteins that contain two Ca2+-
binding motifs called C2 domains. Synaptotagmin 1 and 2 are located on synaptic vesicles and 
play functionally homologous roles in different parts of the nervous system. In mammals, 
synaptotagmin 1 is expressed predominantly in the cerebral hemispheres, while synaptotagmin 2 
is expressed predominantly in the brainstem, spinal cord, and at the neuromuscular junction [81, 
82]. Synaptotagmins 1/2 are low-affinity Ca2+ sensors, meaning they only bind Ca2+ when 
intracellular [Ca2+] is very high, as found in the Ca2+ nanodomains discussed above. In the Ca2+-
bound state, the C2 domains of synaptotagmin interact with both SNARE proteins [83-88] and 
negatively-charged phospholipid membranes in vitro [89-91]. Upon Ca2+ binding in vivo, 
synaptotagmins 1/2 trigger the fast, synchronous phase of neurotransmitter release [92] primarily 
through membrane interactions [93, 94], although Ca2+-dependent SNARE interactions likely 
contribute as well. 
Synaptotagmin 7 is another member of the synaptotagmin family enriched at synapses. It 
is an integral membrane protein localized in the presynaptic membrane [95] that binds Ca2+ with 
a higher affinity than synaptotagmins 1/2. Doc2 is also enriched at synapses and contains two 
Ca2+-binding C2 domains with a high affinity for Ca2+ [96]. Unlike the synaptotagmins, Doc2 is 
a cytosolic protein. Both synaptotagmin 7 and Doc2 are attractive candidates for triggering 
asynchronous release (section V.c) due to their high Ca2+ affinities and slow Ca2+-interaction 
kinetics [97].  
 
V.b. Docking and Priming at the Active Zone 
 To become fusion competent, synaptic vesicles must be precisely targeted to the active 
zone and held in direct contact with the presynaptic membrane. First, vesicles are tethered near 
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the presynaptic membrane at active zones. When the vesicle membrane touches the presynaptic 
membrane, the vesicle is considered docked at the release site. Once docked, additional 
interactions, referred to as priming, increase the probability of vesicle fusion.  
Adaptor proteins piccolo/bassoon are thought to guide synaptic vesicles toward active 
zones in vertebrates [98, 99]. Once there, RIM and Munc13 contribute to vesicle docking [100]. 
RIM binds to Munc13, creating a RIM/Munc13 heterodimer. This heterodimer binds an 
accessory protein, either Rab3 or Rab27, and this complex provides the scaffold needed to 
precisely target and hold synaptic vesicles to active zones (AF 1.2A.b) [101]. These vesicles are 
now considered docked. 
Additional intermolecular interactions are required before vesicles are maximally primed 
and fully fusion competent. Munc13, an essential active zone protein, is thought to orchestrate 
the first step in fusion machinery assembly (note: Munc13 should not to be confused with the 
SM protein, Munc18, discussed in section V.a). Munc13 binds to the closed conformation of 
syntaxin and facilitates a conformational change in syntaxin from its “closed” to its “open” state 
[62, 102]. Only then can syntaxin’s SNARE motif interact with the SNARE motifs of SNAP-25 
and synaptobrevin to form a trans-SNARE complex. Upon syntaxin’s conformational change, 
the Munc18 interaction adjusts to facilitate the assembly of the trans-SNARE complex [70, 71], 
thereby contributing to the fusion-competency of the vesicle. 
Recent work in the McMahan lab suggests that vesicle priming is in a state of dynamic 
equilibrium (AF 1.6A, arrows), such that only docked vesicles with the largest area of contact 
with the presynaptic membrane are maximally primed and ready to fuse upon Ca2+ influx [52]. 
One mechanism of accomplishing variable priming would be a balance between the repulsive 
forces of the vesicular and presynaptic membranes that result in SNARE complex uncoiling to 
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favor minimal priming (AF 1.6A, left) and SNARE complex coiling to favor maximal priming 
(AF 1.6A, right) [52]. At any given moment, only a subpopulation of docked synaptic vesicles 
have a sufficient number of maximally-coiled trans-SNARE complexes to produce maximal SV-
PM contact area. These synaptic vesicles constitute the maximally-primed population that is 
most likely to fuse upon Ca2+ influx. Once triggered by Ca2+, these maximally-primed synaptic 
vesicles complete the SNARE coiling process all the way into the transmembrane domains of 
syntaxin and synaptobrevin [103]. The synaptic vesicle membrane merges with the presynaptic 
membrane, resulting in cis-SNARE complex formation. Thus, the coiling of SNARE complexes 
provides the energy needed to induce membrane fusion.  
 
AF 1.6. Docking and variable priming of synaptic vesicles. (A) Left, schematic depicting a 
docked, minimally-primed vesicle at the presynaptic membrane, defined by the small area of 
contact between the vesicle and plasma membranes. Right, the fusion machinery located in the 
AZM (ribs, pegs) and in pins pulls the vesicle and presynaptic membranes together, increasing 
the area of contact, resulting in a maximally-primed vesicle that has the highest fusion 
probability. The degree of priming is in a state of dynamic equilibrium (arrows). Those vesicles 
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that happen to be maximally primed when Ca2+ influx occurs are thought to be the vesicles that 
fuse. (Adapted from [52]). (B) A docked synaptic vesicle viewed by electron tomography. White 
* represents AZM. (Adapted from [104]). (C) Freeze-fracture electron micrograph at the frog 
neuromuscular junction showing the characteristic parallel double-rows of particles that 
comprise the pegs of the AZM and include the voltage-gated Ca2+ channels required for 
triggering fusion. (Adapted from [72] ©1979 Journal of Cell Biology. 81:275-300. 
DOI:10.1083/jcb.81.2.275). (D) Schematic showing the relationship of docked synaptic vesicles, 
the AZM, and the double row of particles that include Ca2+ channels at the frog neuromuscular 
junction. (Reprinted with permission from [73], Springer Nature: Springer, Nature, The 
Architecture of active zone material at the frog’s neuromuscular junction. Mark L Harlow, David 
Ress, Arne Stoschek, Robert M Marshall, Uel J McMahan, ©2001). 
 
 
V.c. Vesicle Fusion 
 Fusion events can occur spontaneously or can be evoked. When an action potential 
depolarizes the presynaptic terminal, voltage-gated Ca2+ channels open. The subsequent influx of 
Ca2+ triggers a series of intermolecular interactions that results in the fusion of multiple 
maximally-primed vesicles with the presynaptic membrane (AF 1.2A,C and 1.7). 
 
AF 1.7. Vesicle fusion. (A) Schematic depicting a vesicle that has just fused with the presynaptic 
membrane such that the vesicle membrane is now incorporated into the plasma membrane, 
forming an omega figure. (B) Electron tomograph of a fusing vesicle. V1 and V2 represent 
additional synaptic vesicles located near the active zone that are linked to the fusing vesicle 
(arrows). White * represents AZM. (A,B adapted from [104]). (C) Freeze-fracture electron 
micrograph showing the openings of fusing vesicles (box) just lateral to the double-rows of 
particles found at active zones. Cluster of particles characteristic of fully-collapsed vesicles 
(black * bold arrows) are also found lateral to the double-row of particles. (Adapted from [72] 
©1979 Journal of Cell Biology. 81:275-300. DOI:10.1083/jcb.81.2.275).  
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Ca2+-independent Neurotransmitter Release 
Ca2+-independent neurotransmitter release is referred to as spontaneous release. This 
form of neurotransmitter release occurs in resting nerve terminals when a single vesicle fuses 
with the presynaptic membrane in the absence of presynaptic Ca2+ influx (AF 1.3A). Classically, 
spontaneous release is considered to be random fusion events caused by low-probability 
conformational changes that complete coiling of the SNARE proteins and result in fusion. Since 
these spontaneously fusing vesicles would be in a maximally-primed, fusion-competent state, 
little energy is required to overcome the fusion barrier.  
Spontaneous and evoked fusion events can occur at distinct active zones [105, 106] from 
separate recycling pools [107, 108]. Thus, location may partially determine the probability of a 
vesicle participating in spontaneous versus evoked neurotransmitter release. These recent studies, 
together with the classic spontaneous release hypothesis, suggest multiple mechanisms occurring 
during spontaneous fusion, with a subpopulation originating from maximally-primed vesicles 
reacting to transient changes in their environment, and another subpopulation occurring at 
specialized, Ca2+-independent fusion sites. 
 
Ca2+-dependent Neurotransmitter Release 
 Ca2+-dependent neurotransmitter release is differentiated temporally into two phases: 
fast, synchronous release and a slower, asynchronous release (AF 1.8) [109, 110]. The fast, 
synchronous phase is the large burst of neurotransmitter release that occurs within milliseconds 
of the arrival of the action potential and constitutes the classical neurotransmitter release 
pathway typically described in textbooks (AF 1.8, upper trace). However, there is an additional 
slower, or asynchronous, phase of elevated release that is still Ca2+-dependent and lasts for tens 
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to hundreds of milliseconds [109, 110]. This phase of release is most notable following periods 
of high frequency stimulation, at specialized synapses, and at synaptotagmin 1 knock out 
synapses (FA 1.8, lower trace) [110-114].  
 
AF 1.8. Ca2+-dependent neurotransmitter release at cultured hippocampal synapses. Upper, 
voltage trace depicts the fast, synchronous neurotransmitter release in cultures from wild type 
mice. Lower, voltage trace depicts the slower, asynchronous neurotransmitter release in cultures 
from synaptotagmin 1 knock out mice. (Reprinted from [115], Cell, 79/4, Martin Geppert, 
Yukiko Goda, Robert E Hammer, Cai Li, Thomas W Rosahl, Charles F Stevens, Thomas C 
Sudhof, Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse, p. 717-
27. ©1994, with permission from Elsevier). 
 
 Fast, synchronous release of neurotransmitter occurs when multiple synaptic vesicles fuse 
within milliseconds of depolarization (AF 1.8, upper trace). The structure of the active zone 
provides optimal conditions to accomplish this task. Synaptotagmin 1/2 is a low-affinity Ca2+ 
sensor with fast binding/unbinding kinetics. Thus, saturated Ca2+ binding requires the 
exceptionally high [Ca2+] that only occurs in nanodomains around open Ca2+ channels. Since 
this high [Ca2+] drops off rapidly in time and space by diffusion [76-79], only synaptotagmin 1/2 
located within such a nanodomain would be expected to trigger fusion; the rapid decrease in high 
[Ca2+] ensures that the signal to fuse is terminated. Therefore, synaptotagmin’s precise location 
relative to the presynaptic Ca2+ channels has profound effects on the release probability of the 
vesicle. As the SNAREs coil and pull the vesicle and plasma membranes together, not only does 
the membrane contact area increase, the distance between the Ca2+ channel and synaptotagmin is 
predicted to decrease [52]. According to this hypothesis, only the subpopulation of docked 
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synaptic vesicles that are maximally primed would situate synaptotagmin at its closest to Ca2+ 
channels. The closer synaptatogamin 1/2 is to the Ca2+ channel at the time of Ca2+ influx, the 
higher the [Ca2+] that reaches its C2B domains, favoring fusion.  
Upon Ca2+ binding, the net charge of the Ca2+ binding pockets of synaptotagmin changes 
from negative to positive. This enhances interactions with the negatively charged presynaptic 
membrane and potentially with trans-SNARE complexes [83, 89, 116, 117]. Thus, Ca2+ binding 
allows synaptotagmin 1/2 to act as an “electrostatic switch” [118-121]. Switching from 
electrostatic repulsion to electrostatic attraction permits hydrophobic residues in the C2 domains 
of synaptotagmin 1/2 to escape the hydrophilic cytosol by penetrating into the hydrophobic core 
of the presynaptic membrane. Therefore, synaptotagmin 1/2 can be thought of as providing the 
final push, much like popping a tightly-inflated balloon, to trigger fusion. This hypothesis can 
account for both the spatial and temporal restriction observed during fast, synchronous 
neurotransmitter release.  
 
Asynchronous Release  
 Asynchronous release continues for several 100’s of milliseconds up to a second (AF 1.8, 
lower trace). Asynchronous neurotransmitter release is observed in many neuronal types during 
and following extended high frequency activity [111]. Under these circumstances, the [Ca2+] 
builds up since Ca2+ clearance is slower than Ca2+ entry. During the prolonged Ca2+ clearance 
phase, the residual [Ca2+] is thought to drop below saturating binding levels for synaptotagmin 
1/2 [109], but it remains high enough to activate a high-affinity Ca2+ sensor. While most 
synapses exhibit little to no asynchronous release following a single action potential, 
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asynchronous release is predominant in some specialized synapses [112-114]. Asynchronous 
release has been implicated in modulating postsynaptic responses [122].  
 The identity of the Ca2+ sensor(s) for asynchronous release is still debated. Like the fast, 
synchronous Ca2+ sensor, the asynchronous Ca2+ sensor needs be present at synapses and 
enriched at fusion sites. However, it must have a higher affinity for Ca2+ so that it can bind at 
lower [Ca2+], permitting this protein to trigger release over a longer time course. Synaptotagmin 
7 and Doc2 are current candidates for the Ca2+ sensor for triggering asynchronous 
neurotransmitter release, as they exhibit these characteristics [96, 97, 123].  
 
V.d. SNARE and Vesicle Recycling 
After a synaptic vesicle fuses, the SNARE complex is in a cis conformation since the 
vesicle membrane is incorporated into the presynaptic membrane. Cytosolic adaptor proteins 
specifically recognize and bind to cis-SNARE complexes and recruit N-ethylmaleimide-sensitive 
factor (NSF). NSF is an ATPase responsible for disassembling the SNARE complex [64]. This 
disassembly is required before the vSNAREs can be endocytosed for incorporation into new 
vesicles and before the tSNAREs can be reused in subsequent rounds of fusion events.  
The synaptic vesicle membrane and all associated vesicle proteins must be rapidly 
recycled within nerve terminals to maintain the pool of vesicles available for fusion. There are 
multiple proposed mechanisms of synaptic vesicle recycling, but clathrin-mediated endocytosis 
(CME) is currently the best understood. CME was first described over 50 years ago [124] and 
occurs in many cell types (reviewed in [125]). It was first implicated in synaptic vesicle 
recycling in 1973 when it was shown to occur away from active zones following full collapse of 
the synaptic vesicle membrane into the presynaptic membrane (AF 1.2A,h) [124]. During CME, 
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a plethora of adaptor and accessory proteins facilitate appropriate membrane invagination and 
recruitment of clathrin to form spherical clathrin-coated membrane pits that project into the 
presynaptic cytoplasm [126]. The GTPase, dynamin, is then recruited to mediate a scission event 
that separates the clathrin-coated pit from the presynaptic membrane. The new vesicle is 
uncoated, targeted to endosomes or synapses, reloaded with neurotransmitter, and transported 
back to active zones. This completes the synaptic vesicle cycle, and can occur as fast as ~20-40 
seconds [127].  
Recently, a clathrin-independent endocytic mechanism was reported in both invertebrate 
[128] and vertebrate [129] neurons. This mechanism, called ultrafast endocytosis, occurs 200 
times faster than CME. However, it must be stressed that this pathway still requires the action of 
clathrin for reformation of synaptic vesicles. The clathrin-independent bulk internalization of 
membrane produces large vesicles that form endosomes. The reformation of synaptic vesicles 
requires clathrin-mediated vesicle budding from these endosomes [130]. Another mechanism 
postulated to mediate vesicle recycling is known as “kiss and run”, where vesicles undergo a 
transient connection to the plasma membrane via a fusion pore, but the vesicle never collapses 
[131]. While this mechanism occurs in endocrine cells [132], its role in nerve terminals is 
questionable (reviewed in [133]).  
 
VI. Synaptic Cleft  
 The synaptic cleft contains proteins and glycoproteins that support cell adhesion and 
regulate synaptic development and stability. Cleft proteins also clear neurotransmitter. The vast 
majority of proteins in the synaptic cleft provide structural support to the pre- and postsynaptic 
membranes from development through maturity. Many of these proteins are transmembrane cell 
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adhesion molecules (reviewed in [32]). Their cytosolic domains generally interact with 
intracellular synaptic proteins while their extracellular domains bind to transmembrane synaptic 
proteins of the opposing cell. Some extracellular and transmembrane synaptic proteins direct 
synaptogenesis, while others are important for neurotransmitter clearance, including enzymes 
that break them down and transporters that sequester them.  
The protein machinery and organization varies by synapse type and location. A CNS 
synapse connects two neurons, and in some locations, it is functionally important for the strength 
of CNS synapses to be easily modified. At the neuromuscular junction, the postsynaptic cell is a 
muscle fiber where there is less need for rapid changes in synaptic strength. Nevertheless, many 
general processes are conserved across synapses. Machinery for synaptogenesis, scaffolding, and 
neurotransmitter clearance are universally required, but the individual molecular interactions will 
be synapse specific. 
 
VI.a. Synaptogenesis 
 A specific role for an extracellular matrix molecule in regulating the formation and 
maintenance of synaptic connections has been best elucidated at the frog neuromuscular 
junction. Dr. U.J. McMahan and colleagues discovered that the synaptic basal lamina contains 
molecules that direct the formation of synaptic specializations in both regenerating nerve 
terminals [7] and regenerating muscle fibers [8]. They purified the basal lamina molecule 
responsible for directing postsynaptic specializations and named it agrin [19].  
 Agrin is a critical signal for synaptogenesis and synaptic maintenance [134, 135]. It is 
secreted from presynaptic nerve terminals and is stably incorporated into the synaptic basal 
lamina. It binds to and activates a receptor complex in the plasma membrane of the muscle fiber, 
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which then induces postsynaptic specializations [134]. This receptor complex is composed of the 
low-density lipoprotein receptor-related protein 4 (LRP4), which binds agrin, and a muscle-
specific kinase (MuSK), which triggers a postsynaptic signaling cascade [136-138]. This cascade 
recruits acetylcholine receptors, acetylcholinesterase (AChE), and numerous other components 
of the postsynaptic apparatus to postsynaptic sites immediately opposite the nerve terminal 
[139]. Precise alignment is critical for the formation, organization, maintenance, and function of 
the neuromuscular junction.  
 CNS synaptogenesis is not well understood. However, the neuroligin and neurexin 
families of proteins may play a role. The neuroligins are postsynaptic cell adhesion molecules 
[140] that bind to the presynaptic cell adhesion molecules, the neurexins [141]. This heterotypic 
interaction across the cleft aggregates the machinery (both pre- and postsynaptic) necessary for a 
functional synapse [142, 143]. Neuroligin-1 is present exclusively in excitatory synapses [144], 
while neuroligin-2 is present exclusively in inhibitory synapses [145]. Knockdown of neuroligins 
[146] or interference with neuroligin-neurexin signaling [147] diminishes the number of fully 
developed synapses. This research has led to the hypothesis that in addition to offering the 
structural stability of cell adhesion molecules at developing synapses, the postsynaptic 
neuroligins and presynaptic neurexins are critical for aggregating synaptic components and 
assigning the valence of the synapse. 
 
VI.b. Scaffolding  
The stability of synaptic connections is tightly regulated based on the functional 
requirements of the particular synapse. Some synapses, like neuromuscular junctions, are 
relatively stable and provide reliable transmission for proper locomotion over long time periods. 
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While there is minor synaptic remodeling, the function at this synapse remains relatively 
constant in healthy individuals. Other synapses are short lived or exhibit synaptic strengths that 
vary widely within seconds. In the cerebral cortex, synaptic plasticity may strengthen some 
synapses in response to heavy activity while pruning others that are less active. Such alterations 
in synaptic strength are foundational to the mechanisms of learning and memory first posited by 
Donald Hebb [148]. Scaffolding molecules spanning the synaptic cleft can either maintain and 
support a synapse or promote retraction and weakening.  
The cadherins are a family of transmembrane cell adhesion molecules (reviewed in [149]) 
present at most synapses. They are thought to provide critical support for synapse stability, 
particularly in dendritic spines [150, 151]. They are present both pre- and postsynaptically and 
bridge the synaptic cleft through homotypic binding interactions. Cadherins are generally 
concentrated around the edges of synapses [152]. This localization may form a diffusion barrier 
that helps sequester receptors and maintain the structural integrity of the synapse [153]. 
Other classes of transmembrane proteins have more varied affects. The Eph receptor 
tyrosine kinases and their binding partners, epherins, interact across the cleft through heterotypic 
interactions. Signals in both antero- and retrograde directions are postulated to promote 
remodeling of synaptic structure [154, 155]. Different subtypes of Eph receptors and epherins 
have alternate affects. Knockdown of EphB2 leads to decreased synapse number and loss of 
synaptic superstructure [156]. Therefore, EphB2 signaling encourages the stability of synapses 
[157]. Ephrin-A3 and EphA4 signaling, on the other hand, results in decreased synapse number 
and retraction of synaptic ultrastructure [158]. Thus, these scaffolding molecules are critical for 
both maintenance and alteration of existing synapses across time, and their trans-synaptic 
signaling is necessary during many neurological processes. 
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VI.c. Neurotransmitter Clearance 
Removal and/or breakdown of neurotransmitter by cleft proteins is pivotal for regulating 
the temporal aspects of the signal strength between neurons. The dopamine transporter, a well-
defined example of this role [159], is the primary regulator of dopamine concentration in the 
synaptic cleft in a key reward center in the brain. Inhibition of this transporter by cocaine 
prevents the removal of dopamine from the presynaptic cell into the cleft [160]. The resulting 
build up causes increased signaling to the postsynaptic cell and consequent over-activity of the 
reward circuitry, leading to addiction.  
Enzymatic breakdown is the other way to clear neurotransmitter after release. A well-
characterized example of this clearance mechanism is the enzyme AChE [161], which 
hydrolyzes ACh. The action of AChE is so fast that the rate-limiting step in the breakdown of 
ACh is diffusion of the transmitter. This rapid breakdown is critical for proper synaptic function 
as it regulates ACh concentration and thus the postsynaptic response. AChE inhibitors provide 
effective treatment for diseases involving deficits in ACh signaling. In myasthenia gravis, the 
immune system attacks ACh receptors such that normal ACh release from motor neurons cannot 
provide sufficient muscle stimulation. By slowing down the clearance of ACh, AChE inhibitors 
counteract the muscle’s decreased ability to respond [162]. Presynaptic defects are similarly 
amenable to treatment. According to the cholinergic hypothesis of Alzheimer’s disease [163], 
loss of cholinergic neurons may underlie some cognitive deficits. AChE inhibitors are again used 
to slow down clearance, resulting in an accumulation of the ACh released by the remaining 
cholinergic neurons. Thus, it is essential that proteins specific for clearance of each type of 
neurotransmitter(s) released are present in the synaptic cleft. 
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VII. Postsynaptic Function  
 The postsynaptic membrane is uniquely specialized to detect neurotransmitters and 
transduce this chemical signal back into an electrical signal. Binding of neurotransmitters to 
receptors can elicit either a fast, transient or slower, longer-lasting response which may activate 
or inhibit electrical signaling in the postsynaptic cell. The specific response depends on the 
neurotransmitter released as well as the postsynaptic receptor subtype(s) present. Ionotropic 
receptors are ion channels that open upon neurotransmitter binding. Metabotropic receptors are 
GPCRs that activate G-protein second messenger systems, leading to changes in ion channel 
opening. Activating either type of receptor can result in postsynaptic depolarization or 
hyperpolarization depending on the ion selectivity of the activated channels.  
 
VII.a. Postsynaptic Receptors 
Ionotropic Receptors  
Ionotropic receptors are ligand-gated ion channels that form pores in the membrane 
allowing the passage of ions down their electrochemical gradients [164]. Ion channels are 
generally closed at rest. Binding of their specific neurotransmitter causes a conformational 
change, opening the pore and allowing ion influx. Early studies at the frog neuromuscular 
junction measured ACh-induced changes in ion conductances in muscle fibers demonstrating 
channel opening in response to a ligand [165]. This process is extremely rapid, allowing 
immediate ion influx that abruptly ceases when the ligand unbinds, and the channel closes. In 
addition, some channels inactivate, stopping ionic conductance even while a ligand remains 
bound. In this way, ionotropic channels generate fast and transient electrical signals in response 
to the presence of neurotransmitter. 
 
	   	   	  168	  
Metabotropic Receptors 
Metabotropic receptors have extracellular binding sites for specific neurotransmitters and 
bind to intracellular G-proteins [166]. Binding of neurotransmitter to these GPCRs causes 
activation of the intracellular G-protein, which dissociates from the receptor and may activate 
intracellular kinase cascades, phosphatases, and/or other second messengers, which then act on 
various downstream effectors, including opening of ion channels. The necessity of multiple 
protein interactions before the opening of an ion channel means that the time scale of 
metabotropic receptor effects will be much slower than those of ionotropic receptors. Second 
messenger cascades can also amplify the original signal. One neurotransmitter molecule can 
activate a G-protein, which can activate multiple kinases, which can activate multiple ion 
channels. In addition, the downstream second messengers may remain activated after the ligand 
comes unbound from the GPCR. Thus, the postsynaptic response generated by metabotropic 
receptors, though slower, tend to be larger and more persistent.  
Second messenger systems can have additional wide-ranging affects independent of 
electrical changes in the postsynaptic cell. Some second messengers act as transcription factors, 
altering gene expression [167]. Others cause release of internal Ca2+ stores and lead to changes 
in synaptic strength [168]. The potential downstream effects of multiple, simultaneously 
activated signaling pathways can vary widely depending on the downstream machinery present 
in the postsynaptic cell. 
 
VII.b. Generation of Postsynaptic Potentials  
The postsynaptic membrane’s ability to transduce the chemical signal into an electrical 
signal is dependent on the opening of ion channels (either ionotropic receptors, or downstream 
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effectors of GPCRs) that allow ions to travel down their electrochemical gradients. Thus, the ion 
selectivity of the activated channels determines the net potential generated in the postsynaptic 
cell. At a typical excitatory synapse, the open ion channels allow positively-charged ions, such as 
Na+ and Ca2+, to flow down their electrochemical gradients into the postsynaptic cell. The influx 
of positive charge depolarizes the post-synaptic cell, otherwise known as an excitatory 
postsynaptic potential (EPSP). If the activated channels are permeable to either Cl- or K+, the 
postsynaptic membrane will be hyperpolarized. The concentration gradient for each of these ions 
is great enough to drive them against the electrical gradient, so Cl- will enter or K+ will leave the 
cell, which drives the membrane potential to a more negative value. Such a hyperpolarization is 
called an inhibitory postsynaptic potential (IPSP). 
  The net change in membrane potential depends on the summation of all synaptic inputs. 
Mammalian neuromuscular junctions are exclusively excitatory. At these synapses, sufficient 
ACh is released to ensure that the postsynaptic muscle fiber is depolarized past threshold, 
resulting in muscle fiber contraction (AF 1.3B). In the CNS, all synaptic inputs to the 
postsynaptic neuron, which may include both EPSPs and IPSPs, are summated. If the 
postsynaptic neuron is sufficiently depolarized at its axon initial segment, its firing rate will 
increase. If the net effect at the axon initial segment is a hyperpolarization, its firing rate will 
decrease. Thus, it is the net activity that determines the overall response in the postsynaptic cell 
(reviewed in [169]). 
 
VIII. Modulation of the Chemical Synapse 
The response of a given postsynaptic cell to the same level of activity in a presynaptic 
cell can vary depending on the efficacy of the synapse. Synaptic efficacy is based on many 
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factors, including the quantal content (number of neurotransmitter-filled synaptic vesicles that 
fuse in response to a given stimulus, discussed in section IV.b) and the type and number of 
postsynaptic receptors. Importantly, these pre- and postsynaptic parameters can be regulated by 
activity patterns. The capacity to modulate synaptic efficacy is an important mechanism 
underlying learning and memory. These activity-dependent changes are known as synaptic 
plasticity.  
Experimentally, synaptic plasticity is measured both pre- and postsynaptically. 
Presynaptically, the amount of neurotransmitter released can be decreased or increased, leading 
to depressed or facilitated responses, respectively. Specifically, the quantal content of a synapse 
(m) depends on the number of vesicles available to fuse (n), and the release probability of each 
vesicle (p) (section IV.b). The release probability is dependent on the magnitude and duration of 
Ca2+ influx, the speed of Ca2+ clearance, and the proximity of the Ca2+ sensor to the channel 
(section V.a). Higher quantal content causes larger responses in the postsynaptic cell, barring any 
postsynaptic adaptations. Synapses with a high quantal content result from some combination of 
a large readily releasable pool of vesicles, high vesicle release probability, high Ca2+ influx, 
and/or slow Ca2+ clearance. Alternatively, low quantal content synapses have the opposite 
characteristics and result in smaller postsynaptic responses.  
Postsynaptically, changes in synaptic activity can lead to changes in the morphological 
makeup of the postsynaptic membrane through insertion or removal of receptors. Any change in 
receptor density results in a change in response strength to a given signal. Therefore, activity-
dependent alteration of the postsynaptic machinery allows for flexible modulation of 
postsynaptic responses to neurotransmitter release. 
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VIII.a. Depression 
Synaptic depression is defined as a reduction in the amplitude of the postsynaptic 
response following a given presynaptic stimulus. This can be observed at high quantal content 
synapses during paired pulse experiments, in which two closely spaced stimuli are administered 
to a cell [170, 171]. The first response, or EPSP, is robust, while the second response is reduced. 
At a high quantal content synapse, the first stimulation is sufficient to release a large fraction of 
the readily releasable vesicles. Accordingly, there are fewer vesicles available to fuse during the 
second stimulus, which results in a reduced EPSP. Another example of synaptic depression is 
seen during a high-frequency stimulus train to the presynaptic cell [172, 173]. Since exocytosis is 
more rapid than endocytosis, such stimulation depletes the readily releasable pool of synaptic 
vesicles, even at low quantal content synapses, and quantal content is decreased. 
 
VIII.b. Facilitation 
Facilitation is an incremental increase in the postsynaptic response to a given presynaptic 
stimulation observed in paired pulse experiments at low quantal content synapses. Since the first 
stimulus at such a synapse results in the fusion of only a small fraction of the readily releasable 
pool, the number of vesicles available for fusion following the second impulse is not 
significantly reduced. If the delay between the two stimuli is within tens of milliseconds, not all 
the Ca2+ that entered during the first pulse has been removed by the time of the second pulse. 
Therefore, the [Ca2+] experienced by vesicles during the second pulse is higher and triggers a 
greater number of synaptic vesicles to fuse. If the delay between stimuli is long enough to allow 
the Ca2+ from the first pulse to be removed, the second response is not facilitated. This is known 
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as the residual Ca2+ hypothesis [174-176], and this form of presynaptic facilitation is very short-
lived. 
 
VIII.c. Long-term Potentiation 
Long-term potentiation (LTP) is characterized by a long-lasting facilitated response in the 
postsynaptic cell following a brief tetanic stimulation of a strong input (AF 1.9A) or 
simultaneous stimulation of multiple weaker inputs. Since its discovery in the rabbit 
hippocampus in 1966 [4], the study of LTP has grown into an immense field. In the intervening 
50 years, multiple forms of LTP have been detected in many different cells and brain regions. 
These changes can last from hours to days and rely on presynaptic and postsynaptic mechanisms 
(reviewed in [67, 177]). Here we describe a prototypic form of postsynaptic LTP, namely 
NMDA receptor-dependent LTP at excitatory synapses in the hippocampus (reviewed in [178]). 
In this form of LTP, the postsynaptic neuron contains two classes of ionotropic glutamate 
receptors, AMPA receptors and NMDA receptors. NMDA receptors have extracellular Mg2+ 
bound in their pores at the resting membrane potential. Following a single stimulus, glutamate 
binds to both types of receptors. The AMPA receptors open, which allows Na+ influx and results 
in an EPSP. However, little to no current passes through the NMDA receptors due to the voltage-
dependent Mg2+ block [179, 180].  
During tetantic stimulation, the postsynaptic cell is sufficiently depolarized to remove the 
Mg2+ block from the NMDA receptor pore. With the block removed, glutamate binding results in 
a robust influx of Ca2+ through the NMDA receptor [181]. This is the essential step in the 
induction of LTP [182-184]. The increase in intracellular Ca2+ activates Ca2+/calmodulin-
dependent kinase II (CaMKII), resulting in the addition of more AMPA receptors in the 
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postsynaptic membrane [185-187]. This is an essential step in the expression of LTP [188-192], 
and AMPA receptor phosphorylation is likely involved [193-196]. The additional AMPA 
receptors may be locally inserted from intracellular pools and/or captured by the postsynaptic 
density from extrasynaptic receptors already in the membrane. While the precise mechanisms 
mediating the increase in AMPA receptors remain an active area of research, the presence of 
additional AMPA receptors in the postsynaptic membrane causes a given amount of glutamate 
release to elicit a potentiated response in the postsynaptic cell. 
 
AF 1.9. Long-term potentiation and long-term depression. (A) Example of long-term potentiation 
induced by a brief high frequency stimulation (50 Hz for 900 pulses). (B) Example of long-term 
depression induced by a longer low frequency stimulation (3 Hz for 900 pulses). (Adapted from 
[197]). 
 
VIII.d. Long-term Depression  
Much like LTP, long-term depression (LTD) consists of multiple forms found in many 
different cell types and brain regions (reviewed in [198-200]). This chapter covers NMDA 
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receptor-dependent LTD in the hippocampus. LTD is a long-lasting, activity-dependent change 
in the efficacy of a synapse that results in a depressed postsynaptic response to a given 
presynaptic stimulus. It can be induced by prolonged low-frequency stimulation (AF 1.9B) 
[197]. As in LTP, this form of LTD requires both AMPA and NMDA receptors and is dependent 
on Ca2+ entry through unblocked NMDA receptors [197, 201-205]. Long duration, low-
frequency synaptic stimulation results in a consistent, long-lasting, but smaller Ca2+ influx than 
the large, short-lived Ca2+ influx that causes LTP. This lower [Ca2+] does not activate CaMKII 
[204]. Instead, it activates the phosphatases calcineurin and protein phosphatase 1 [66, 204, 206-
208]. These phosphatases modify the phosphorylation state of AMPA receptors [196, 204, 209, 
210] and tag them for internalization by clathrin and dynamin-dependent endocytosis [211-214]. 
The decrease in the number of AMPA receptors causes a depressed postsynaptic response. The 
structural changes in the number of postsynaptic AMPA receptors following either LTP or LTD 
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